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Abstract 
Technologies that enable scientists to record and modulate neural activity across spatial scales are 
advancing the way that neurological disorders are diagnosed and treated, and fueling breakthroughs in 
our fundamental understanding of brain function. Despite the rapid pace of technology development, 
significant challenges remain in realizing safe, stable, and functional interfaces between manmade 
electronics and soft biological tissues. Additionally, technologies that employ multimodal methods to 
interrogate brain function across temporal and spatial scales, from single cells to large networks, offer 
insights beyond what is possible with electrical monitoring alone. However, the tools and methodologies 
to enable these studies are still in their infancy. Recently, carbon nanomaterials have shown great 
promise to improve performance and multimodal capabilities of bioelectronic interfaces through their 
unique optical and electronic properties, flexibility, biocompatibility, and nanoscale topology. 
Unfortunately, their translation beyond the lab has lagged due to a lack of scalable assembly methods for 
incorporating such nanomaterials into functional devices. In this thesis, I leverage carbon nanomaterials 
to address several key limitations in the field of bioelectronic interfaces and establish scalable fabrication 
methods to enable their translation beyond the lab. First, I demonstrate the value of transparent, flexible 
electronics by analyzing simultaneous optical and electrical recordings of brain activity at the microscale 
using custom-fabricated graphene electronics. Second, I leverage a recently discovered 2D nanomaterial, 
Ti3C2 MXene, to improve the capabilities and performance of neural microelectronic devices. Third, I 
fabricate and validate human-scale Ti3C2 MXene epidermal electrode arrays in clinical applications. 
Leveraging the unique solution-processability of Ti3C2 MXene, I establish novel fabrication methods for 
both high-resolution microelectrode arrays and macroscale epidermal electrode arrays that are scalable 
and sufficiently cost-effective to allow translation of MXene bioelectronics beyond the lab and into clinical 
use. Thetechnologies and methodologies developed in this thesis advance bioelectronic technology for 
both research and clinical applications, with the goal of improving patient quality of life and illuminating 
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ABSTRACT 
BUILDING AND VALIDATING NEXT-GENERATION NEURODEVICES 
USING NOVEL MATERIALS, FABRICATION, AND ANALYTIC 
STRATEGIES 
Nicolette Driscoll 
Flavia Vitale  
Brian Litt 
 
Technologies that enable scientists to record and modulate neural activity across 
spatial scales are advancing the way that neurological disorders are diagnosed and treated, 
and fueling breakthroughs in our fundamental understanding of brain function. Despite the 
rapid pace of technology development, significant challenges remain in realizing safe, stable, 
and functional interfaces between manmade electronics and soft biological tissues. 
Additionally, technologies that employ multimodal methods to interrogate brain function 
across temporal and spatial scales, from single cells to large networks, offer insights beyond 
what is possible with electrical monitoring alone. However, the tools and methodologies to 
enable these studies are still in their infancy. Recently, carbon nanomaterials have shown 
great promise to improve performance and multimodal capabilities of bioelectronic 
interfaces through their unique optical and electronic properties, flexibility, biocompatibility, 
and nanoscale topology. Unfortunately, their translation beyond the lab has lagged due to a 
lack of scalable assembly methods for incorporating such nanomaterials into functional 
devices. In this thesis, I leverage carbon nanomaterials to address several key limitations in 
the field of bioelectronic interfaces and establish scalable fabrication methods to enable their 
translation beyond the lab. First, I demonstrate the value of transparent, flexible electronics 
by analyzing simultaneous optical and electrical recordings of brain activity at the microscale 
using custom-fabricated graphene electronics. Second, I leverage a recently discovered 2D 
nanomaterial, Ti3C2 MXene, to improve the capabilities and performance of neural 
microelectronic devices. Third, I fabricate and validate human-scale Ti3C2 MXene epidermal 
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electrode arrays in clinical applications. Leveraging the unique solution-processability of 
Ti3C2 MXene, I establish novel fabrication methods for both high-resolution microelectrode 
arrays and macroscale epidermal electrode arrays that are scalable and sufficiently cost-
effective to allow translation of MXene bioelectronics beyond the lab and into clinical use. The 
technologies and methodologies developed in this thesis advance bioelectronic technology 
for both research and clinical applications, with the goal of improving patient quality of life 
and illuminating complex brain dynamics across spatial scales.  
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Chapter 1: Introduction 
Since the first evidence of electrical activity in the nervous system was observed by 
Luigi Galvani in the 1790s, a host of technologies have evolved to enable recording and 
modulating electrical activity in excitable tissues. These technologies have enabled 
breakthroughs in our understanding of brain function and neuropathologies, have provided 
diagnostic and therapeutic tools for diseases such as epilepsy and Parkinson’s disease, and 
have even enabled locked-in patients to control external effectors through brain computer 
interfaces (BCIs) to regain some independence. 
Today, neurotechnologies are shedding new light on the fundamental mechanisms 
governing the structure and function of neural circuits, which is essential to advance 
diagnostics and therapies for debilitating neurological diseases and disorders. In epilepsy, for 
example, targeted therapies such as surgical resection, thermal ablation, or responsive 
neurostimulation rely on precise localization of seizure onset regions to be effective. 
Currently, these seizure onset regions are identified by a combination of electrophysiological 
recordings from mm-scale implanted electrodes, non-invasive imaging techniques such as 
magnetic resonance imaging (MRI) and positron emission tomography (PET), and through 
observing seizure semiology. These techniques offer limited spatial resolution, however, and 
a growing body of literature suggests that seizure activity may begin at the scale of neural 
microcircuits, which current clinical technologies cannot observe [1]–[3]. Thus, there is great 
interest in observing the cell and microcircuit level dynamics of seizure initiation and linking 
these to the macroscale, brain-wide activity observed with current clinical technologies. This 
notion of recording neural activity across spatial scales is critical for improving our 
understanding and targeting of therapies not only for epilepsy, but for many neurological 
diseases and disorders, and it was one of the primary motivations for the BRAIN Initiative 
launched in 2013.  
There remain significant technological hurdles to achieving this goal, many of which 
stem from challenges associated with interfacing manmade electronics with soft biological 
tissues such as the brain. Recently, carbon nanomaterials such as graphene and carbon 
nanotubes have shown significant promise for improving the electrical properties, flexibility, 
biocompatibility, and multimodal capabilities of tissue-interfacing electrodes. Despite their 
promise, a lack of scalable assembly methods for producing devices using nanomaterials has 
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so far been a significant barrier to their translation and widespread adoption. The goal of this 
thesis is to develop new technologies for mapping and modulating neural and neuromuscular 
activity across spatial scales by leveraging the unique properties of carbon nanomaterials and 
by establishing scalable fabrication methods that will enable translating these technologies 
beyond the lab and into clinical and consumer use. 
At one end of the spatial scale, tools and techniques have been evolving to observe 
brain activity at the cellular level. In particular, the rise of optogenetics has enabled optical 
imaging and modulation of targeted cell types in the brain to discern the functions of different 
cell assemblies [4]. Optical imaging techniques, such as calcium imaging, enable observing 
activity with high spatial resolution, however their temporal resolution is limited by the 
kinetics of the fluorescent reporter molecules and it remains challenging to image at high 
resolution across a broad field of view [5]. Electrophysiology with microelectrodes offers a 
complimentary approach, with high temporal resolution but sparse spatial sampling. 
Combining these two recording modalities presents a unique opportunity to harness the 
spatial resolution of optical imaging along with the temporal resolution of electrophysiology, 
however this requires imaging and recording simultaneously in the same location. This is not 
possible using conventional microelectrode arrays utilizing opaque materials, as these block 
optical access and suffer from photoelectric artifacts. Recently, progress in transparent 
microelectrode array technology, predominantly utilizing graphene, has enabled such 
multimodal studies [6]–[9]. However, innovation is still needed in experimental and 
analytical methods to fully realize their potential. So far, these multimodal studies have 
mainly focused on 2-photon imaging either from brain slices or from the cortical surface of 
anesthetized animals. This approach offers a limited field of view that may fall beneath only 
one or a small number of the transparent electrodes. Thus, there is a need to establish new 
experimental methods enabling broader area coverage to observe brain dynamics across 
spatial scales relevant in epilepsy. Additionally, new analytical approaches are needed to link 
the spatial and temporal information contained in the two modalities. In Chapter 3 of this 
thesis, I build upon previous work to improve the performance of transparent graphene 
electronics, I establish new experimental techniques for multimodal recording across a mm-
scale area of cortex, and I develop a framework for combining data features from optical and 
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electrical domains. Taken together, these advances offer the ability to study neural circuits 
with unprecedented spatiotemporal resolution, making it possible to link cell-level behavior 
to broader network oscillations. 
While graphene offers excellent optical transparency for multimodal studies, these 
electrodes cannot be scaled down to cellular dimensions to record individual neuron spiking 
activity because they are hindered by high impedance. Thus, it has not yet been possible to 
record one-to-one optical and electrical spiking activity of individual cells except through the 
use of cumbersome patch pipettes. This highlights one of the main challenges in achieving 
high density neural recording from microelectrodes, even setting aside optical transparency 
requirements. Microelectrodes suffer from a trade-off between geometric surface area and 
interface impedance: as electrodes are scaled down to cellular dimensions, a concurrent rise 
in their impedance causes a degradation in recorded signal quality [10]. This challenge is 
often addressed by increasing the effective surface area over which ionic species can interact 
with the electrode without increasing the geometric area. This can be achieved through 
nanopatterning [11], surface roughening [12], or electroplating with porous additives [13] 
and has led to significant interest in the use of nanomaterials to achieve nanoscale topology 
[14]–[16]. Though nanomaterials have shown great promise for improving microelectrode 
performance, due to their intrinsically high specific surface areas and their favorable 
electronic properties, incorporating these materials into flexible substrates has proven 
challenging. For example, graphene and carbon nanotubes must be synthesized through high-
temperature chemical vapor deposition processes which are incompatible with flexible 
polymeric substrates, and thus require tedious manual steps to transfer and pattern films 
after their growth [17].  
Recently, a newly discovered family of 2D nanomaterials, MXenes, have attracted 
interest for applications in energy storage [18], electromagnetic interface shielding [19], and 
supercapacitors [20] owing to their exceptional electronic, thermal, and mechanical 
properties. Of the dozens of MXenes that have been discovered, Ti3C2 has been the most 
extensively characterized and optimized, and it exhibits remarkably high electronic 
conductivity (~15,000 S/cm) [21] and volumetric capacitance (1500 F/cm3) [22]. Ti3C2 also 
contains abundant surface-terminating functional groups, such as hydroxyl (–OH), oxygen    
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(–O), and fluorine (–F), which endow it with a hydrophilic nature and allow for flexible 
surface modification and functionalization. These unique properties make Ti3C2 an appealing 
candidate for improving neural microelectrode performance, while also enabling the use of 
simple and scalable solution processing methods which are more practical than those 
required to use other carbon nanomaterials. In Chapter 4 of this thesis, I develop a fabrication 
method to produce microelectrodes of Ti3C2 MXene, and I demonstrate their effectiveness for 
high-resolution neural recording, the first-ever demonstration of any MXene for in vivo 
electrophysiology. I show that Ti3C2 microelectrodes possess exceptionally low 
electrochemical impedance and improved signal quality compared to gold electrodes, thus 
identifying Ti3C2 as a promising new bioelectronic material.  
While Chapters 3 and 4 of this thesis focus on microscale interrogation within the 
brain, macroscale electrodes deployed across the body can offer a broader view of activity 
and key capabilities for medical therapeutics, healthcare monitoring, and wearable devices. 
For example, non-invasive epidermal electronics can offer important insights into the 
function of the heart (via electrocardiography; ECG), muscles (via electromyography; EMG), 
nerves (via nerve-conduction studies), and brain (through electroencephalography; EEG). 
Additionally, active bioelectronic devices capable of delivering targeted electrical stimulation 
can be used to treat a number of conditions, including neurological diseases [23], [24], heart 
arrythmias [25], [26], and inflammatory disorders [27], [28]. The promise of such devices has 
fueled a revolution in “bioelectronic medicine”, where electrical modulation of neural 
circuitry is used in place of pharmacotherapy [29].  
In both passive recording and active stimulation devices, conventional materials and 
fabrication processes still remain inadequate for producing high-density multielectrode 
arrays that can map and modulate activity in excitable tissues at high spatiotemporal 
resolution and over broad areas. For example, in epidermal electronics achieving low 
electrode-skin interface impedance has proven a key challenge that has limited the spatial 
resolution of epidermal interfaces. Typically, these interfaces require a conductive gel to 
reduce the impedance, and these gels are problematic on many fronts: they can be irritating 
to the skin [30], they leave unwanted residues in the hair, they can short neighboring 
electrodes and thus limit high density recording, and they dry out over time, causing changing 
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electrode impedances and preventing practical long-term monitoring. New materials may 
hold the key for overcoming this and other crucial challenges.  
In Chapter 5, I develop a highly scalable method for producing large-area, high-
density Ti3C2 MXene multielectrode arrays − which we name MXtrodes − of arbitrary size and 
geometry for varied bioelectronic applications. I perform a comprehensive evaluation of the 
electrochemical properties of the MXtrodes relevant for recording and stimulation of 
excitable tissues, and I show that they are comparable, and in many aspects superior to, 
conventional bioelectronic materials, especially in the context of delivering charge for safe 
and effective electrical stimulation. I demonstrate MXtrodes of different scales and 
geometries for mapping and modulating excitable networks in different applications, 
including scalp electroencephalography (EEG), electromyography (EMG), 
electrocardiography (ECG), electrocorticography (ECoG), and neural stimulation. Notably, I 
show that mm-scale MXtrodes achieve low electrode-skin interface impedance without any 
conductive gel, enabling high-density epidermal electronics. Finally, I characterize the 
compatibility of MXtrodes with clinical imaging modalities and demonstrate artifact-free 
high-field magnetic resonance and computed tomography imaging. MXtrodes represent a 
new class of flexible, multichannel, high-density bioelectronic interfaces which leverage the 
exceptional properties of Ti3C2 MXene to enable human-scale, clinically-translatable 
neurodevices that show great promise for numerous applications in healthcare, research, and 







Chapter 2: Background 
2.1 The promise of bioelectronics  
Devices which can record and modulate electrical activity in the brain and other 
excitable tissues are a mainstay for medical diagnostics and monitoring and increasingly for 
therapeutic interventions. They are key tools in neuroscience research, allowing scientists to 
decipher the neural basis of movements, behaviors, and even abstract thoughts. They are 
enabling a revolution in at-home health and activity monitoring via wearable devices and 
have allowed the development of brain-computer interfaces to restore lost functions. In 
recent years, there has also been growing interest in the use of neuromodulation as a 
treatment option for a number of chronic diseases as a complementary approach to 
traditional pharmacotherapy, a concept known as bioelectronic medicine [29].  
In the field of medical diagnostics and monitoring, the use of electrodes to monitor 
electrical activity in the body is not new. The first ECG was recorded by Willem Einthoven in 
1902 [31], and the first EEG recordings were performed by Hans Berger in 1924 [32]. Since 
that time, both techniques have become mainstays of clinical care. In addition to these 
noninvasive recording methods, techniques in which electrical activity is recorded directly 
from brain tissue have become essential for informing resection surgeries for brain tumors 
and epilepsy treatment. Intraoperative recordings can help a surgeon distinguish between 
healthy and pathologic tissue during a tumor resection surgery, and long-term recordings 
from implanted electrocorticography electrodes in epilepsy patients can help identify seizure 
foci to target resection surgery. These are just a few examples of the numerous ways in which 
electrophysiologic recording is used in clinical medicine.  
In addition to passive recording, modulating activity through electrical stimulation 
has also become a key therapeutic approach. The first demonstration of this notion was the 
invention of the cardiac pacemaker in 1952, with the earliest implants in human beings 
carried out between 1958 and 1960 [33]. Since then, stimulation devices have been 
developed for the brain and peripheral nerves to treat a variety of diseases. Deep brain 
stimulation (DBS), which delivers consistent electrical stimulation to focal areas within the 
brain, was approved in the U.S. in 2002, and it has been heralded as providing “a new life for 
people with Parkinson’s disease” as it can effectively eliminate debilitating tremor and other 
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motor symptoms [34]. While the exact mechanisms for how DBS achieves its effects are still 
not fully understood, this approach has shown so much promise that it is currently being 
evaluated for treating a number of additional disorders, including dystonia, depression, 
multiple sclerosis, and obsessive compulsive disorder. Stimulation of nerves can achieve 
similar effects, and one such example is vagus nerve stimulation (VNS), which was approved 
in the U.S. in 1997 for the treatment of medically refractory partial-onset seizures. Like DBS, 
VNS has also gained attention as a potential treatment option for numerous disorders beyond 
its initial indication, including depression, mood disorders, migraines, and inflammatory 
disorders such as rheumatoid arthritis, diabetes, and cardiovascular disease [35]. More 
recently, closed-loop neuromodulation systems have emerged which are capable of 
monitoring activity and delivering electrical stimulation only when needed, rather than 
constantly stimulating. These devices, which are likened to “pacemakers for the brain”, have 
shown great promise for the treatment of medically refractory epilepsy by sensing the onset 
of abnormal brain activity and stimulating to inhibit seizure initiation [36].   
In recent years, bioelectronics have also enabled the development of brain-computer 
interfaces (BCIs) which can restore lost sensory or motor functions. For example, cochlear 
implants have proven effective for restoring partial hearing to the deaf [37], and retinal 
prostheses have been developed for restoring limited vision to the blind [38]. These devices 
relay signals from external sensors to small, implanted electrodes which stimulate the 
sensory cells in the cochlea and retina, respectively. For patients suffering from paralysis or 
locked-in syndrome, motor BCIs capable of decoding movement intention from electrodes 
placed in motor areas of the brain and translating this into the movement of an external 
effector, such as a computer cursor or a robotic arm, offer great promise for restoring some 
independence and greatly enhancing quality of life [39].  
Beyond their uses in clinical medicine, bioelectronics are increasingly finding their 
way into consumer use in the form of wearable devices. While many of these devices sense 
signals other than the biopotentials which are the main focus of this work, including 
temperature, motion, and metabolites in sweat, there are growing applications where 
monitoring of electrophysiologic signatures is useful. For example, heart rate monitors have 
been used by athletes for decades but sensors that now collect the full ECG waveform are 
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increasingly being incorporated into smartwatches to check for abnormal heart rhythms. 
There has also been increasing interest in consumer-grade EEG headsets for monitoring 
stress and attention, for enabling “brain training” with neurofeedback, for tracking sleep and 
meditation, and even for brain-controlled videogaming [40], [41]. Wearable EMG sensors 
have also gained attention for monitoring muscle activity during exercise to tune sports 
performance [42].  
Finally, it is difficult to overstate the importance of devices for recording and 
modulating the activity of excitable tissues in neuroscience research. Such devices have 
contributed in profound ways to our understanding of the nervous system and other 
excitable tissues, from the level of individual cell behavior up to large scale network activity. 
To choose just one notable example, the development of microelectrodes in the 1950s 
allowed “micromapping”: precisely mapping regions of the cortical surface that 
corresponded to particular sensory and motor areas on the body. Through a series of 
micromapping experiments in monkeys, Michael Merzenich showed that the cortical maps 
corresponding to individual fingers were plastic and would rearrange in response to the 
amputation of a finger [43]. These and other experiments using microelectrodes eventually 
gave rise to the concept of neuroplasticity, overturning the longstanding belief that the adult 
brain was static and leading to revolutionary new therapies for deficits in speech, language, 
memory, and reading which had been believed to be untreatable.  
The numerous examples of bioelectronic interfaces outlined in this section highlight 
the tremendous potential of these technologies for applications across healthcare, research, 
and consumer electronics. At their core, such technologies all rely on an interface between 
manmade electronics and biological tissues. Improving the properties of this interface is one 
of the core themes of this thesis work.  
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2.2 Methods for neural recording and modulation  
“There are only a handful of tools at the neuroscientist’s disposal to monitor 
brain activity without seriously interfering with it. Can we finish the job with 
these tools alone? Maybe not, but for now, we have to live with them and 
believe that we will not fail or falter. Each of the existing methods is a 
compromise between spatial and temporal resolution. The desired temporal 
resolution is the operation speed of neurons, that is, the millisecond scale. The 
desired spatial resolution depends on the goal of the investigation and 
expands from the global scale of the brain down to the spines of individual 
neurons. No current method is capable of continuously zooming from the 
decimeter to the micrometer scale, which is why several methods are being 
used, often in combination.”  
− Gyorgy Buzsaki [44] 
There are numerous methods for recording and modulating the activity of the brain 
and other excitable tissues, and as Gyorgy Buzsaki so nicely stated, they each offer a specific 
range of temporal and spatial resolution. These methods span multiple modalities, including 
electrical, optical, magnetic, acoustic, and chemical. The work of this thesis focuses on the 
electrical and optical domains, however in this section I will provide a brief overview of the 
numerous approaches for neural recording and modulation. I will focus on methods primarily 
applied to the study of the brain, however many of these approaches can be extended to the 
study of the peripheral nervous system. A useful schematic depicting the spatiotemporal 
resolution of some of these methods is shown in Figure 2.1.  
2.2.1 Electrical  
The origin of extracellular fields and currents 
Activity within the nervous system is a complex interplay of electronic and chemical 
signaling. The primary information-encoding cells in the nervous system are neurons, though 
glial cells also play important roles. Neurons communicate with each other by firing action 
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potentials (APs), also called “units” or “spikes”, which result in the release of chemical 
neurotransmitters at synapses, which in turn influence the behavior of other neurons. During 
an action potential, voltage-gated ion channels embedded in the cell membrane facilitate a 
coordinated pattern of Na+ ion influx into the cell, followed by K+ ion outflux, resulting in a 
large amplitude voltage spike ~1 ms in duration which is largest in amplitude near the soma 
(Figure 2.2). Even when neurons are not firing APs, smaller ionic currents at the postsynaptic 
membrane, called excitatory or inhibitory postsynaptic potentials, affect the neuron’s 
membrane potential, causing it to deviate from its resting state of approximately -70 mV. 
These voltage fluctuations are much smaller than those of APs, but they last for 10s of 
milliseconds and contribute significantly to the extracellular field. 
Figure 2.1 The spatiotemporal domain of neuroscience methods. Each colored region represents 
the useful domain of spatial and temporal resolution for one method available for the study of the 
brain. Open regions represent measurement techniques; filled regions represent perturbation 
techniques. Inset, a cartoon rendering of the methods available in 1988, notable for the large gaps 
where no useful method existed. Regions allocated to each domain are somewhat arbitrary and 
represent estimates. From [375]. 
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At any point in the extracellular space, the measured potential Ve is the superposition 
of all ionic processes, from fast action potentials, to synaptic currents and Ca2+-mediated 
spikes, to even slow fluctuations in glia. This potential is often referred to as the local field 
potential (LFP) when recorded on the cortical surface. The voltage arising from any 
transmembrane current, assuming a current dipole, decays as 1/r2, where r is the distance 
between the recording electrode and the source current [45]. Another consistent feature of 
extracellular potential is that the magnitude of the power (or the square of the Fourier 
amplitude), is inversely related to temporal frequency f. This 1/f power scaling relation is 
attributed in part to the low-pass frequency filtering properties of dendrites [46], as well as 
to broader network mechanisms: in a brief time window only a limited number of neurons 
can be recruited in a given volume, whereas in a longer time window the activity of many 
more neurons can contribute to the LFP, generating a larger amplitude LFP at slower 
frequencies [45].  
Figure 2.2 Extracellular contribution of an action potential (“spike”) to the LFP. The peak-to-
peak voltage range is indicated b the color of the traces. Note that the spike amplitude decreases 
rapidly with distance from the soma. Note the widening of the spike with distance from the soma, 
owing to greater contributions from dendritic currents and intrinsic filtering of high-frequency 
currents by the cell membrane. From [45]. 
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In measuring extracellular potentials, it is important to keep these relations in mind 
as both the size of the electrode and its distance from the active neurons will affect the signal 
content. Importantly, the Ve that is measured by an electrode reflects a spatial average of the 
activity near the electrode. Thus, electrodes record a “spatiotemporally smoothed” version of 
the extracellular potential integrated over their surface, and a larger electrode will record 
less high frequency signal content corresponding to individual neuron activity. A summary of 
the various scales of neural recording and their frequency content is shown in Figure 2.3. 
Macroscale recording: Scalp EEG  
Scalp electroencephalography is one of the oldest and most widely used methods for 
investigating the electric activity of the brain. EEG electrodes are typically ~10 mm in 
diameter, and the signals they detect represent only the largest, most synchronous neural 
signals since they must travel through the brain, cerebrospinal fluid, skull, and scalp before 
reaching the electrode. The skull and scalp act as low-pass filters, thus the EEG typically 
retains little high frequency content and little relationship to the firing patterns of the 
Figure 2.3 Methods for brain recording at different scales. Several types of brain signals can be 
recorded from noninvasive and invasive electrodes: EEG signals are recorded from the scalp, ECoG  
from the brain surface, and spikes from brain-penetrating electrodes. From [376]. 
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contributing individual neurons [47]. The spatial resolution of EEG is inherently quite poor, 
however computational methods for source localization can give theoretical approximations 
for the areas of cortex responsible for the activity recorded on the scalp [48], [49].  
Mesoscale recording: Intracranial EEG 
When EEG recordings are obtained with intracranial electrodes, it is referred to as 
intracranial EEG (iEEG). This can be in the form of electrocorticography (ECoG) using grids 
and strips of electrodes placed subdurally onto the surface of the brain, or stereotaxic EEG 
(sEEG) using thin penetrating electrodes placed into deeper targets within the brain. These 
techniques are used in patients with drug-resistant epilepsy, for whom surgical resection of 
seizure foci may offer seizure freedom. Typically, these patients are implanted with a number 
of ECoG and sEEG electrodes, then weaned off of their antiepileptic medications and 
continuously monitored in the hospital with the goal of recording seizures or abnormal 
interictal activity that can help to localize the patient’s seizure foci. iEEG recordings offer 
much higher resolution than EEG and they can resolve a wider range of frequency content 
due to their placement directly on the surface (ECoG) or within (sEEG) the brain. ECoG 
electrodes are typically Pt or stainless steel flat electrodes 2.3 mm in diameter with a 10 mm 
pitch between contacts, while sEEG electrodes are typically cylindrical contacts ~2mm in 
length spaced along a probe ~1 mm in diameter [50]. Using known estimates of the number 
of neurons per cortical area along with the size of these electrodes, it can be assumed that 
there are ~500,000 cells beneath or surrounding one of these electrodes [51]. Still, iEEG 
signals typically contain information in frequency bands ranging from delta (1-3 Hz) all the 
way up to high-gamma activity (60-250 Hz), which is a correlate of averaged neuronal spiking 
activity [52].  
Microscale recording: Microelectrodes 
In the electrical domain, microelectrodes offer the highest spatial and temporal 
resolution for recording and stimulating neural activity. They are typically <100 µm in 
dimension and can resolve the spiking activity of individual neurons. Microelectrodes were 
originally developed as research tools for academic investigation into the neural mechanisms 
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that regulate attention, movement, and behavior. They fall into three general categories: (1) 
microwire arrays, (2) microfabricated planar arrays, and (3) micromachined arrays (Figure 
2.4). Microwire electrodes are typically conductive core wires, with an insulation layer such 
as glass, parylene, or polyimide coating the wire except at the very tip, where the recording 
contact is located. Multiple microwires can be arranged into an array, typically requiring 
manual assembly [53] (Figure 2.4a). 
Planar microelectrode arrays (Figure 2.4b) are typically produced using 
microfabrication techniques drawn from the well-established methods of the semiconductor 
industry, and these include both surface micro-ECoG (µECoG) arrays and penetrating shank 
arrays. µECoG arrays typically consist of thin metal films patterned through photolithography 
on polymer substrates. Achieving high electrode density on a surface µECoG array to 
maximize spatial resolution has been quite challenging due to the need to wire out the signals 
from each individual electrode, however recent advances allowing the incorporation of active 
multiplexing electronics onto such arrays have pushed the limits of µECoG resolution [54] 
(Figure 2.5a). Additionally, surface µECoG arrays typically cannot resolve individual neuron 
APs because the neuronal cell bodies that generate them are located ~100s of micrometers 
deep in the cortex, however recent work has shown that unit activity can be recorded from 
Figure 2.4 Classes of implantable microelectrodes. (a) 50 µm polyimide-insulated tungsten 
microwires with chiseled tips (Tucker-Davis Technologies). (b) Microfabricated silicon planar 
Michigan array with iridium electrode sites (NeuroNexus Technologies). Scale bar: 100 µm. (c) 
Micromachined boron-doped silicon array (Blackrock Microsystems). Scale bar: 400 µm. From [377]. 
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the cortical surface with electrodes that are sufficiently small (~10 µm2 in size) and low in 
impedance [55] (Figure 2.5b-d). The other class of planar microelectrode arrays are 
penetrating shank arrays. These are typically fabricated on rigid silicon substrates, with 
multiple electrode contacts along the length of the shank. This enables recording neural 
activity at multiple depths spanning the cortex or other brain areas with just a single probe 
inserted. Recently, the use of complementary metal-oxide-semiconductor (CMOS) processing 
has enabled pushing the bounds of electrode density on these planar depth electrodes to 
unprecedented new limits. The Neuropixels probe unveiled in 2017 offers 384 recording 
channels, programmably addressable from a selection of 960 possible recording sites along 
a 10 mm-long, 70 x 20 µm cross-section shank, the highest density electrode array reported 
to date [56].  
The final main class of microelectrodes are micromachined arrays. These are similar 
to microwire arrays in that each “probe” contains a single electrode contact located at its tip, 
however they are produced by micromachining a block of silicon into an array of needle-like 
probes. This “bed of nails” type electrode array was introduced in the late 1990s and became 
known as the Utah array [57]. Today’s version of the Utah array offers 100 penetrating 
electrode contacts within a 2 x 2 mm area, and it is the only microelectrode array that has 
been approved for human use in the U.S. This had made the Utah array central in human BCI 
Figure 2.5 Advanced µECoG array technologies. (a) Actively multiplexed high-density µECoG array. 
Active transistors within the array allow for sampling from 360 electrodes with just 40 wires. From 
[54]. (b-c) NeuroGrid high-density µECoG array. 10 µm2 electrodes are arranged in 2x2 tetrode 
arrangement for isolation of individual neuronal spikes from the cortical surface. Scale bars: (b) 1 mm, 
(c) 1 mm, (d) 20 µm.  From [378].  
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research [58], despite the fact that its rigid needle-like architecture presents significant 
challenges for long-term recording reliability [59].  
Electrical stimulation 
While recording electrodes provide insight into the activity within the nervous 
system, they do not allow for control over its dynamics. Electrical stimulation is one way to 
perturb neural activity, both for research purposes (i.e. to see how the system responds to a 
change in stimuli) and also for therapeutic purposes (i.e. to inhibit or alter pathologic 
activity). As mentioned in section 2.1, electrical stimulation in the brain and peripheral 
nervous system has proven an effective therapy for Parkinson’s disease, depression, and 
many other conditions.  Electrical stimulation is non-selective, meaning that any excitable 
cells within the vicinity of the stimulation delivery will be affected. The amount of charge that 
can be safely delivered for electrical stimulation depends largely a quantity known as charge 
injection capacity (CIC), which depends on innate electrochemical properties of the electrode 
material, as well as the geometry and surface roughness of the electrode [60]. CIC will be 
discussed further in Section 2.4. Common materials for stimulation electrodes include 
platinum and platinum-iridium, though coatings of iridium oxide and titanium nitride are 
often used to improve the CIC of electrodes [61].  
2.2.2 Optical  
Calcium imaging  
Calcium imaging is a sensitive method for monitoring neuronal activity because most 
depolarizing electrical signals are associated with Ca2+ influx attributable to the activation of 
one or more of the numerous types of voltage-gated Ca2+ channels abundantly expressed in 
the nervous system [62]. These signals are often further amplified by Ca2+ release from 
intracellular Ca2+ stores. Fluctuations in intracellular Ca2+ concentration in response to cell 
activity can be observed using fluorescent indicators that exhibit altered fluorescent 
properties when bound with free Ca2+ ions. There are two general classes of Ca2+ indicators: 
genetically encoded fluorescent proteins and chemically engineered fluorophores [63]. 
Chemical Ca2+ indicator dyes, such as Orgeon Green BAPTA provide large signal-to-noise 
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ratios, but they can be difficult to load into cells in intact tissue, they can compartmentalize 
into cellular organelles, and they leak out of cells over longer recording periods, making 
chronic imaging infeasible [64]. Genetically encoded Ca2+ indicators (GECIs), such as the 
GCaMP family, have the advantage of genetic targeting so that imaging can be performed with 
only specific cell types containing the Ca2+ indicator. They also do not suffer from the 
challenges that prevent chronic imaging with synthetic dyes. There have been many types of 
Ca2+ indicators developed over the years, and they each have slightly different Ca2+ binding 
affinity, excitation/emission wavelengths, and signal-to-noise ratios [62]. A few key 
limitations of calcium imaging techniques include: (i) their temporal resolution is limited by 
the kinetics of Ca2+ binding and unbinding from the fluorescent indicators, as well as by the 
speed of the imaging instrumentation such that neuronal action potentials cannot be clearly 
resolved [5], (ii) it is challenging to image at high resolution across a broad field of view [65], 
(iii) due to light scattering in tissue, it is difficult to image deep structures, although new 
implantable GRIN lens scopes have improved these capabilities [66], and (iv) calcium 
transients are an indirect measure of neuronal activity.  
Voltage imaging  
Another technique for observing neural activity is the use of voltage-sensitive 
fluorescent indicators. These enable direct imaging of voltage, which is an attractive method 
for studying neural circuits [67]. Small molecule voltage-sensitive fluorescent indicators 
generally fall into two classes: electrochromic-type dyes which posses fast response speeds 
sufficient to track action potentials but with low sensitivity, and oxonols, which have larger 
fluorescent responses to voltage but respond too slowly to visualize discrete action potentials 
[68]. Voltage imaging offers a direct measure of neural activity, in contrast to the indirect 
measure of calcium transients in Ca2+ imaging, and it is capable of resolving the fast dynamics 
of individual action potentials. However, voltage imaging has several inherent challenges 
which have limited its widespread adoption. First, to resolve action potentials the speed of 
image acquisition must be fast, on the order of 1000 Hz to accurately sample action potentials, 
while acquisition speeds for Ca2+ imaging can be in the range of 1-10 Hz [68]. This means that 
voltage indicators have less time to deliver photons to the imaging detector, making each 
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measurement inherently noisier. Achieving fast acquisition speeds while maintaining a large 
field of view is also a significant challenge for imaging instrumentation. Also, voltage 
indicators must localize to the plasma membrane to properly sense voltage, in contrast to 
Ca2+ indicators which are localized to the cytosol. This makes it challenging to segment 
adjacent cells in the image processing to resolve activity from individual cells [68]. Finally, 
voltage imaging is hindered by background autofluorescence and signal decay by 
photobleaching [69]. A comparison of voltage imaging to Ca2+ imaging is shown in Figure 2.6.  
Optogenetics  
Optogenetics is a powerful technique that enables modulating the activity of 
genetically-targeted cell types with light. It involves manipulating neurons so that they 
express genes taken from algae that encode light-sensitive ion channels and pumps, called 
opsins. In the first key demonstration in 2005, the gene encoding channelrhodopsin-2 (ChR2) 
was delivered to neurons via a lentivirus vector, and subsequently these neurons could be 
induced to fire action potentials upon delivery of millisecond-timescale pulses of blue light 
[70]. Since that initial demonstration, the optogenetics toolkit has been expanded to include 
Figure 2.6 Comparison of voltage and Ca2+ imaging in neurons. (a) Ca2+ (green) and voltage 
(magenta) responses to single, spontaneous action potentials in the same rat hippocampal neuron, as 
recorded by GCaMP6s (green) and the voltage-sensitive dye RhoVR 1 (magenta). Panels (b) and (c) 
depict the neuron (white star) analyzed in panel (a). Scale bar: 20 µm. Adapted from [379]. 
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opsins that mediate neural activation with green and red light, and light-sensitive chloride 
pumps that act as inhibitory opsins, among others [71]. Optogenetics has made it possible to 
causally probe the contributions of specific cell types to neural circuits, since activation and 
silencing of those specific cells can reveal the impact they have on the generation of behaviors 
and pathologies. The ability to selectively perturb the activity of specific cell types is a key 
advantage for optogenetics over electrical stimulation, which is nonspecific.  
One of the primary challenges in optogenetics is that the visible light needed for opsin 
activation is scattered and absorbed by neural tissue. The mean scattering length for visible 
light in biological tissues is on the order of 100s of micrometers, though it is slightly higher 
for infrared light [72]. Thus, methods of light delivery to the brain have become a key research 
area. Approaches include implantable optical fibers [73], implantable probes with integrated 
optical waveguides [74] or micro-LEDs [75], and more exotic methods such as ultrasonic 
guiding of light [76]. Even more recently, methods have been evolving for finely directing 
light stimulation using spatial light modulation to enable studies with single-cell targeting 
precision [77].  
Optogenetics has proven a powerful technique in neuroscience research, and it is still 
in the early years of its adoption. An open question that remains is how optogenetic tools 
might someday be used clinically. It is still too early to know whether the opsin genes will be 
well tolerated in the human body, especially over long timescales. Even so, one promising 
candidate for optogenetics-based treatment in humans is retinitis pigmentosa, which is 
attractive because the retina is both immune-privileged and allows simple light delivery 
through the eye [78]. 
2.2.3 Magnetic  
Imaging  
Magnetic fields are perhaps the only modality that can access arbitrarily deep tissues 
with little signal attenuation, due to the low magnetic susceptibility of biological tissues [79]. 
Functional magnetic resonance imaging (fMRI) exploits the differences between the magnetic 
properties of oxygenated and deoxygenated hemoglobin to measure local increases in blood 
flow that accompanies neural activity [80]. It is a noninvasive method that allows whole-brain 
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imaging, however it has limited spatial and temporal resolution and it an indirect metabolic 
correlate of neural activity. The spatial resolution is primarily defined by the voxel size, which 
is on the order of ~1 mm3 or larger, and the signal-to-noise ratio of the acquired data [81]. 
The temporal resolution is on the order of ~1 s, and it is limited both by the image sampling 
rate and the inherently slow hemodynamic response time [82]. Despite its relatively poor 
spatiotemporal resolution, fMRI has enabled many insights into the functions of specific 
regions in the human brain and their contributions to different cognitive processes.  
Modulation 
In addition to enabling non-invasive, whole brain imaging, magnetic fields can be 
leveraged to modulate activity in the brain. Transcranial magnetic stimulation (TMS) is a 
technique in which magnetic fields with frequencies <1 kHz and amplitudes >1 T can 
inductively evoke ionic currents it order to non-invasively modulate brain activity through 
the skull [83]. TMS pulses are produced by sending a brief, high-current pulse through a coil 
of wire, which produces a transient magnetic field with lines of flux passing perpendicularly 
to the plane of the coil. This magnetic field in turn induces an electric field in the tissue, 
perpendicular to the magnetic field, which can excite neurons and induce currents [83]. 
Different coil geometries have been engineered to target the TMS stimulation area, however 
the spatial resolution is still limited to ~1 cm. TMS is most frequently used as a research tool 
to probe brain physiology, however it has also shown potential as a therapeutic option for 
treating depression and other psychiatric disorders [84].  
Another method for exploiting magnetic fields to achieve neuromodulation is the use 
of magnetic nanoparticles (MNPs) as transducers. There are two primary mechanisms by 
which MNPs can transduce magnetic fields into neural activation: magnetothermal and 
magnetomechanical. In the first, MNPs exposed to an alternating magnetic field generate heat 
through hysteresis, which in turn activates heat-sensitive cation channels in neurons to 
trigger action potentials [85]. In the second, iron-containing MNPs tethered to the cell 
membrane produce a torque on the membrane in the presence of magnetic fields, which 
triggers mechanosensitive cation channels in neurons to achieve neuromodulation [86]. In 
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contrast to neuromodulation using DBS or TMS, the use of these magnetic transducers allows 
modulation on the microscale, as well as cell-type specific targeting.  
2.2.4  Acoustic  
Ultrasound (US) is a form of acoustic energy that easily penetrates soft tissues at 
wavelengths on the order of ~100 µm. This allows US-based methods to deliver focused 
energy several centimeters deep into tissue, and with spatial precision corresponding to the 
wavelength [87]. Furthermore, sound waves propagate at speeds of ~1.5 km/s in soft tissue, 
which allows US to operate with temporal precision below 1 ms. These properties have made 
US a widely used technology in clinical medicine, and more recently have drawn attention in 
the neuroscience research community.  
Imaging  
 US has long been used as a tool for imaging soft tissues throughout the body. US 
imaging is a pulse-echo technique involving the transmission of brief pulses of US into tissue 
and recording the backscattered echoes from objects and interfaces in the tissue [87]. 
Scattering arises from materials with different density or compressibility relative to the 
surrounding medium, including tissue interfaces and blood cells. Although US is strongly 
attenuated by bone, brain imaging is possible through the intact skull in mice, and through 
cranial windows in other species. Recently, methods using ultrafast US have been 
demonstrated for visualizing hemodynamic correlates of neural activity in behaving animals 
with brain-wide coverage. The technique, known as functional US imaging (fUSI) can image 
cerebral blood flow with greatly enhanced temporal resolution compared to fMRI, and it has 
the added advantage that it can be used to image awake, behaving subjects (including during 
locomotion) by fixing a miniaturized US probe onto the skull [88].     
Modulation  
 The same properties that make US attractive for neural imaging also make it 
appealing for neuromodulation, including the ability of sound waves to penetrate deep into 
tissues and achieve high spatiotemporal precision. For neuromodulation, US waves only need 
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to travel in one direction (backscattering is no longer important), which allows lower 
frequencies to be used which more easily travel through the intact skull, including the human 
skull [87]. In awake nonhuman primates and humans, focused ultrasound (FUS) applied to 
the brain has been shown to modify perception, behavior, and other neurophysiological 
responses [89]. The exact mechanisms by which FUS achieves its neuromodulatory effects 
are not fully understood, but it is believed to act through mechanical force on neurons, 
transduced by mechanosensitive ion channels [90]. More work is needed to explore the safety 
and efficacy of FUS for neuromodulation, but it offers great promise as a non-invasive method 
that can target cm-deep brain areas with higher spatial precision that TMS.  
 
The list of neural recording and modulation methods outlined in this section is by no 
means exhaustive, but it gives an overview of some of the primary modalities for interacting 
with the nervous system, as well as their pros and cons, in order to provide context for the 
methods explored in this thesis.  
2.3 Challenges for bio-interfacing electrodes  
The design and fabrication of bioelectronic interfaces are guided by some universal 
principles, including low interfacial impedance and intimate integration with soft and 
curvilinear tissues. The inherent mismatch between biological tissues and manmade 
electronics cannot be ignored, it and has required significant innovation to realize electronics 
which can intimately and safely interact with tissues. At epidermal interfaces, human skin is 
both stretchable and breathable, but electronics are typically non-stretchable and require 
impermeable encapsulation for prolonged lifetimes. At implanted interfaces, tissues are soft 
and ionically conductive while conventional electronics are rigid and electronically 
conductive. These and other inherent mismatches between tissues and electronics pose 
significant challenges.   
2.3.1 Implantable interfaces   
 Electrodes that are implanted inside the body face the challenge of long-term 
exposure to a warm, aqueous, saline environment and must contend with the body’s innate 
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immune response. Decades of investigations into the long-term performance of implanted 
neural electrodes have established that the quality of signals transduced across this interface 
considerably decays over time [91], [92]. One of the primary factors that limits the functional 
lifespan of implanted bioelectronics is the mismatch in mechanical properties between the 
materials composing the device and the surrounding soft tissues. Numerous studies have 
shown that chronic implantation of stiff, penetrating microelectrode probes into brain tissue 
triggers a cascade of biological responses that are detrimental to the recording performance 
of the electrode [93], [94]. There is an acute wound-healing response triggered by the initial 
probe insertion, characterized by the migration of activated microglia, reactive astrocytes, 
and blood-borne macrophages to the cite as well as the secretion of inflammatory cytokines, 
reactive oxygen species, and other neurotoxic factors [95], [96]. If the probe remains in the 
tissue, this acute response transforms into a chronic foreign body response. This response is 
characterized by the formation of an insulating glial scar around the implant, composed of 
fibroblasts, reactive astrocytes, and activated microglia, as well as the formation of a 
neurodegenerative zone around the implant where neurons die or migrate away from the 
site [92], [97]. The acute and chronic phases of the biological response to a stiff implant are 
shown in Figure 2.7. The glial scar limits ionic exchange between the electrode and 
surrounding tissue, effectively insulating it from the neural signals, and the death and 
migration of neurons away from the implant means that there are fewer signals to record.  
 Several strategies have proven effective for minimizing the biological response to 
implanted electrodes. For instance, the addition of coatings which elute anti-inflammatory 
drugs can significantly reduce the inflammatory response [98]. The most effective 
approaches for improving the long-term performance of implanted electrodes, however, 
center on making electrodes smaller and softer. Neural tissues are soft (<10 kPa), compliant, 
and constantly undergoing micro and macroscopic motions caused by pulsatile blood flow 
and motions of the human body [99]. Conventional electronic materials, notably noble metals 
and silicon, have Young’s moduli orders of magnitudes higher than that of the neural tissue 
(~100 GPa), which means that rigid electronics in these tissues are constantly undergoing 
micromotions with respect to the surrounding tissue, exacerbating the inflammatory 
response. To combat this challenge, new ultrasoft and flexible probes have been developed, 
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which can move with the tissue and have been shown to elicit a significantly reduced 
biological response [100]. In addition to using soft, compliant materials, reducing the size of 
the electronics can also reduce the inflammatory response by reducing the tissue 
compression forces and damage to capillaries and vasculature during insertion [101].  
This poses another significant challenge for implantable electrodes: while making 
them ultra-compliant and reducing their dimensions can greatly improve their long-term 
recording functionality, implanting such devices into neural tissues becomes challenging 
because they may be too compliant to bear the necessary insertion forces to enter the tissue, 
and instead buckle. Numerous strategies have emerged for implanting soft probes into neural 
tissue, including the use of temporary rigid insertion shuttles [100], dissolvable coatings 
[102], shape memory polymers [103], and microfluidic actuation [104], among others [105].  
Figure 2.7 Biological response to implantation of a stiff probe. Illustration of the (A) acute, and (B) 
chronic phases of the biological response to stiff microelectrodes implanted into brain tissue. (C) 
Legend of symbols used in (A) and (B).  
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Another key challenge for implantable interfaces is the durability of the electrode and 
insulation materials in the warm, wet, oxidizing environment of the body. The electrode 
material must be corrosion-resistant over the planned life of the implant, which is one reason 
noble metals, such as Pt and its alloys, have been widely used in clinical devices such ECoG 
and sEEG. If the electrode will be used to deliver electrical stimulation, avoiding 
electrochemical corrosion during charge injection cycles also becomes an important 
consideration. The insulation materials must also withstand cracking and delamination, as 
this leads to current leakage and potential shorts, parasitic capacitances, fluctuations in 
electrode impedance, and accelerated degradation of the underlying conductive layers [106].  
Finally, minimizing electrode impedance is an important consideration for any 
implantable interface, and it becomes a significant challenge when electrodes are 
miniaturized to achieve high spatial resolution recording or microstimulation. Electrode 
impedance will be discussed in more detail in Section 2.4, however a key relation is that 
impedance rises as the size of an electrode is reduced. Achieving a low interface impedance 
is key for recording high-fidelity signals, as well as for safely and efficiently delivering charge 
for stimulation. Thus, choosing electrode materials that effectively minimize impedance is a 
primary consideration for implantable interfaces.  
2.3.2 Epidermal interfaces   
Epidermal electrode interfaces face a different set of challenges compared to 
implantable devices, however there are many areas of overlap. Like implantable interfaces, 
mismatch in mechanical properties between electronics and the soft, flexible skin is one 
important challenge. Human skin has a Young’s modulus of ~20-100 kPa, and can sustain up 
to 15% tensile strain during normal motions [107], [108]. Thus, achieving compliant and 
conformal contact between an epidermal sensor and the skin requires using soft, flexible, and 
even stretchable materials. Insulating elastomeric substrates can meet these requirements, 
however this is a more challenging problem for the conductive materials used for the 
electrodes and interconnects. One common strategy for enabling deformable electronics is to 
pattern thin metallic films into serpentine or fractal mesh geometries to minimize local 
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strains [108], however other strategies incorporating stretchable hydrogels [109], liquid 
metals [110], and carbon nanotube composites [111] have been demonstrated.  
In epidermal interfaces, the electrode-tissue interface impedance is an even bigger 
challenge than it is for implantable interfaces. The epidermis is essentially an “information 
barrier”, insulting external electronics from the signals coming from deeper muscle or nerve 
tissues [112]. The topmost layer, the stratum corneum, consists of dead skin cells and 
intercellular lipids and it is electrically insulating, with a resistance that is significantly higher 
than that of the underlying layers of the epidermis [112]. This layer dominates the electrode-
skin interface impedance, which can be variable depending on skin hydration. 
There are two main classes of epidermal interfaces: “wet” electrodes that use a 
conductive hydrogel at the interface, and “dry” electrodes which do not have a hydrogel. Wet 
electrodes typically achieve lower impedance because they hydrate the stratum corneum and 
facilitate ionic exchange, and they are the preferred type for clinical ECG and EEG monitoring. 
The hydrogels employed in these wet interfaces can pose significant problems for long-term 
use, however, including skin irritation, and impedance variability as the gels dry out [113], 
[114]. For scenarios where long-term wear, repeated placement and removal of the device, 
or easy at-home use are desired, a dry electrode format may be more suitable. Achieving low 
electrode-skin interface impedance is even more challenging for dry interfaces: they do not 
offer direct skin-hydrating effects, and the roughness of the skin may introduce air pockets 
between the skin and sensor, causing increased resistance [112]. Artifacts induced by motion 
of the electrode relative to the skin are also typically more pronounced in dry electrodes 
[115]. To overcome these challenges, new dry electrode technologies have focused on ultra-
thin, ultra-conformable architectures in order to ensure robust, gap-free contact [116] and 
some have utilized microneedles capable of penetrating through the stratum corneum layer 
[117]. 
Another important challenge for epidermal electronics, particularly in long-term 
wear applications, is that most plastics and elastomers have poor gas permeability which 
blocks perspiration and can induce skin irritation and inflammation [118]. Strategies to 
address this challenge include using breathable textile-based electronics [119] and 
engineering pores into soft silicone substrates [120]. These strategies must ensure 
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appropriate insulation of conductive components while still allowing gas and moisture to 
escape from the skin surface.  
2.4 Properties at the electrode-tissue interface 
2.4.1 Electrode impedance  
 One of the most important properties of the interface between an electrode, whether 
intended for sensing or for stimulation, and a biological tissue is the electrochemical 
impedance. Electrochemical impedance spectroscopy (EIS) measures the response of an 
electrode to a small sinusoidal input signal, usually between 10 and 100 mV in amplitude. By 
comparing the amplitude and phase of the input signal with the recorded output signal, the 
electrochemical impedance, Z, can be deduced. Impedance is frequency-dependent, so the 
measurement is typically repeated over a range of frequencies to result in a spectrum. It is 
often plotted in two separate parts: the magnitude of Z in logarithmic scale, 
 |𝑍| =  𝑅𝑒{𝑍} + 𝐼𝑚{𝑍}  (1) 
and the phase shift of Z, 
 𝜑 =  arctan (𝐼𝑚{𝑍}/𝑅𝑒{𝑍}) (2) 
in linear scale at each frequency tested. This representation is known as the Bode plot, and it 
represents the ‘transfer function’ of the electrode interface, or how well signal content at 
various frequencies is transferred over the electrode-electrolyte boundary. EIS is typically 
measured in a phosphate buffered saline (PBS) solution approximating the ionic liquid 
environment of the body, however it can also be measured on the skin.  
 A typical Bode plot for a metal electrode in PBS shows high-pass filtering behavior, 
with high frequency signal content being authentically transferred while low-frequency 
signal content is attenuated (Figure 2.8a) [121]. The mechanisms underlying this behavior 
can be understood by modeling the electrode interface with an equivalent circuit model, 
which describes the physical processes contributing to charge transfer (Figure 2.8b). The 
ionic medium separating the working electrode and the counter electrode contributes a 
frequency-independent attenuation, the access resistance, RA. At the boundary between the 
working electrode and the ionic medium, the behavior is more complex and several 
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mechanisms acting in parallel contribute, which strongly depend on the material 
characteristics of the surface. One mechanism that contributes is the double-layer 
capacitance, or Helmholtz capacitance, that forms at the interface between a solid electrode 
and surrounding electrolyte medium. Two layers of charge with opposing polarity form, one 
at the surface of the electrode in the form of electrons, and one in the electrolyte consisting 
of solubilized ions which self-organize into a layer (Figure 2.8c). This capacitance 
contributes more at low frequencies, introducing a phase shift and attenuating the signal 
[121]. 
The effect of the double-layer capacitance is directly proportional to the contact area 
of the electrode with the electrolyte solution. This is one reason why rough or porous 
electrode interfaces have lower interface impedance: the full three-dimensional contact area 
Figure 2.8 EIS at the electrode-tissue interface. (a) Example Bode plot for a smooth metal electrode 
in PBS. The top plot shows the magnitude and the bottom plot shows the phase of the impedance. The 
colored zones indicate typical behavior in low (green), intermediate (yellow), and high (blue) 
frequency ranges. (b) An equivalent circuit model outlining the different contributors to the overall 
impedance between two electrodes. Here µE is referring to a microelectrode as the working electrode, 
and CE refers to the counter electrode. At the interfaces, each electrode contributes a double-layer 
capacitance, C, in parallel to an impedance, Z, representing all additional charge transfer mechanisms 
available at the surface. The electrolyte between the two comprises the resistive contribution, RA. (c) 
The double-layer capacitance at the electrode-electrolyte interface. Adapted from [121]. 
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of the electrode surface can contribute to charge transfer, enhancing the capacitance of the 
surface (Figure 2.9).  
 EIS is used broadly for benchmarking the performance of recording and stimulating 
electrodes. For neural electrodes, it is common to report the impedance magnitude at 1 kHz, 
as this is around the frequency where the information content in an action potential occurs. 
It is important to note, however, that in many bioelectronic applications the primary 
biosignals have much lower frequency content. EEG, for example, typically contains useful 
information only below 100 Hz. In many epidermal sensing applications, therefore, it has 
become more common to report the impedance magnitude at 10 Hz, although there is not yet 
standardization across the field.  
 One reason the electrochemical impedance is used so broadly as a performance 
measure is that it is believed to correlate with signal-to-noise ratio (SNR). The theoretical 
basis for this notion is that Johnson or thermal noise, vn, scales with impedance according to 
equation (3), where k is the Boltzmann constant, T is the temperature, and Δf is the bandwidth 
of the amplifier:  
 𝑣 =  4𝑘𝑇𝛥𝑓𝑅𝑒{𝑍} (3) 
Because of this relation, a lower impedance electrode is expected to collect less thermal noise 
and thus provide a higher SNR. Thus, signal losses at the interface will be smaller when low-
impedance electrodes are used [121].  
Figure 2.9 Impedance in relation to electrode size. (a) Impedance comparison between smooth Pt 
electrodes and nano-roughened Pt electrodes at 1 kHz for different electrode diameters. (b) Increased 
electrode roughness leads to a reduction in cutoff frequency in addition to the reduction in overall 
impedance. (c) Impedance magnitude for different electrode diameters. The high-frequency 
impedance is dominated by the access resistance, RA. From [121]. 
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2.4.2 Charge injection capacity   
Stimulating electrodes allow current to be driven over the solid-liquid boundary by 
exchanging electronic charge carriers in the solid state to ionic charge carriers in the 
biological medium. For bio-stimulating electrodes, it is important that this process does not 
induce irreversible reactions that alter the electrode material. This means that the charge 
injection mechanisms should allow for equal charge transfer in the opposite direction to 
restore the original state of the electrode. In most bio-stimulation paradigms, charge is 
delivered in the form of biphasic, charge-balanced pulses, meaning that the current injected 
in the first half-phase is immediately compensated for by reversing the polarity over the 
second half-phase such that the net charge transfer over the interface is zero.  
 There are several mechanisms which can contribute to charge injection. Capacitive 
charging and discharging over the Helmholtz double-layer often contributes significantly, a 
non-faradaic process in which no species are exchanged. Electrochemical reactions at the 
electrode surface may also contribute to charge injection, such as the formation of an oxide 
at the surface of a metal electrode when metal atoms react with oxygen in the electrolyte. 
Here electrons are exchanged to ions in a faradaic reaction, which changes the chemical 
composition of the electrode and the surrounding electrolyte. Over time, faradaic reactions 
at the electrode interface can corrode or degrade the electrode, however this is not always 
the case. Reactions where the products remain bound to the surface have a high degree of 
reversibility, and these can be important contributors to charge injection. While capacitive 
charge injection is preferable for safe and stable stimulation electrodes, in practice most 
electrodes have mixed charge injection.  
 One irreversible faradaic reaction that can be generated by any electrode, regardless 
of its material properties, is the electrolysis of water:  
 2H2O + 2e− → H2 + 2OH−  (reduction) (4) 
 2H2O → O2 + 4H+ + 4e−  (oxidation) (5) 
This reaction results in the formation of oxygen or hydrogen gas and local pH changes, which 
may damage the electrode and are harmful to the surrounding tissue. Thus, stimulation 
electrodes are often characterized by their ‘water window’, or the outer voltage boundaries 
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which are safe to apply to the electrode and will not induce electrolysis. These voltage 
boundaries are material-dependent. Using these limits, stimulation electrodes are then 
further characterized by their ‘maximally safe charge injection capacity’, CIC, which is defined 
as the maximum charge per pulse that can be injected before water splitting occurs under 
either the cathodic or anodic phase. In bio-stimulation, it is more common to lead with the 
cathodic pulse to depolarize cell membranes, so the CIC in the cathodic phase, CICC, is often 
the value reported for performance benchmarking. 
 To measure the CIC experimentally, biphasic, charge-balanced current pulses are 
delivered through the working electrode in PBS while the voltage at the electrode interface 
is monitored (Figure 2.10). Several key parameters can then be deduced from the observed 
voltage excursion, or ‘voltage transient’. The access voltage, Va, is the instantaneous voltage 
change when the current pulse is applied or removed, and it is related to the interface 
impedance. The maximum cathodic voltage or excursion potential, Emc, is measured at the 
termination of the access voltage in the cathodic phase, where the transient potential begins 
to decay asymptotically towards the open circuit voltage. The CICC is then defined as the total 
injected charge (current × pulse width) at which Emc reaches the reduction potential for 
water, or the water window limit.  
 The voltage produced across an electrode for a particular charge density is inversely 
proportional to the surface area, meaning that in general larger electrodes are able to inject 
more charge before exceeding the electrochemically safe limits [122]. However, this 
Figure 2.10 Schematic of a biphasic voltage transient potential. The metrics used in assessing the 
charge injection limit include Va, the access voltage, and Emc, the maximum cathodic voltage, found at 
the termination of Va. From  [122]. 
 
Chapter 2: Background 
 
 32   
 
relationship is complicated by the fact that higher field and current densities are typically 
reached at edges or corners, which means that reactions may be inhomogeneously 
distributed over the surface. Thus, increasing the surface roughness of an electrode is one 
way to improve the CIC because this increases the charge transfer area [123].   
 In addition to the CIC, another empirical relation has been established for 
determining the safe limit of stimulation charge density: the Shannon limit. The limit derives 
from histological evaluation of electrical stimulation-induced tissue damage observed in the 
brains of animal models, and it is a useful relation for determining the boundary between 
damaging and non-damaging levels of stimulation [124]. Shannon described the boundary 
between tissue damaging and non-damaging levels of stimulation on a log charge density (D) 
versus log charge per phase (Q) plot as a line with the equation:  
 log(𝐷) = 𝑘 − log (𝑄) (6) 
where the adjustable parameter k is typically chosen between 1.5 and 2.0, with a more 
conservative estimate of damage thresholds using a lower k. While this empirical relation is 
useful, studies have shown that it is less accurate for microelectrodes and that the limit for 
damage also varies significantly with both pulse width and pulse frequency [125].  
2.4.3 Charge storage capacity   
 Another useful characterization of stimulation electrodes is the charge storage 
capacity, CSC, which is evaluated using slow-scan-rate cyclic voltammetry (CV) in PBS over a 
potential range that is just within the water electrolysis window for the given electrode. CSC 
is a measure of the total charge available from an electrode for delivering stimulation. It has 
become common practice to characterize stimulation electrodes by their cathodic CSC, CSCC, 
which is the time integral of the cathodic current during the CV scan (Figure 2.11). It is 
important to note, however, that only a fraction of the charge enclosed by the CV is typically 
available in practice for injection during a short pulse. Thus, while some electrode materials 
can offer enhanced CSC due to internal pseudocapacitance, it is misleading to interpret this 
as if the full internal surface area of the electrode is available for stimulation. In practice, only 
the most superficial layers of the electrode will be actively involved in charge transfer during 
a short stimulation pulses, and the CSC therefore overestimates the charge available [121]. 
 
Chapter 2: Background 
 
 33   
 
 
2.5 Carbon nanomaterials for bioelectronics  
 In recent years, a variety of carbon-based nanomaterials have emerged as promising 
candidates for addressing some of the primary challenges of bioelectronic interfaces. These 
nanocarbons exhibit a wide variety of structures, morphologies, and physical and chemical 
properties which can be leveraged for different applications (Figure 2.12). They offer a 
combination of mechanical flexibility, nanoscale topology, oxidation stability, and 
biocompatibility which are advantageous for bioelectronics. Furthermore, their electrical, 
physical, and chemical properties can be tuned through covalent or non-covalent 
functionalization. In this thesis work, I leverage some of these key properties to build new 
bioelectronic technologies based on graphene, and Ti3C2 MXene. To provide context for the 
work in this thesis, in this section I will briefly summarize the current state of research into 
using carbon nanomaterials for bioelectronics.  
2.5.1 Carbon nanotubes   
Carbon nanotubes (CNTs) are cylindrical nanostructures of carbon, structured as 
seamlessly rolled-up sheets of graphene, which is an atomic layer of two-dimensional (2D) 
sp2-hybridized carbon lattice. CNTs can be single-walled (SWCNTs), composed of one layer 
of carbon lattice, or they can consist of multiple nested single-walled CNTs to form multi-
Figure 2.11 CV of activated iridium oxide film (AIROF). The cathodic CIC is shown by the blue area 
of the voltammogram. From [60]. 
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walled CNTs (MWCNTs). CNTs have been explored in bioelectronics due to their high intrinsic 
surface area, conductivity, mechanical flexibility, and wide electrochemical water window 
which contributes to a high charge injection capacity.   
In neural recording applications, both CNT coatings on metallic microelectrodes and 
electrodes entirely composed of vertically-aligned CNTs have shown significantly reduced 
interface impedance and improved SNR compared to metallic controls of the same geometric 
area [126], [127]. These improvements are attributed to their high specific surface area and 
high conductivity. In stimulation applications, CNTs and CNT-coated surfaces have also been 
shown to exhibit increased capacitance, and a wide water window [128]. Together with their 
low interface impedance, these properties contribute to enhanced charge injection capacity, 
and they have been demonstrated in several studies for effective neural stimulation [129]. 
CNT films are also quite mechanically flexible, and this property has been used to generate 
flexible and even stretchable electrode arrays with all-carbon circuitry [14], [130]. The 
Figure 2.12 Various carbon nanomaterials and their key advantages in bioelectronic interfaces. 
Materials are shown in black boxes across the top, and their properties are shown in purple ovals 
across the bottom. Modified from [380].  
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unique properties of CNTs on the nanoscale have also been harnessed at the macroscale by 
combining aligned CNTs to form carbon nanotube fibers (CNTfs) through a wet-spinning 
process [131], [132]. These CNTfs have been used for chronic neural recording and 
stimulation in vivo, and their advantages include mechanical flexibility, low impedance, high 
SNR, and resistance to biofouling [133].  
In terms of biocompatibility, the safety of CNTs is a topic of some debate. Pristine 
CNTs are highly hydrophobic, and thus they tend to aggregate in physiologic medium. When 
freely circulating in the body, CNTs can aggregate in tissues and cause toxicity in the kidney, 
liver, and spleen [134]. When CNTs are bound to an electrode interface, however, a more 
important consideration is their cytotoxicity to the cell types with which the electrode will 
directly interface. Several studies have demonstrated that neurons cultured on CNT 
substrates actually exhibit increased neurite outgrowth, synapse formation, and activity 
compared to neurons cultured on planar conductive controls [135], [136]. It is believed that 
the nanoscale topology and positive surface charge of CNTs promote neuronal adhesion and 
encourage growth [137].  
2.5.2 Nanocrystalline diamond   
Nanocrystalline diamond (NCD) refers to diamond films with grains smaller than 100 
nm. NCD has been gaining interest for bio-interfacing microelectrodes due to its chemical 
stability, biocompatibility, wide water potential window, optical transparency, and tunable 
electrical conductivity [138]–[140]. When doped with boron, NCD can exhibit high 
conductivity and excellent stability in physiologic medium, in addition to tunable optical 
transparency [138]. The optical transparency can be utilized for combining optical imaging 
and electrophysiological recording, however as the boron doping concentration increases to 
improve conductivity, the optical transparency decreases [141]. NCD has been used as a 
coating on microelectrodes and has shown promise for neural recording, though it has not 
been as widely studied as CNTs and graphene derivatives.   
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2.5.3 Graphene  
Graphene is a one-atom thick 2D lattice structure of sp2-hybridized carbon. Graphene 
and its derivatives have gained attention for bioelectronics due to their exceptional physical 
and chemical properties, including high electrical conductivity, mechanical strength and 
flexibility, high surface area, high chemical stability, and high optical transparency. Beyond 
these properties, a number of studies have demonstrated a favorable biocompatibility profile 
of graphene, though the material preparation (i.e. the synthesis and subsequent processing) 
can influence its purity and surface chemistry to negatively affect biocompatibility [142]. In 
this section, I will discuss three different forms of graphene that have gained attention: 2D 
planar graphene, porous graphene, and out-of-plane/fuzzy graphene.  
2D planar graphene 
Planar monolayer graphene has attracted attention for enabling transparent 
bioelectronics that allow studies combining electrophysiology with optical methods such as 
optogenetics, Ca2+ imaging, optical coherence tomography imaging, or monitoring 
biochemical activity of cells using fluorescent dyes. Similar transparent electronic platforms 
have been demonstrated using indium tin oxide (ITO), however its brittle nature has made 
integrating the electronics with soft tissues challenging. Thus graphene, with its high optical 
transparency and conductivity along with its excellent mechanical flexibility, has largely 
dominated this space and has enabled fabrication on flexible polymeric substrates. A number 
of studies have demonstrated successful neural recording with graphene microelectrodes, 
and several have also combined optical methods [6], [7], [143], [144]. Transparent graphene 
microelectrodes have high impedance, though chemical doping methods have been shown to 
reduce the impedance somewhat [6]. Planar graphene has also been shown to exhibit good 
corrosion resistance, and thus it has also been explored as a coating material on metallic 
electrodes to improve stability [145].  
Porous graphene 
 3D porous graphene structures can be synthesized by various methods, including 
hydrothermal treatment of graphene oxide nanosheet suspensions [146], template-directed 
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CVD synthesis on Ni foam [147], and by laser pyrolysis of polymer substrates [16]. The high 
accessible surface area of porous graphene has made it an attractive material for 
electrochemical biosensing platforms and for bioelectronic devices. In one notable 
demonstration, porous graphene microelectrodes were fabricated by laser pyrolysis of 
polyimide films and used for neural recording and cortical microstimulation. The electrode 
arrays showed good mechanical flexibility, low impedance, high charge storage and charge 
injection capacity, and good long-term stability in a PBS environment [16].  
Out-of-plane graphene 
 An alternative approach to forming 3D graphene structures is to perform out-of-plane 
or vertical growth of graphene on a 3D Si nanowire mesh template, an approach which was 
developed just in the past few years [148]. This produces so-called “fuzzy graphene” with a 
different morphology and an even larger surface-to-volume ratio than the porous graphene 
forms discussed above. The exceptionally high surface area of fuzzy graphene makes it an 
attractive candidate for bioelectronics platforms. While this form of graphene is still quite 
new, one study reported recordings of neuronal activity for neurons cultured on a fuzzy 
graphene microelectrode array with high SNR [149]. The electrodes also showed significantly 
reduced impedance and enhanced charge storage capacity compared to size-matched gold 
electrodes [149].  
Carbon nanomaterials show excellent promise for bioelectronic interfaces due to their 
unique properties, and new devices incorporating various forms of nanocarbons may soon 




Chapter 3: Multimodal seizure mapping with transparent 
graphene electronics  
Neurological disorders such as epilepsy arise from disrupted brain networks. Our 
capacity to treat these disorders is limited by our inability to map these networks at sufficient 
temporal and spatial scales to target interventions. Current best techniques either sample 
broad areas at low temporal resolution (e.g. calcium imaging) or record from discrete regions 
at high temporal resolution (e.g. electrophysiology). This limitation hampers our ability to 
understand and intervene in aberrations of network dynamics.  In this chapter, I develop 
transparent graphene microelectrode arrays, and establish experimental techniques to map 
the onset and spatiotemporal spread of acute epileptic seizures in vivo by simultaneously 
recording high bandwidth microelectrocorticography and calcium fluorescence. I then 
integrate dynamic data features from both modalities using non-negative matrix 
factorization to identify sequential spatiotemporal patterns of seizure onset and evolution, 
revealing how the temporal progression of ictal electrophysiology is linked to the spatial 
evolution of the recruited seizure core. This integrated analysis of multimodal data reveals 
otherwise hidden state transitions in the spatial and temporal progression of acute seizures. 
The techniques demonstrated here may enable future targeted therapeutic interventions and 
novel spatially embedded models of local circuit dynamics during seizure onset and 
evolution. 
3.1 Introduction  
Understanding the dynamics underlying seizure generation and spread at the scale of 
neural microcircuits is critical for improving epilepsy therapies and enabling more efficient 
seizure control. For example, targeted epilepsy treatments such as surgical resection, thermal 
ablation, or responsive neurostimulation rely on precisely localizing seizure onset regions to 
be effective. Currently, clinicians localize these regions by observing seizure semiology, 
identifying electrophysiological signatures from millimeter-scale implanted electrodes, and 
combining these features with non-invasive imaging techniques such as magnetic resonance 
imaging (MRI) and positron emission tomography (PET). Unfortunately, the spatial and 
temporal resolution of these techniques is limited to collective, region-wide network 
oscillations, which hampers the development of precision therapy approaches. A growing 
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body of literature indicates that seizures, in fact, begin at the scale of neural microcircuits, 
which current clinical technologies cannot observe [1], [3], [150], [151]. Thus, there is great 
interest in observing cellular and microcircuit level dynamics as seizures begin and spread, 
and in linking these to the macroscale, brain-wide activity recorded by current clinical 
technologies.  
Recently, microelectrode array recordings in humans have opened a window into 
complex, microscale ictal dynamics within the cortical area usually covered by a single 
clinical electrocorticography (ECoG) electrode. Similarly, microarray and microwire studies 
have revealed spatially distinct territories near the seizure onset zone [152], characterized 
by heterogeneous firing of single cells [153] and associated with different states of excitation-
inhibition balance [154]. Observing seizures at this new scale has led to the idea that the 
cortical areas involved can be divided into a core territory of recruited neurons (the ‘ictal 
core’), surrounded by areas that receive intense synaptic input but do not show 
hypersynchrony and pathologically high firing rates (the ‘ictal penumbra’). Observations at 
the microscale have also revealed previously unobserved temporal phenomena at play 
during epileptic seizures: individual ictal and interictal epileptiform discharges observed on 
intracranial EEG (iEEG) can spread near-synchronously across macroscopic brain areas 
[155], [156]. In contrast, microscale neurophysiological markers of the so-called ‘ictal 
wavefront’ spread locally at much slower speeds, typically not exceeding ~5 mm/s [157]. It 
has now become apparent that macroscale signatures of these microscale dynamics are 
present in particular frequency bands of clinical iEEG, but were only identified with the 
benefit of concurrent microelectrode recordings [158], [159].  
Although microelectrode array recordings are significantly advancing our 
understanding of microscale epileptic dynamics, these electrode arrays still cannot offer a 
complete picture of neural circuits due to their limited spatial sampling. Recordings with the 
Utah array (96 electrodes in a 4 x 4 mm area), for example, typically detect the activity from 
several dozen up to ~180 neurons, at most, from patches of cortex that are just a few 
millimeters across, and which contain hundreds of thousands of neurons [153]. Evolving 
alongside implantable microelectrode technologies, optical tools and techniques enable 
investigators to observe neural activity at cellular and even sub-cellular spatial scales [65], 
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[160], [161]. Optogenetics gives these techniques tremendous power to image and modulate 
the function of specific, genetically-targeted cell types in the brain to discern the roles of 
different cell assemblies [4]. Calcium fluorescence imaging has provided insights into the role 
of inhibitory interneurons in seizure initiation and spread [162], and in the microstructure 
of synchronous neuronal assemblies in epileptic networks [163]–[165]. However, such 
imaging studies typically suffer from low temporal resolution limited by the kinetics of the 
fluorescent reporter molecules as well as the speed of currently available imaging systems 
[5], [160], [166].  
Combining electrophysiological and optical recording modalities presents a unique 
opportunity to harness the spatial resolution of optical imaging along with the temporal 
resolution of electrophysiology. However, such a combination requires imaging and 
recording simultaneously in the same location, which is not possible with conventional 
microelectrode arrays composed of opaque metallic materials, as these block optical access 
and suffer from photoelectric artifacts [167]. Recently, progress in transparent 
microelectrode array technology, predominantly utilizing graphene, has enabled such 
multimodal studies [6]–[9]. However, innovation is still needed in experimental and 
analytical methods to fully realize the potential of these multimodal mapping techniques. 
Notably, there is currently a lack of analytical methods to combine high density optical and 
neurophysiology datasets, while accounting for their differences in temporal and spatial 
sampling.   
In this work, we demonstrate a novel experimental and methodological paradigm 
which combines mapping of microscale local network dynamics at high spatiotemporal 
resolution with a quantitative analysis framework to distill the dynamics underlying seizure 
generation and evolution in vivo. Specifically, we utilize custom-made, transparent graphene 
microelectrode arrays to simultaneously record electrophysiology and optical signals of 
microscale brain activity in a rodent model of acutely induced epileptic seizures. We combine 
dynamic data features from both modalities in a sparsity-constrained non-negative matrix 
factorization (NMF) approach in order to identify spatiotemporal patterns across these 
acquisition modalities. NMF is used for dimensionality reduction, similar to principal 
component analysis, but yields sparser and potentially more interpretable factors due to the 
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non-negativity constraints on both the original feature matrix and the resultant factors. Such 
an approach has previously been used to decompose dynamic functional connectivity into 
sets of variably expressed subnetworks and track their temporal evolution in human 
neuroimaging [168]–[170]. 
This analysis reveals how the temporal progression of ictal electrophysiology is 
linked to the spatial evolution of the recruited seizure core. We show that locally synchronous 
increases in broadband micro-ECoG (µECoG) power are associated with a progressive 
expansion of the ictal core at seizure onset, and that state transitions occur during an 
established seizure that are accompanied by subtle changes in ictal discharge morphology. 
These microscale spatiotemporal dynamics are not apparent from electrophysiology alone, 
and highlight the unique advantages of multimodal recording enabled by transparent 
electronics. The analytical framework presented here serves as a proof of concept for future 
studies combining data from multiple modalities, with the potential to illuminate 
mechanisms underlying seizure initiation, spread, and microscale network interactions that 
may characterize other types of brain disorders.  
3.2 Development of transparent graphene microelectrode array 
technology   
3.2.1 Prior work 
 The first demonstrations of transparent graphene electronics for multimodal neural 
recording were published simultaneously in 2014 by two separate groups. Dong-Wook Park 
et al. developed a transparent array of 250 µm-diameter graphene electrodes encapsulated 
in a flexible parylene C substrate and demonstrated the ability to optogenetically stimulate 
neurons through the array while simultaneously recording local field potentials (LFPs), as 
well as to image cortical vasculature through the array (Figure 3.1a) [7]. In that work, the 
graphene arrays were fabricated by stacking 4 layers of CVD-grown graphene by coating each 
graphene layer with PMMA, chemically etching the copper foil substrate, transferring the 
PMMA/graphene to the wafer substrate, and subsequently dissolving the PMMA. This 
transfer process is known to induce cracking defects in the graphene monolayers as well as 
 
Chapter 3: Multimodal seizure mapping with transparent graphene electronics 
 
 42   
 
to leave PMMA and Cu residues on the graphene film [171]. Thus, while Park et al. showed 
functional devices, the 1 kHz impedance of their graphene electrodes was quite high at 244 ± 
6 kΩ for 250 µm-diameter electrodes, likely due to defects and residues present on the 
graphene films.  
The second group, led by Duygu Kuzum, developed an array of 50x50 µm2 graphene 
electrodes encapsulated in a polyimide (PI) substrate, and demonstrated simultaneous two-
photon calcium fluorescence imaging and low-noise electrophysiology (Figure 3.1b) [6]. The 
recordings were performed in brain slices ex vivo. Kuzum et al. achieved superior impedance 
performance compared to Park et al. by utilizing a cleaner graphene transfer method which 
eliminated the copper etching step, and subsequently using nitric acid chemical doping to 
reduce electrode impedance (541 kΩ for 50x50 µm2 electrodes). However, the choice of PI 
substrate resulted in electrode arrays with inferior optical transparency. While parylene C is 
highly transparent across the visible spectrum, PI absorbs light at wavelengths below 550 
nm, which is within the emission range of common optical reporter molecules such as Oregon 
Green BAPTA-1 (OGB-1) (Figure 3.1c).  
Since these initial demonstrations, some progress has been made toward improving 
transparent electrode technology. Kuzum’s group showed that electrodepositing Pt 
nanoparticles onto graphene electrodes could significantly lower the impedance, however 
this approach sacrifices optical transparency [144]. Another group took a different approach, 
developing a transparent electrode array based on a nanomesh of Au coated with PEDOT:PSS, 
rather than using graphene [9]. These Au nanomesh electrodes achieved far lower impedance 
Figure 3.1 Early demonstrations of transparent graphene microelectrodes. (a) CLEAR graphene 
device from Dong-Wook Park et al. in parylene C substrate. Scale bar 500 µm. (b) Graphene electrode 
array from Duygu Kuzum et al. in polyimide substrate. (c) Optical transmission of the device in (b), 
showing reduced optical transparency within the OGB-1 emission range. (a) from [7], (b) and (c) from 
[6]. 
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than their graphene counterparts, however they had reduced optical transparency and were 
more prone to light-induced artifacts than graphene electrodes are.  
Here, we sought to build upon this foundational work, and to further optimize the 
fabrication of transparent graphene microelectrodes to offer an improved combination of 
high optical transparency and low electrochemical impedance. By optimizing the properties 
of the graphene microelectrode array, we can improve the quality of data which can be 
obtained during in vivo multimodal recording.   
3.2.2 Fabrication optimization 
To fabricate transparent graphene devices, we began with the protocol outlined by 
Park et al. and made several important modifications to improve the graphene quality and 
reduce electrode impedance [172]. We initially designed a µECoG array of nine 50 x 50 µm2 
electrodes in a parylene C substrate and used this device design to test and optimize the 
graphene processing conditions.  
As the first modification, we used a bubble transfer method similar to that described 
by Gao et. al. [173] to transfer monolayers of graphene grown on copper foils via chemical 
vapor deposition (CVD) to the wafer substrate. While conventional graphene transfer 
methods rely on complete etching of metal substrates (typically copper) in suitable etchants, 
which causes damage to the graphene and leaves metal residues, bubble transfer using 
electrolysis of water enables transferring large-area graphene films with high purity and 
without inducing cracking or damage. Using this improved transfer method, we sought to 
determine an optimal number of stacked monolayers of graphene. We fabricated devices with 
either one or two stacked monolayers of graphene and assessed the relationship between 
number of graphene layers and electrochemical impedance (Figure 3.2a). While we found 
that adding a second layer of graphene reduced the impedance (2.16 ± 0.23 MΩ for 2-layer 
vs. 2.75 ± 0.26 MΩ for 1-layer graphene at 1 kHz), we sought to reduce the impedance further 
without adding additional graphene layers, as these would reduce the optical transparency 
of our devices and also add significant time to the fabrication process, as each graphene 
transfer is performed sequentially. To this end, we next explored chemical doping methods 
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for enhancing the out-of-plane conductivity of graphene, similar to those described by Kuzum 
et al [6].  
Exposing graphene to nitric acid (HNO3) results in the adsorption of electropositive 
NO3–  groups onto the graphene surface. Specifically, the HNO3 molecule physisorbs onto the 
graphene sheet, without breaking any C-C bonds, and then dissociates into three groups: two 
radicals NO20 and NO30, and a water molecule: 2HNO3 = NO20 + NO30 + H2O. The two radicals 
have a singly occupied state below the Fermi energy of the graphene layer, which allows two 
electrons to transfer from graphene into these states, creating two holes and causing p-type 
doping [174]. This p-type or hole doping has been shown to reduce electrochemical 
impedance and improve the noise characteristics of graphene electrodes [174]–[176]. 
Figure 3.2 Optimization of graphene processing. (a) Electrochemical impedance spectra for 50 µm 
x 50 µm graphene µECoG electrodes of three preparations: 1-layer graphene, 2-layer graphene, and 
HNO3-doped 2-layer graphene. Impedance magnitude significantly decreased with doping, 
particularly at frequencies below 1 kHz. Noise in the low-frequency range for the un-doped graphene 
samples is attributed to the high impedance modulus. Shaded bounds represent standard deviations. 
(b) Impedance magnitude at 1 kHz for the three device preparations. Horizontal black bars indicate 
means. (c) Impedance magnitude at 100 Hz for the three device preparations. Horizontal bars indicate 
means. (d) Cyclic voltammograms showing superior CSCC in an HNO3-doped 2-layer graphene 
electrode, as compared to an un-doped 2-layer graphene electrode (CSCC is 22.4 µC/cm2 and 15.9 
µC/cm2, respectively). The scan rate was 500 mV/s. 
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Additionally, layer-by-layer doping has been shown to produce doped graphene sheets with 
reduced and more stable sheet resistance values compared to doping after stacking of 
graphene monolayers, where only the topmost layer experiences doping [175], [177].  We 
optimized a process for HNO3 doping of graphene and performed this doping layer-by-layer 
after the transfer of each graphene sheet to the wafer substrate. We tested various HNO3 
exposure times and temperatures, and found that exposing the graphene to 75% HNO3 for 15 
minutes at room temperature produced the largest and most stable impedance reduction. We 
used these doping conditions for all subsequent device fabrication.  
A summary of the results of these optimization procedures is shown in Figure 3.2, in 
which we compare impedance values both at the commonly-used 1 kHz reference frequency, 
and at the lower frequency of 100 Hz (Figure 3.2b,c). We show the values at 100 Hz because 
many physiologic signals of interest in the brain are of lower frequency content than the 
typical 1 kHz reference frequency. We find that the impedance relationships between 1-layer, 
2-layer, and doped 2-layer graphene devices are similar at 1 kHz and 100 Hz, with the 
advantage of chemical doping being more pronounced at lower frequencies: the 100 Hz 
impedance of 1-layer devices is 25.6 ± 11 MΩ, 2-layer devices is 15.9 ± 5.5 MΩ, and HNO3-
doped devices is 2.07 ± 0.65 MΩ. The significant spread of 100 Hz impedance values for the 
un-doped device preparations can be attributed to their high impedance in this lower 
frequency range, which limits the accuracy of the EIS measurement. As a low electrode 
Figure 3.3 Raman spectroscopy. (a) Raman spectra of monolayer un-doped (red), bilayer un-doped 
(green), and bilayer HNO3-doped (blue) graphene on Si wafer. The spectrum for the Si wafer substrate 
(black) is included as a reference. (b) Raman spectrum of doped bilayer graphene between parylene C 
layers in a completed device. 
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impedance is essential for obtaining recordings with high signal-to-noise ratio (SNR) [10], 
[126], these results indicate that HNO3 doping is a useful approach for improving the 
performance of graphene microelectrodes, especially at lower frequencies where most 
physiologic signals of interest occur. In addition to EIS measurements, cyclic voltammetry 
(CV) measurements were taken to assess the effect of HNO3 doping on the charge storage 
capacity of graphene electrodes. Doping with nitric acid increased the charge storage capacity 
from 22.87 µC/cm2 to 64.44 µC/cm2, indicating that this method of doping may also improve 
the performance of graphene electrodes for neural stimulation applications (Figure 3.2d). 
In addition to electrochemical characterization, we also performed Raman 
spectroscopy to assess the quality of the graphene films and confirm successful p-type doping 
after exposure to HNO3 (Figure 3.3a). First, Raman spectra for monolayer un-doped, bilayer 
un-doped, and bilayer doped graphene films on an Si wafer substrate were evaluated. 
Monolayer un-doped graphene exhibited a D peak at 1309.3 cm-1, a G peak at 1583.1 cm-1, 
and a 2D peak at 2673.2 cm-1. The average ID/IG ratio, which is an indicator of defect 
concentration, was 0.65. The fact that this ratio is less than unity indicates that our graphene 
films are of high crystalline quality [178]. The addition of a second layer of un-doped 
graphene resulted in a narrowing of the G peak, a broadening of the 2D peak, and an upshift 
in position of the 2D peak, which agrees with previously reported results [178], [179]. In the 
doped bilayer preparation, further broadening and upshift of the 2D peak was observed, and 
the I2D/IG ratio was decreased significantly. These results indicate successful p-type doping 
of our graphene films after HNO3 exposure [178], [180]. Values for FWHM(G), FWHM(2D), 
Pos(2D), I2D/IG, and ID/IG for each of the three graphene preparations can be found in Table 
Table 3.1 Raman spectroscopy analysis. Summary of results from Raman analysis of 
graphene preparations on Si wafer 
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3.1. Next, Raman spectra for a doped graphene electrode in a fully-fabricated µECoG array 
was evaluated to confirm that the doped graphene remained of high quality following device 
fabrication (Figure 3.3b). The G and 2D peaks retained similar intensity and width as those 
seen in the doped graphene on Si preparation, indicating that device fabrication does not 
significantly alter the graphene properties. The peaks at 1210, 1340, 1440, and 1610 cm-1 are 
attributed to parylene-C, and the graphene D peak is obscured by the parylene peak at 1340.    
Using the optimal graphene processing conditions determined here, we proceeded 
with device fabrication for in vivo testing. A schematic of the electrode fabrication process is 
shown in Figure 3.4, and a detailed description of the process is provided in the methods at 
the end of this chapter.  
3.2.3 Electrode characterization  
For in vivo experiments, we designed an µECoG electrode array consisting of a 4 x 4 
grid of 50 µm x 50 µm square electrode contacts with 500 µm pitch (total recording area of 
1.55 mm x 1.55 mm and total array footprint 2.75 mm x 2.75 mm). In each device, graphene 
forms the electrodes and conductive traces in the distal end of the array, and overlaps with 
Ti/Au conductive traces outside of the array, such that the entire recording area of the device 
is fully-transparent (Figure 3.5a).  The graphene electrodes and Ti/Au traces were patterned 
Figure 3.4 Fabrication of transparent graphene µECoG devices. Details of the fabrication are given 
in the Methods section. Briefly, parylene C is deposited onto a Si wafer and Ti/Au traces are patterned 
on the parylene C. CVD-grown graphene is transferred to this substrate using a bubble transfer 
method. An SiO2 layer is deposited to protect the graphene during later processing steps, then the 
graphene and SiO2 layers are patterned and etched. A top layer of parylene C is deposited to 
encapsulate the device, then VIAs are etched to open the graphene electrode contacts as well as open 
the Ti/Au bonding pads at the back end of the device. Finally, the SiO2 covering the graphene electrode 
contacts is chemically etched away and the devices are removed from the wafer. 
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on a 4 µm-thick bottom parylene C substrate and encapsulated by another 4 µm-thick 
Figure 3.5 Optically transparent graphene µECoG arrays. (a) Schematic of graphene µECoG device: 
A fully transparent array of graphene microelectrodes and traces connects to gold traces in a flexible 
cable which can be interfaced with a data acquisition system through a ZIF connector. (b) A graphene 
µECoG device wrapped around a pipette tip to demonstrate its flexibility. Scale bar: 2 mm. (c) Images 
of the graphene electrode array overlaid on the Penn logo to demonstrate optical transparency. Scale 
bars, left to right: 1 mm, 250 μm, 100 μm. (d) Optical transmission spectra for different locations in the 
graphene µECoG array. Overall, the device is > 90% transparent across the visible to near infrared 
spectrum. The ringing behavior in the spectra is attributed to parylene C. Scale bar: 50 µm. (d) Mapping 
of optical transmittance at 550 nm for the locations shown in (d). (e) 1 kHz impedance magnitude for 
each 50 μm x 50 μm transparent graphene electrode in the array, averaged over 4 devices. Values are 
overlaid in the corresponding electrode locations on a light microscopy image of a single device. For 
clarity, electrodes are not shown to scale. 
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parylene C layer to yield devices with a total thickness of 8 µm. The combination of the thin 
profile of the device, the low Young’s modulus of parylene C and the extreme broadband 
optical transmittance of both parylene-C and graphene endow the device with high flexibility 
(Figure 3.5b) and optical transparency (Figure 3.5c). We found that the devices showed on 
average >90% optical transparency across the visible spectrum (Figure 3.5d,e). The average 
impedance over 4 such devices (n=64 channels) was 908 ± 488 kΩ at the 1 kHz reference 
frequency (Figure 3.5f), which corresponds to an area-normalized impedance of 22.7 ± 12.2 
Ω·cm2. 
3.3 Acute, multimodal recording of pharmacologically-induced 
seizures on the cortex 
3.3.1 Experimental overview  
We utilized our transparent graphene arrays to perform simultaneous calcium 
epifluorescence imaging of neurons and electrophysiology recording in vivo in an acute 
murine model of epilepsy. GCaMP6-expressing mice were anesthetized, and the graphene 
µECoG arrays were placed on the cortical surface following craniotomy. Electrode arrays 
were connected to a NeuroNexus amplifier/digitizer through a custom interface connector 
for electrophysiological recording, and wide-field epifluorescence microscopy was used to 
simultaneously capture GCaMP6 activity at low magnification at a frame acquisition rate of 
10 Hz. Several previous studies combining electrophysiology and neuroimaging with 
transparent microelectrodes have utilized two-photon imaging [181], [182], which offers 
high spatial resolution but a limited field of view, thus providing detailed information for only 
a small population of cells lying beneath one or a small number of individual electrodes. For 
this study, we instead used wide-field epifluorescence imaging to observe the calcium 
dynamics across the entire millimeter-scale cortical region covered by the array in order to 
maximally leverage data features from each modality. This choice also allowed us to observe 
the spatial dynamics of seizure spread across a millimeter-scale cortical area. The flexible 
electrode arrays readily conformed to the cortical surface and their high broad-band optical 
transparency allowed penetration of the excitation light (470 nm) and fluorescence emission 
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light (500-550 nm). A potassium channel blocker, 4-aminopyridine (4-AP), was bath-applied 
to induce epileptiform activity. A schematic of the recording and imaging setup is shown in 
Figure 3.6a, and an image of the graphene electrode array on the cortex, outlined in white to 
show the locations of the transparent electrodes is shown in Figure 3.6b. Seizure events 
were recorded on the graphene array and were visible in epifluorescence imaging through 
the electrodes as changes in normalized fluorescence, where each imaging pixel was 
normalized by the amplitude and standard deviation of fluorescence changes observed in the 
baseline, pre-seizure condition.  
3.3.2 Multimodal data   
The advantages of our experimental setup are underscored in Figure 3.7. With the 
high-density graphene µECoG arrays, we obtained high temporal resolution recordings of 
seizure activity, including the fast dynamics of seizure onset as well as discrete high 
frequency oscillations (HFOs). HFOs are of particular interest because of their potential role 
in ictogenesis and their use as a biomarker to identify seizure onset regions [183]–[185]. 
Throughout our study, we observed 200-300 Hz “fast-ripple” HFOs consistent with a 
pathologic, seizure-prone state as determined by a clinician trained in EEG marking (Figure 
3.7a). These oscillations are too brief and high frequency to be observed with calcium 
imaging alone.  
Figure 3.6 Multimodal recording setup. (a) Schematic of the in vivo recording and imaging setup. 
(b) Image of the graphene electrode array placed over barrel cortex, with baseline calcium 
epifluorescence visible in green, and array outlined in white to show locations of the electrodes. Scale 
bar: 300 μm. 
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While electrophysiological recordings offer the high temporal resolution necessary 
to observe fast activity such as pathologic HFOs, the spatial resolution of these recordings is 
limited by the minimum size and spacing achievable for microelectrodes in an array. Despite 
recent advances in the development of ultra-high-density microelectrode arrays [54], 
imaging modalities still offer superior spatial resolution for observing the spatial spreading 
dynamics of neural activity, albeit with limited temporal resolution. Using calcium 
fluorescence imaging, we observed complex, non-stereotyped spatial patterns of seizure 
Figure 3.7 Simultaneous electrophysiology and calcium imaging of 4-AP-induced seizure 
activity in an anesthetized mouse. (a) Examples of two clinician-validated high frequency 
oscillations (HFOs) recorded on graphene electrodes. Raw, wideband signal from 3 adjacent electrodes 
highlights the localized nature of the HFOs. Below these, the 80-600 Hz bandpass-filtered signal and 
the spectrogram, which reveals 200-300 Hz power consistent with fast ripple HFOs, are shown for the 
bottom-most wideband signal trace. (b) Two representative examples of ictal wavefront onset and 
propagation patterns observed in the calcium epifluorescence imaging for different seizure events, 
showing complex non-stereotyped spatial patterns of activation and spread. Ictal wavefront 
progression is overlaid on images of baseline fluorescence. Scale bars: 500 μm. 
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initiation and spread, which we illustrate by plotting the putative ictal wavefront evolution 
over time for two different seizure events (Figure 3.7b).  
It is important to note that our transparent graphene electrodes recorded seizure 
activity with high signal-to-noise ratio (SNR). Despite some variability in electrode 
impedance across the array during in vivo recordings, we found that all electrodes had SNR 
>5, and that SNR was not in fact correlated with electrode impedance (Figure 3.8a,b). 
Instead, the SNR values across the electrode array mapped more closely to the seizure onset 
pattern, with electrodes closer to the seizure focus showing larger amplitude ictal spikes and 
thus higher SNR (Figure 3.8c). While higher impedance electrodes do pick up more 60 Hz 
noise interference, this artifact is removed in the data filtering step such that electrode 
impedance does not affect the results of our analysis.  
 We performed our analysis on the data recorded during the first acute seizure onset 
in one animal. While the animal experienced multiple seizure events following the drug 
application, we were primarily interested in the dynamics at play during the brain’s initial 
transition into the ictal state. Because it was not clear that the brain returned to a normal 
baseline state in between seizures, we chose to focus solely on the initial seizure onset. The 
multimodal data recorded during this seizure onset are shown in Figure 3.9. The locations 
of the graphene electrodes on the cortex, and their position relative to the 4-AP application 
site, are shown in Figure 3.9a. Upon visual inspection of the ECoG time series, we determined  
Figure 3.8 SNR vs. electrode impedance. (a) SNR vs. 1 kHz impedance magnitude for each electrode 
during the in vivo recording analyzed in this work. No correlation between SNR and impedance was 
found, as evidenced by the poor linear fit shown. Note that while the impedance magnitudes measured 
in vivo are significantly higher than those measured in saline, these electrodes still achieve high SNR 
>5. (b) Map of in vivo electrode impedances across the 16 ch graphene array. (c) Map of SNR values 
across the 16 ch graphene array.      
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Figure 3.9 Concurrent multimodal data obtained during a single seizure onset. (a) Relative 
positions of the graphene contacts on the cortex (individual electrodes not shown to scale) and the 
location of 4-AP drug application. Electrodes labeled e, f, g, and h are highlighted and shown as example 
data. (b) Fluorescence intensity (normalized to baseline mean and variance) beneath each individual 
electrode and simultaneous µECoG recordings from the graphene array. The period of acute seizure 
onset is magnified in the bottom panel. (c) Series of image frames corresponding to the seizure onset 
shown in panel b. (d) Ictal wavefront evolution over time for the seizure shown in b. Note particularly 
the early recruitment of channel e and the comparatively late recruitment of channel h. (e) Density 
plot indicating the significant relationship between µECoG broadband power and local calcium 
fluorescence averages. The colormap indicates the density, or normalized observed frequency of 
values distributed along the two dimensions (µECoG broadband power, calcium fluorescence).   
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the time of ictal onset by identifying changes in rhythmic background activity that evolve in 
time and space; the determination was validated by a board certified epileptologist. In the 
recording event shown here, µECoG traces first show an increasing frequency of epileptiform 
discharges which appear near-synchronously across the whole electrode array, followed by 
a higher frequency, evolving rhythm that changes in amplitude and frequency for the 
duration of the seizure (Figure 3.9b).  
Associated with these changes in the electrophysiological activity, we observe an 
increase in high amplitude calcium transients, followed by a transition of the global calcium-
fluorescence to a higher overall amplitude. When fluorescence is instead measured at the 
location of individual µECoG contacts, we further see a separation in the temporal dynamics 
of this progression of seizure-associated calcium activity. While individual calcium transients 
beneath each electrode appear to be timed nearly synchronously, channels to the left of the 
array (nearer the location of chemoconvulsant drug application) show an earlier and higher 
amplitude transition into the seizure state overall. This spatial evolution of the seizure is 
apparent in the sequence of normalized calcium images (Figure 3.9c), where high amplitude 
calcium fluorescence indicates that ictal activity evolves slowly from the bottom left corner 
of the image to reach maximum amplitude near the end of the recorded segment shown here. 
High amplitude fluorescence corresponds to temporal summation of very fast neuronal firing, 
indicative of recruitment into the seizure. This intense, hypersynchronous activity in the 
recruited ‘ictal core’ stands in stark contrast to the less synchronous and lower frequency 
firing behavior of surrounding cortical areas, commonly referred to as the ‘ictal penumbra’. 
The distinct neuronal dynamics of these areas are separated by a slowly traveling ‘ictal 
wavefront’ that gradually expands throughout the recording to ultimately engulf nearly the 
entire field of view (Figure 3.9c,d). Features of this core-penumbra organization of epileptic 
activity have previously been described both in human microelectrode recordings in chronic 
epilepsy, and in vitro using optical imaging of acutely induced seizures in cortical slices, 
where these dynamics unfold across temporal and spatial scales comparable to the ones 
reported here [154]. Similar to previous reports [154], [186], individual ictal discharges may 
spread near-synchronously across the whole µECoG recording array, while calcium 
fluorescence, and to some extent signal amplitude on the µECoG array, expands slowly across 
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the recorded surface. We treat this slow spatial evolution of the seizure as a traveling wave 
phenomenon [156], where we consider the boundary between significantly increased 
calcium fluorescence and activity nearer the resting state background level to be the edge of 
the ictal core (Figure 3.9d).  
Despite the apparently synchronous onset of ictal features across individual channels 
in the µECoG, there is a clear relationship between the spatial distribution of the calcium 
signal, and local features of the electrophysiological recording. Specifically, we observe a 
correlation between normalized µECoG broadband power (Pearson’s correlation coefficient 
r = 0.71, p < 0.001 for linear fit), and local average normalized calcium fluorescence (Figure 
3.9e). While less obvious in the µECoG signal alone, this observation indicates that both 
calcium imaging and electrophysiology capture related, local spatiotemporal phenomena of 
ictal onset.  
3.4 Non-negative matrix factorization identifies sequences of state 
transitions during seizure onset and evolution  
3.4.1 Low dimensional representation of seizure dynamics  
We next aim to describe the spatiotemporal profile of ictal onset across multimodal 
data in a lower dimensional representation. We make the assumption that the high 
dimensional dynamics of seizure onset and early ictal evolution can be well captured through 
time varying expression of latent spatial factors and subnetworks, whose individual makeup 
does not change with time, but fluctuates in its relative expression. First, we calculate features 
previously identified as dynamic markers of ictal territories [152] using temporal windows 
matching the calcium imaging frame acquisition speed: phase locked high gamma, high 
gamma power, and local network synchrony. This choice enables us to downsample the 
µECoG data while preserving the information afforded by its high temporal resolution, and 
align in time with the calcium fluorescence images. To detect latent spatial factors and 
subnetworks that best explain the temporal variation in key data features, we use a sparsity 
constrained non-negative matrix factorization (NMF) [187], [188] with the number of factors 
chosen to optimize the variance explained per factor for a limited total number of factors used 
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for dimensionality reduction (Figure 3.10). This method yields interpretable and sparse 
individual factors while remaining computationally tractable (Figure 3.11a). With this 
approach, we are able to integrate insights across different recording modalities, and to 
include many data features to trace latent dynamics that might not otherwise be easily 
discernible from single data features alone [189].  
The spatial evolution of the ictal core is apparent both in the calcium imaging- and 
electrophysiology-derived components of the factors obtained with NMF. For example, as we 
move from factor 1 to factor 6, we observe an increase in both µECoG broadband power and 
calcium fluorescence amplitude (Figure 3.11b), which at the time of seizure onset is maximal 
at the bottom left corner of the array, closest to the drug application site. Similar to these 
univariate measures, NMF also yields µECoG-derived pairwise dynamic functional 
connectivity factors, or ‘subgraphs’ (Figure 3.11c). These are modules of functional 
connectivity whose variable expression over time approximates the full scale original 
dynamic connectivity matrix in linear supposition [190]. Their temporal progression also 
tracks transition into the seizure, and further evolution. For example, high gamma 
connectivity is lowest for factors expressed during seizure onset; and higher for factors 
expressed in the established seizure, when the ictal core occupies the majority of the 
electrode grid (Figure 3.11c).   
Figure 3.10 Variance explained by number of factors. Residuals for NMF fits after optimization for 
preset factor numbers ranging from 1 to 25. The final number of factors (k = 6) was selected as a trade-
off between maintaining a low number of factors and achieving a low residual variance. 
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Figure 3.11 Non-negative matrix factorization (NMF) of time varying feature matrix.  (a)  The 
feature matrices supplied to the NMF (V matrix), and the resultant factorized matrices (H matrix 
showing temporal expression of six factors; W matrix showing factor weights for six factors). The ictal 
onset transition can be seen in most of the feature matrices, and occurs around the time factor 2 is 
expressed most highly. (b) Example factor weights are illustrated for LFP raw power, and calcium 
fluorescence in the sequence in which they are most highly expressed. Both show sequential increases 
in combined overall weights, with a maximum in the bottom left quadrant of the matrix, corresponding 
to the contact nearest the drug application site. (c) Factorized edge-weights can be used to reconstruct 
frequency-band specific subnetworks of which the high gamma derived subnetworks are shown here. 
These show a decoupling at seizure onset, with subsequent increases in coupling.   
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The time varying expression of the six factors further identifies a sequence of state 
transitions: periods that are characterized by expression of just a single factor alternate with 
periods characterized by mixed expression of multiple factors, indicating a gradual transition 
between states (Figure 3.11a). Thus, the factor loadings allow us to track transitions through 
a reduced dimensionality feature space, and to identify key transitions between transiently 
expressed states. It is of interest to determine whether these state transitions could be 
identified without the calcium imaging data, which captures a clearer spatial evolution of 
activity at slower time scales than the electrophysiology. To address this question, we 
perform the same analysis separately with calcium imaging features, or with 
electrophysiological data features alone. We observe that the state transitions are not 
detectable in the electrophysiology-only analysis. The timing of state changes appears to be 
preserved in the calcium-only analysis, although the dynamics of individual factor expression 
differs from the combined analysis (Figure 3.12). These findings indicate that identifying the 
sequential latent factors reported here requires the inclusion of calcium imaging data. 
Using NMF, we derive a low-dimensional state space representing ictal onset. We 
depict this state space as a 3-D plot for the three factors that are predominantly expressed  
Figure 3.12 Factor loadings (i.e. H-matrix) derived from non-negative matrix factorization. (a)
Results derived from matrices containing electrophysiology-derived data features only show 
transition into seizure and some progressive changes, but no clear sequential states. (b) Factor 
loadings derived from calcium imaging features only shows sequential states similar to those of the 
combined analysis.  
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Figure 3.13 Spatiotemporal trajectories during induced epileptic seizure. (a) Weighting along 
three factors showing high loadings early during the seizure, with each point colored by the cortical 
surface area recruited to the size of the ictal core estimated from the number of suprathreshold pixels 
on calcium imaging. Seizure onset is associated with a smooth trajectory through this state space. (b)
Three time points are sampled based on the extrema of the state-space trajectory, showing normalized 
calcium fluorescence, raw electrophysiology, and dynamic subnetwork configuration. (c) Analogous to 
the seizure onset, this plot illustrates the transition through state space based on three factors with 
maximum activation late in the seizure. (d) Data for three time points late in the seizure are shown, 
and are associated with gradual µECoG desynchronization along with continuing spatial increase of 
the seizure core on calcium imaging.    
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early in the seizure (Figure 3.13a,b). Next, we depict the 3-D state space of three factors that 
are predominantly expressed later during the established seizure (Figure 3.13c,d). 
Throughout the recording, transitions between factors are accompanied by smooth slow 
increases in the spatial extent of the recruited seizure core as defined by imaging features. In 
Figure 3.13b,d we show data segments that most closely correspond to each factor, by 
selecting time windows around the maximum expression of a given factor. These segments 
show distinctive patterns of specific dynamic features: a gradual increase in the spatial 
distribution of the calcium signal, changes in ictal discharge morphology and frequency, and 
strong initial synchronization with subsequent desynchronization in the between-channel 
functional network.   
3.4.2 State transitions are associated with changes in ictal discharge electrophysiology   
Next, we explore whether features which are in principle measurable in clinical ECoG 
recordings change quantitatively between seizure states identified from the multimodal NMF 
analysis. The most prominent features of abnormal cortical dynamics observed in clinical 
seizure recordings are often ictal epileptiform discharges, which are present in our µECoG 
recordings (Figure 3.14a). For this analysis, we were interested in quantifiable features of 
ictal discharges that (i) do not depend on the spatial resolution afforded by µECoG (e.g. 
excluding between-electrode correlation measures), and (ii) were not already included in the 
NMF analysis (e.g. excluding discharge amplitude). We identify two features that fulfil these 
criteria, which we hypothesize could act as indicators for ictal state transitions: ictal 
discharge frequency and ictal discharge stereotypy. We evaluate both features in 3s non-
overlapping sliding time windows that are labelled according to the factors maximally 
expressed during that time window. We then compare median values of discharge frequency 
and between-discharge correlation, as a measure of discharge stereotypy, for temporally 
adjacent states (Figure 3.14b,c). 
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This analysis reveals contrasting changes in discharge frequency and discharge 
stereotypy. Discharge frequency monotonically increases from ictal onset, with increasing 
frequency at each state transition, and reaches a maximum at the end of the recording. 
However, discharges are most stereotyped early in the seizure, and become most variable in 
the established seizure around the time windows characterized by high expression of factor 
5, before returning to a more stereotyped state towards the end of the recording. 
  
Figure 3.14 Electrophysiological changes associated with ictal state transitions. (a) Peak-
centered averages of ictal discharges are shown for all discharges detected in a 10 s time window 
around the peak expression of each of the six sequential factors derived from NMF. Note that for 
visualization purposes we show averages at a lower detection threshold, meaning that some 
fluctuations in the baseline are shown for comparison. For subsequent panels, thresholds were 
selected to not include baseline fluctuations in the detected discharges. (b) Ictal discharge frequency 
was estimated for non-overlapping 3s sliding windows labelled according to the factor that was 
maximally expressed during the time window. This shows progressive increases in ictal discharge 
frequency for the duration of the seizure. (c) Stereotypy of ictal discharges was measured by 
calculating for each channel the between-discharge correlation for all discharges identified within a 3s 
sliding window. This shows that discharges are very stereotyped early in the seizure and become most 
heterogeneous around the expression of factor 5. 
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3.5 Discussion  
3.5.1 Transparent graphene electrode arrays enable multimodal seizure mapping  
To truly harness the combined advantages of electrophysiology and optical imaging, 
it is necessary to record and image in the same locations simultaneously. While insights have 
been gained by utilizing single micropipette local field potential (LFP) recordings in locations 
proximal to the imaging region [162], these studies do not offer spatial information about the 
propagation of high frequency ictal activity, which requires the use of multi-electrode arrays. 
In recent years, marked progress has been made in realizing transparent microelectrode 
array technology, initially using graphene and more recently utilizing other materials [9]. One 
of the key challenges in developing transparent microelectrodes has been a trade-off between 
optical transparency and electrode impedance. For example, the impedance of graphene 
electrodes, which are subject to graphene’s fundamental quantum capacitance limit [144], 
can be reduced by electrodeposition of platinum nanoparticles on the surface [191], although 
at the expense of optical transparency. In this study, we have optimized the process for 
fabricating transparent graphene microelectrodes by utilizing a bubble transfer method to 
deposit clean and defect-free graphene layers [171], a layer-by-layer HNO3 doping procedure 
[192], and sequentially stacked layers of graphene [193]. This optimization resulted in 
electrodes with a combination of high optical transparency and low impedance which is the 
best reported so far for graphene-based transparent electrodes of this size. 
Electrophysiological signals detected with µECoG are extracellular in origin, and this 
allows mixing of signals from different spatial origins and cell types through volume 
conduction. Thus, even with the most advanced high-density surface µECoG arrays, the 
effective spatial resolution is limited not only by the electrode spacing, but also by the 
contributions of volume conduction and the unknown cellular origins of the recorded signal. 
In contrast, calcium imaging relies on intracellular changes in calcium concentrations which 
can be more precisely localized to their cellular origins. Furthermore, calcium indicators can 
be genetically targeted to provide access to precisely isolated signals from specific neuronal 
subpopulations in a way that is not currently achievable by electrophysiology [194], [195].  
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Here, we used widefield calcium epifluorescence imaging to offer a broad field of view 
encompassing the entire area covered by the 16-channel graphene array. Widefield imaging 
combined with somatically expressed calcium indicators is more sensitive to dendritic 
synaptic currents than individual action potentials, giving a readout of population activity 
rather than individual neuronal firing. For epileptic seizures, which emerge at the population 
level, this resolution is an appropriate spatial scale for subsequent analysis. However, some 
phenomena that characterize seizure activity (e.g. HFOs) cannot be captured with calcium-
based methods at all, given the slow dynamics of both calcium transients and the fluorescent 
calcium indicators. Therefore, our approach allowed us to analyze the complex spatial 
patterns of ictal wavefront progression over a millimeter-scale cortical area in combination 
with spatially distributed measures of electrophysiology. In contrast to previous multimodal 
studies which have utilized cellular resolution multiphoton imaging, our approach also offers 
a much larger field of view.  
To observe the contributions of excitatory neurons to ictal dynamics, in this study we 
utilized an animal model expressing GCaMP6s in excitatory pyramidal neurons. In the future, 
our approach can be extended to study the contributions of inhibitory interneurons. This 
direction would be particularly valuable for shedding light on the delicate balance between 
excitation and inhibition, and its role in seizure propagation, which is currently a subject of 
much debate [152], [154].  
3.5.2 Ictal dynamics unfold on multiple temporal scales  
Seizures are characterized by abnormalities in neuronal dynamics spanning across 
spatial and temporal scales. There is an extensive body of literature mapping these 
phenomena using a variety of recording setups in a range of different model systems [152], 
[196]. Convergent evidence from these studies suggests that at the onset of a focal seizure, 
the cortical sheet organizes into distinct territories characterized by particular dynamics 
signatures [156]. The recruited, intensely active ictal core is separated by an ictal wavefront 
from the surrounding cortex (the ictal penumbra) that may be propagating ictal discharges 
but lacks intense single neuron firing [1], [154]. These distinct seizure territories are best 
characterized by microelectrode arrays that can record invasively from electrodes piercing 
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pial layers and recording within cortical lamina, but evidence has also arisen from imaging 
acute seizure-like events in vitro [154].  
In our analysis, we quantitatively combine surface µECoG recording of ictal onset 
with more spatially resolved calcium mesoscopic imaging, and find that we can identify 
signatures of these distinct seizure territories in our acute in vivo model of epileptic seizures. 
We further replicate previous observations of ictal dynamics unfolding on multiple temporal 
scales: we observe fast spread of individual ictal discharges in both calcium imaging and 
electrophysiology, as well as the slow, wave-like recruitment of the cortical surface into an 
ictal core. Similar findings have previously been described based on a variety of 
electrophysiological features (including multi-unit activity [197]), as well as demonstrated in 
neural field models of cortical physiology [198].  
While previous studies have demonstrated simultaneous electrophysiology and 
imaging, none has so far addressed the challenges that arise in combining and interpreting 
quantitative features from multiple modalities that operate on different spatial and temporal 
scales. Dimensionality reduction techniques, such as NMF, are frequently applied to 
neurophysiological data to extract low-dimensional information from high-dimensional 
signals, and are thus relevant for the multimodal data on which we report in this study [189]. 
NMF provides linear representations of non-negative data, and the algorithm applied here 
contains a sparsity constraint, allowing us to identify low-dimensional factorizations of the 
data that contain only a limited number of active contributors to each factor [199]. To apply 
NMF to multimodal data, modality-specific data matrices are concatenated into a single 
matrix and aligned in time. This procedure allows us to utilize the high temporal resolution 
of electrophysiological data by calculating key quantitative features that have been 
associated with distinct ictal territories – such as phase-locked high gamma. Such features, 
while requiring high temporal resolution to detect, evolve slowly enough in time to be related 
to the slower dynamics identified from calcium imaging. The NMF analysis then provides us 
with temporal loadings on sparse factors that span multiple imaging and electrophysiological 
features, fully leveraging the strengths of both recording modalities. 
Using this approach, we demonstrate that the ictal onset transition – defined by 
changes in the ongoing oscillatory dynamics of electrophysiological recordings – can be 
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factorized using a data-driven approach into a sequence of states that evolve on the time scale 
of minutes. Identification of these spatiotemporal patterns is made possible by the 
combination of recent advances in both transparent electrode fabrication and analytical 
techniques for processing neuronal data. The framework demonstrated here, enabled by our 
transparent graphene array technology, allows characterization of ictal phenomena observed 
with multimodal experimental setups, and helps quantitatively integrate information from 
concurrent calcium imaging and µECoG recordings.  
3.5.3 Data driven multimodal analysis can identify new hypotheses for clinical 
translation  
Recording seizures with multimodal combined µECoG and calcium imaging will not 
be achievable in human patients in the near future. However, there is already evidence that 
experimental high-resolution recordings can aid in the identification of novel biomarkers 
with translational potential. For example, microelectrode mapping of seizure territories has 
led to the identification of phase-locked high gamma as a potential biomarker for the ictal 
core and the seizure onset zone, even on intracranial macro-electrodes [152], [200].  
In our analysis, we similarly illustrate how high-resolution mapping only achievable 
in experimental settings might be used to provide new hypotheses that could be testable in 
clinically achievable recordings. We show that calcium imaging provides data features that 
separate distinct states within a single seizure, even where aggregate electrophysiological 
features suggest only a monotonic, gradual change. We harness information on the putative 
timing of state-changes identified as changes in expression of NMF factors. We achieve this 
by exploring complementary features in the electrophysiological recordings, through which 
we can identify putative electrophysiological correlates of ictal state changes. One example 
of such a putative correlate is a gradual loss of local synchrony with progressive enlargement 
of the seizure core, which can be seen in the changes to the dynamic subnetwork graphs 
moving from factor 2 to factor 6 (Figure 3.13b,d). Similarly, the increasing variability of ictal 
discharges during the established seizure (Figure 3.14c) may be a marker of a specific ictal 
state which is potentially measurable with macroscopic clinical ECoG electrodes.  
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Such changes may be quantitatively subtle, but informative with regard to the 
underlying dynamical system generating ictal dynamics. If seizures are considered a 
pathological stable oscillation around a limit cycle [201]–[203], reductions in stereotypy of 
discharges may indicate that the system is approaching points of instability where closed-
loop interventions may be most successful. These neurophysiological changes, while 
important, may not themselves be quantitatively sufficient to allow separation into states 
from dimensionality reduction approaches as presented here in neurophysiological data 
alone. However, as demonstrated through our analysis, they may be identifiable from 
combined analysis with modalities that are more sensitive to dynamics of distinct seizure 
territories, such as calcium imaging.  
Characterizing individual seizures in such detail is important for several reasons: 
markers associated with distinct spatial territories may guide resective epilepsy surgery and 
identifying dynamically distinct states within a seizure may enable effective targeting of 
stimulation for seizure abatement, harnessing novel closed-loop stimulation approaches for 
the treatment of seizures. Thus, deriving candidate biomarkers from experimental animal 
studies is an essential step in identifying novel treatment strategies for currently untreatable 
epilepsies.  
3.5.4 Methodological considerations and limitations 
While the graphene electrode technology presented here enables recording of fast 
ictal dynamics, we were not able to resolve multi-unit activity (MUA) in this study due both 
to the size of the electrodes (50 µm x 50 µm) and their placement on the cortical surface 
(relatively distant from the cell bodies which lie in deeper cortical layers). Previous studies 
have reported successful recording of MUA from the cortical surface [55], when the 
electrodes are scaled down to cellular dimensions (i.e. ≤ 30 µm in diameter), however the 
high impedance of current transparent microelectrodes has largely prevented the realization 
of functional electrodes at these cellular spatial dimensions. Further progress in transparent 
electrode technology may enable high-fidelity recording from electrodes at this scale in the 
future. Such progress may be achievable by exploring other materials systems which have 
shown promise for optoelectronics and may offer higher conductivity than graphene, such as 
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MXenes [21], [204]. Access to MUA activity can also be achieved by considering alternative 
implantation strategies that place the graphene electrodes closer to cell bodies. Such 
strategies could include brain slice studies or approaches where the array is implanted over 
deep brain structures, such as the hippocampus, utilizing an implanted cranial window [205]. 
The seizure model used in this study is a bath-application of 4-AP, which offers 
experimental control and the ability to reliably induce acute seizures for validating our 
methodology and analytical methods. Yet, the model also has some limitations that are worth 
noting. In particular, it is challenging to discern the effects of drug diffusion on the spatial 
propagation of ictal activity, and the pharmacologically-induced seizure model may not 
replicate ictal dynamics that occur in spontaneous seizures. While offering less experimental 
control, a chronic seizure model in which mice experience spontaneous seizures following 
drug-induced status epilepticus may offer a more naturalistic view of ictal dynamics [206].   
In terms of analysis, the methodological choices make certain assumptions. Applying 
dimensionality reduction techniques (such as NMF) to high-dimensional neuronal data 
assumes that key information is contained in large signal changes affecting a high proportion 
of recording channels. The representational accuracy of the low-dimensional approximation 
of the full dataset can be arbitrarily increased by increasing the number of factors or 
components, and a trade-off between accuracy and interpretability must be made. 
Furthermore, NMF assumes that the dynamics emerge from variable expression of spatially 
invariant factors, rather than changes in the spatial factors themselves. Other conceptual 
approaches or interpretations may prove more useful for specific cases.   
3.5.4 Conclusion   
Novel recording and analysis methods such as the ones introduced here improve our 
ability to quantify and ultimately understand the dynamics of epileptic activity in local 
microcircuits, and brain-wide epileptogenic networks. Concurrently recorded multimodal 
data may be used to address novel biological questions that are not tractable with a single 
method approach. For example, genetically-targeted calcium imaging of inhibitory neuron 
activity during concurrent measurement of the µECoG may enable separating the 
contributions of excitatory and inhibitory cell types to the ECoG signal. Combining µECoG 
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with imaging of cortical vasculature using injected fluorescent probes may also enable linking 
neural activity patterns to changes in blood flow, offering a direct proxy for fMRI studies 
[207]. 
Increasingly, through resective epilepsy surgery and laser ablation for example, 
patients are being offered interventions that aim to disrupt epileptogenic networks in order 
to reduce or stop their seizures. These therapies are currently driven by a crude 
understanding of cortical dynamics at the scale of ECoG signals. This understanding is based 
on coarse physical models, such as mesoscale neural masses representing large 
homogeneous populations of different neuronal subtypes [208] and equivalent current 
dipoles representing the electromagnetic spread of single source signals [209]. The sequence 
of spatiotemporal patterns constituting distinct states in the ictal onset reported here all 
occur at a spatial scale that would classically be regarded as a single source in most ECoG 
models. We now have the technological ability to acquire data at unprecedented temporal 
and spatial resolutions, and have the computing power and analysis methods at hand to 
identify from these complex data the key features that capture the dynamics at play. Through 
high fidelity recordings in experimental systems we will be able to inform the development 
of new hypotheses and models that may more accurately explain the phenomena observed 
in clinical recordings in human patients.    
There is an urgent unmet need for novel therapies for patients who cannot currently 
benefit from resective surgery or antiepileptic medication. Novel treatment approaches such 
as responsive neuromodulation using electrically stimulating devices [210], [211], or novel 
optogenetic closed-loop control strategies [212] are currently already in clinical use or in 
development. Yet such modulation-based treatments require a detailed characterization of 
state transitions in local epileptogenic circuits as well as models of how interventions may 
disrupt these transitions. The integrated recording and analysis approach presented here is 
one strategy to quantify these state transitions utilizing optical and electrophysiological 
measurements. As such, we provide essential tools for epilepsy research to explore novel 
treatments in experimental systems.  
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3.6 Materials and methods  
Graphene device fabrication  
Three inch silicon wafers were coated with 4 µm parylene-C using a CVD process (SCS 
Labcoter 2 Parylene Deposition System). Following photolithography, 10 nm titanium (Ti) 
and 100 nm gold (Au) were evaporated onto the wafer using an electron-beam deposition 
process, and lift-off techniques were used to pattern the metal to form traces and connection 
pads. Monolayer graphene was transferred from a copper foil to the wafer using a wet bubble-
transfer method consisting of the following steps: spin-coat 950 PMMA A4 on 
graphene/copper foil; bake at 100°C for 2 min; apply 20V potential between tweezers 
gripping copper foil and stainless steel counter electrode placed in 1 mM NaOH solution, and 
grip copper foil in tweezers while slowly submerging into NaOH, releasing graphene/PMMA 
from foil; transfer graphene/PMMA to three water baths for cleaning; transfer 
graphene/PMMA onto wafer substrate and let air dry for 2 hrs; bake wafer at 150°C for 2 min, 
then remove PMMA with acetone, IPA (soak for 20 min), and deionized (DI) water rinse. 
Following each graphene transfer to the wafer, the graphene was doped by soaking the wafer 
in 75% HNO3 in DI water at room temperature for 15 minutes and subsequently dried with 
an N2 gun. SiO2 (30 nm) was then deposited onto the wafer using e-beam deposition to protect 
the graphene from damage during subsequent reactive ion etching (RIE) steps. The SiO2 and 
graphene were patterned using photolithography and RIE to form the electrode array and 
traces, such that graphene traces overlapped Ti/Au traces. A second 4 µm layer of parylene-
C was deposited through CVD and subsequently patterned through photolithography and RIE 
to form the outline of the device and to open the graphene electrode sites and Ti/Au contact 
pads. The protective SiO2 layer was removed from the graphene electrode contacts by 
immersing the wafer in 1:6 buffered oxide etchant (BOE) for 30 s. Devices were released from 
the wafer and Kapton tape was applied to the back of the Ti/Au bond pad region to ensure 
proper thickness and stiffness for insertion into a zero insertion force (ZIF) connector and 
connection to the recording amplifier. 
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Electrochemical characterization  
Electrochemical impedance spectroscopy (EIS) measurements were made using a Gamry 
Reference 600 potentiostat/galvanostat/ZRA in standard three-electrode configuration in 10 
mM phosphate buffered saline (PBS) solution (pH 7.4). A graphitic carbon rod was used as 
the counter electrode, and an aqueous (3 M KCl) Ag/AgCl electrode was used as the reference. 
EIS measurements were taken between 1 Hz and 1 MHz using a 20 mV rms AC voltage. Cyclic 
voltammetry measurements were also taken using the Gamry Reference 600 from -0.8 to 0.8 
V, with scan rates of 200, 300, 400, and 500 mV/s and a potential step of 5 mV. The cathodal 
charge storage capacity (CSCC) was calculated by integrating the area under the average CV 
curve and dividing by the sweep rate (50 mV/s).  
Ultraviolet-visible spectroscopy  
Transmission mode UV-vis spectroscopy was obtained using a Perkin-Elmer Lambda-950 
spectrophotometer over wavelengths from 300 to 1000 nm. Spectra were taken for the inter-
electrode space (consisting of top and bottom parylene-C layers only), for a graphene 
electrode contact (consisting of the bottom layer parylene-C and the graphene layer), and for 
a graphene trace (consisting of top and bottom parylene-C layers and graphene layer). 
In vivo imaging and electrophysiological recording  
All experiments were performed under a protocol approved by the Children’s Hospital of 
Philadelphia Institutional Animal Care and Use Committee. Briefly, 6 to 8-week-old Thy1-
GCaMP6 (Jax #025776, Jackson Laboratory) mice were anesthetized with isoflurane (0.5%-
1.5%) in oxygen. Using a micro-drill, a hole was made for inserting a stainless steel skull 
screw with a silver- ground wire. A metal headplate with 6x6 mm2 square imaging well 
(Narishige USA) was fixed to the skull overlying the somatosensory cortex with dental acrylic 
(Ortho-Jet). A rectangular craniotomy was drilled (right hemisphere, center at 2 mm 
posterior and 2 mm lateral of bregma). The exposed cortical surface was kept wet by ACSF 
containing the following (in mM): 155 NaCl, 3 KCl, 1 MgCl2, 3 CaCl2, and 10 HEPES. After the 
craniotomy surgery, aesthetic was switched to ketamine/xylazine (100/10 mg /kg) and the 
headplate was attached to a small imaging platform (Narishige USA) and mounted on an x,y- 
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translational stage of an upright microscope (Olympus BX-61). The graphene electrode array, 
a custom-connector, and the headstage (SmartLink16, NeuroNexus) were attached to a 
stainless steel bar, which was then attached to a micro-manipulator. The graphene electrode 
array was gently placed on the cortical surface. Signals from the graphene electrode array 
were sampled at 5 kHz via the headstage and the controller (SmartBox, Neuronexus), and the 
data was saved to a PC. The microscope was equipped with blue LED (470nm, Thorlabs), a 
filter cube (49002, Chroma) and sCMOS camera (Orca Flash 4 V2, Hamamatsu). The imaging 
data was captured in TIF format on another PC, and timing of electrophysiological recording 
and imaging was synched by a TTL signal. For epifluorescence imaging, excitation light was 
continuously illuminated and fluorescence images were captured at a constant acquisition 
rate of 10 Hz. Baseline activity was recorded for 20 min prior to seizure induction.  Local 
seizure induction was achieved via bath-application of 100 μL of 4-amino pyridine (4-AP) in 
ACSF (30 mM) on the exposed cortical surface adjacent to the graphene electrode array. 
SNR calculations 
To compute SNR on each electrode, the mean amplitude of 8 ictal spikes that occurred during 
a 4-second window during seizure onset was divided by the RMS of the signal during a 3-
second window of pre-seizure baseline activity.  
Dynamic feature extraction  
Quantitative analysis was performed on custom scripts on MATLAB R2019a; all scripts to 
reproduce analysis figures are available online on https://github.com/BassettLab/Graphene-
Electrode-Seizures.  
Features from µECoG 
For this analysis, we extracted quantitative features that dynamically evolve at a time scale 
similar to that evident in the features of calcium imaging. Specifically, we estimated time-
varying phase locked high gamma amplitude, frequency-band specific power in two 
frequency bands, and sliding-window dynamic functional connectivity.   
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Phase-locked high gamma: We estimated phase-locked high gamma amplitude 𝑎ɸ following 
prior work[152]. Briefly, we applied the Hilbert transform separately to the data recorded at 
each microelectrode contact, after filtering each into two distinct frequency bands: a low 
frequency band (1-40 Hz) and a high frequency gamma band (80-250 Hz). From the Hilbert 
transform we were then able to calculate low frequency instantaneous phase ɸ , and high 
frequency instantaneous amplitude normalized by the average band-passed amplitudes at 
baseline a . From a second Hilbert transform, we derived the instantaneous phase of the 
slowly time-varying instantaneous amplitude of the high frequency content ɸ . From 
these values, we calculated the phase locked high gamma amplitude as a measure of 
normalized high frequency amplitude weighted by the mean cross-frequency band phase 
correlation. Specifically, we calculated this variable within the sliding window ranging from 
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We calculated this variable through sliding windows of length 3s and then then interpolated 
linearly to a full sampling frequency of 10Hz to enable cross modality analysis with the 
imaging features.  
Frequency band-specific power: We calculated frequency band-specific power using the 
Hilbert transform on time series filtered into low (1-40 Hz), and high (80-250 Hz) frequency 
components, tracking evolution of most of the classically visible frequency ranges, and of high 
frequency oscillations separately. We estimated band-specific power in 3 second non-
overlapping sliding windows, before interpolating to the 10 Hz sampling frequency of the 
calcium imaging in order to track slow modulations of frequency power.  
Functional connectivity: To estimate functional networks, we calculated pair-wise 
correlations between individual microelectrode contacts. Full correlation matrices were 
estimated for sliding 3 second windows, edges with correlation values of < 0 were reset to 0, 
and edge-wise temporal evolution was interpolated to the sampling frequency of the calcium 
imaging at 10 Hz.  
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Features from calcium imaging 
For our analysis we derived normalized measures of fluorescence intensity during the 
seizure, as well as a measure of each pixel’s proximity to a putative ictal wave front. Imaging 
yielded raw epifluorescence image sequences for the baseline period, and from the period 
following the application of the chemoconvulsant 4-AP. We used the baseline period to 
quantify pixel-wise mean fluorescence, and fluorescence intensity variability (estimated as 
the standard error of the mean). From the baseline mean and standard error maps, we then 
calculated a t-statistic map for each image in the sequence following chemoconvulsant 
exposure, where 𝑡 = (𝑥 − 𝜇 )/𝜎 ̅ , with 𝑥 being the sample value, 𝜇  the baseline mean, 
and 𝜎 ̅  the baseline standard error of the mean.   
In order to coarse-grain the data, we applied a 2-dimensional gaussian filter with a width of 
15 pixels to each t-map in the sequence, and binarized the resultant images at a manually 
selected threshold that would first be crossed at the time of visually apparent electrographic 
seizure onset. We detected the edge of these binarized maps at each time point and convolved 
the edges with a two-dimensional Gaussian kernel with a width of 15 pixels, which yielded a 
measure of proximity of each imaging pixel to the putative ictal wave front. 
Finally, we sampled both raw fluorescence, and proximity to the putative wavefront from the 
imaging pixels underlying each of the 16 microarray contacts, generating 16 time series for 
both measure, which were then used in the subsequent analysis.  
Non-negative matrix factorization  
We used non-negative matrix factorization on a multimodal feature matrix containing the 
time varying features estimated above in order to identify a subset of composite factors, 
whose time-varying expression could recapitulate the multi-modal feature evolution 
observed in the data. NMF will decompose any 𝑛 ∗ 𝑡 feature matrix 𝑉 (where 𝑛 is the number 
of features, and 𝑡 is the number of temporal samples) into a set of 𝑘 factors (i.e., sets of 
features encoded in the 𝑊 matrix) and their temporal evolution (encoded in the 𝐻 matrix), 
so that the full matrix 𝑉 can be approximately reconstructed from these factors (i.e. 𝑉 ≃
𝑊𝐻 ).  
 
Chapter 3: Multimodal seizure mapping with transparent graphene electronics 
 
 74   
 
In terms of network analysis, these approaches have been previously used to decompose 
dynamic functional connectivity into sets of variably expressed subnetworks and track their 
temporal evolution in human neuroimaging [168]–[170]. Here, we extend the application of 
the approach to integrate data features across modalities and feature types. In contrast to the 
original formulation of the method, the algorithm applied here uses additional sparsity 
constraints and has been previously described elsewhere [187], [188]. The full feature matrix 
𝑉 was concatenated from channel-specific time series of broadband LFP (1-40 Hz), and high 
gamma (80-250 Hz) band power, normalized fluorescence amplitude, and wave front 
proximity estimates, as well as the 𝑛 (𝑛 − 1)/2 unique edge-weights unfolded from the 
symmetrical correlation-based 𝑛  functional connectivity matrix, where 𝑛  is the number of 
channels.   
Ictal discharge analysis 
We quantified between-state differences in features of ictal discharge. For this we divided the 
whole seizure recording included in the NMF analysis into 3s long non-overlapping time 
windows, labelled according to the factor that was maximally expressed during each window. 
We z-transformed data for each time window using baseline data to calculate normalizing 
mean and standard deviations individually for each channel. In the resultant z-normalized 
time series, we identified putative ictal discharges as negative deviations of an amplitude of 
z > 3.9 and a width of at least ~30ms. These parameters were identified by a clinician with 
training in epilepsy (RER) visually confirming that the detected events were ictal in nature, 
and no baseline events were detected (for visualization purposes in Fig 6a, the thresholds 
were slightly relaxed in order to allow inclusion of some baseline detections – but those were 
not included in subsequent statistical analysis).   
We calculated the average inter-discharge interval for each time window as an inverse 
measure of spike frequency. We also estimated the correlation of all ictal discharges within a 
time window. For this we segmented out ictal discharges from 50ms prior to the peak 
amplitude to 150ms after peak amplitude, and calculated Pearson’s correlation coefficient 
between each pair of these segments within time windows and channels. We then averaged 
all correlation coefficients to estimate a single mean correlation value per 3s window, 
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representing ictal discharge stereotypy. We compared each pair of sequential states (defined 
by their factor expression) by Wilcoxon ranksum comparison of discharge frequency and 




Chapter 4: High-resolution neural interfaces using Ti3C2 
MXene  
High-resolution neural interfaces are essential tools for studying and modulating 
neural circuits underlying brain function and disease. As we saw in the previous chapter, they 
can enable new insights into brain dynamics at the microscale that underly phenomena such 
as epileptic seizures. To achieve high spatial resolution and channel count, however, 
electrodes must be miniaturized, even down to the scale of individual neuronal processes 
(~10s of µm). At these scales, maintaining low electrode impedance and high signal quality 
becomes a significant challenge. Nanostructured materials can address this challenge, as they 
can combine high electrical conductivity with mechanical flexibility and can interact with 
biological systems on a molecular scale. Unfortunately, fabricating high-resolution neural 
interfaces from nanostructured materials is typically expensive, time consuming, and does 
not scale, which precludes translation beyond the benchtop. Two-dimensional (2D) Ti3C2 
MXene possesses a combination of remarkably high volumetric capacitance, electrical 
conductivity, surface functionality, and processability in aqueous dispersions distinct among 
carbon-based nanomaterials. In this chapter, I develop a high-throughput microfabrication 
process for constructing Ti3C2 microelectrodes and I demonstrate their superior impedance 
and in vivo neural recording performance in comparison to standard metal microelectrodes. 
Specifically, when compared to gold microelectrodes of the same size, Ti3C2 electrodes exhibit 
a 4-fold reduction in interface impedance. Furthermore, intraoperative in vivo recordings 
from the brains of anesthetized rats at multiple spatial and temporal scales demonstrate that 
Ti3C2 electrodes exhibit lower baseline noise, higher signal to noise ratio (SNR), and reduced 
susceptibility to 60 Hz interference than gold electrodes. Finally, I present a neuronal 
biocompatibility study showing that neurons cultured on Ti3C2 are as viable as those in 
control cultures, and they proliferate, grow axonal process, and form functional networks. 
Overall, these results indicate that Ti3C2 MXene microelectrodes have the potential to become 
a powerful platform technology for high-resolution bioelectronic interfaces.  
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4.1 Introduction  
Understanding the fundamental mechanisms governing the structure and function of 
neural circuits is critical for treating neurological disorders like epilepsy, depression, and 
Parkinson’s disease. Microelectrode technologies are widely used to elucidate neural 
dynamics on fine spatial and temporal scales (~10-100 µm, 1 ms). However, recording stable 
neural signals with high signal-to-noise ratio (SNR) from micro-scale electrodes remains a 
significant challenge. Current microelectrode arrays are stiff, invasive, and limited in their 
ability to provide high fidelity long-term recordings because conventional electrode 
materials, including metals and silicon, are inadequate for interfacing with biological tissues. 
The significant mechanical mismatch between conventional electrode materials and the soft 
brain tissue elicits an inflammatory response that eventually results in the formation of an 
insulating glial scar around the implant [213]. Additionally, as the geometric area of an 
electrode is decreased to approximate the size of individual neuronal processes, a 
corresponding rise in the electrochemical interface impedance leads to an increased 
susceptibility to noise sources, including thermal noise, mains interference, and signal loss to 
shunt pathways, which ultimately degrade signal quality [10]. Solving these issues to achieve 
seamless, stable, long-term integration between man-made devices and neuronal structures 
requires innovation in bioelectronic materials. 
One strategy commonly adopted to overcome the trade-off between electrode 
footprint and interface impedance is to increase the effective surface area over which ionic 
species in the extracellular space can interact with the electrode. This is achieved through 
nanopatterning [11], surface roughening [12], or electroplating with porous additives[10], 
[13]. Nanomaterials such as graphene [16], carbon nanotubes [126], [133], and nanowires 
[214] show great promise for high-resolution neural interfaces because they offer high 
specific surface areas, and desirable thermal, electronic and mechanical properties, including 
flexibility and high conductivity [215]. However, the lack of scalable assembly methods is a 
key barrier to their widespread adoption for neural interfaces. For example, carbon-based 
nanomaterials are typically hydrophobic and require the use of surfactants [216], superacids 
[217], or surface functionalization [218] to allow fluid-phase assembly from aqueous 
dispersions. Residues from surfactants or superacids used in assembly are difficult to remove 
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completely and can be detrimental to electrode performance [219] or toxic to biological 
tissues [220], respectively. Surface functionalization induces defects and reduces the 
conductivity and strength of the resulting structures [218]. Besides solution processing 
methods, chemical vapor deposition (CVD) can also be used to assemble carbon-based 
nanomaterials into thin films for neural electrodes. However these processes are conducted 
at high temperatures that are incompatible with many flexible, biocompatible polymeric 
substrates [221], and thus require tedious subsequent steps to align and transfer the films 
from the catalyst layer to the polymeric substrate [222]. 
MXenes are a large class of 2D nanomaterials, composed of early transition metal 
carbides, nitrides, and carbonitrides that present an exceptional combination of high 
electrical conductivity, strength, flexibility and volumetric capacitance [18]. MXenes contain 
abundant surface terminating functional groups, such as hydroxyl (–OH), oxygen (–O) or 
fluorine (–F), which make them hydrophilic and also allow for flexible surface modification 
or functionalization. MXenes’ hydrophilicity enables the use of high-throughput solution 
processing methods without the need for surfactants, superacids, or surface 
functionalization, and may also provide opportunity for creating functionalized platforms for 
drug delivery or electrochemical sensing. While much of the early research on MXenes 
focused on applications in energy storage [18], [22], more recent work has shown that 
MXenes hold great promise for biomedical applications as well. In the following section, 4.2, 
I will expand upon the synthesis, properties, and biomedical applications of MXenes to 
provide additional context for this chapter. 
Of the dozens of MXenes that have been discovered, the first MXene, Ti3C2, has been 
the most extensively studied, characterized, and optimized [223]–[225]. Ti3C2 demonstrates 
remarkably high volumetric capacitance (1,500 F/cm3) [22] and electronic conductivity 
(~20,000 S/cm) [226]. The volumetric capacitance of Ti3C2 exceeds that of activated 
graphene (~60–100 F/cm3) [227], carbide-derived carbons (180 F/cm3) [228], and graphene 
gel films (~260 F/cm3) [229]. The outstanding electrical properties of Ti3C2, coupled with its 
processability and high specific surface area make it an extremely promising material for 
neural interfaces, particularly for overcoming the trade-off between geometric surface area 
and electrochemical interface impedance, which is a primary limitation to achieving high-
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fidelity recording from micro-scale electrodes. The high capacitance of Ti3C2 films is also a 
significant advantage for biosensing and stimulation applications, where capacitive electrode 
interfaces are preferable as they avoid harmful Faradaic reactions. Finally, the hydrophilic 
nature of Ti3C2, an uncommon attribute among carbon-based nanomaterials, allows the use 
of simple, scalable, high-throughput solution processing methods. 
Prompted by its outstanding properties, in this study we investigate the suitability of 
Ti3C2 MXene for high-resolution, implantable electrodes for neural signal sensing. First, we 
describe a high-throughput fabrication process which combines standard photolithographic 
patterning with an ad-hoc method for forming precise, micropatterned MXene films from a 
colloidal solution on flexible polymeric substrates. Using this custom approach, we 
demonstrate the feasibility of producing implantable, multichannel neural electrode arrays 
comprised of Ti3C2, developing different geometries for recording both from the cortical 
surface and from deeper brain regions. We show that Ti3C2 electrodes exhibit markedly 
reduced impedance compared to gold (Au) electrodes of the same size, and that this 
impedance reduction is accompanied by significant improvement in neural recording signal 
quality in vivo. In particular, when used in vivo for high-fidelity recording of neural spiking 
activity, Ti3C2 electrodes show significantly improved sensitivity, reduced noise, and the 
ability to detect a larger number of spikes compared to Au electrodes. Finally, we 
demonstrate that Ti3C2 MXene is biocompatible with neuronal cultures and does not affect 
cell viability, proliferation or synapse formation, though neurons are known to be highly 
sensitive to their local environment and surface interactions. 
4.2 MXenes: background and prior work 
 4.2.1 Synthesis and properties  
MXenes, which are a large family of early transition metal carbides, nitrides, and 
carbonitrides, were first discovered in 2011 by Drexel University scientists [223]. They are 
produced by selectively etching out the A layers from MAX phases, which are so-called 
because of their composition: Mn+1AXn, where M is an early transition metal, A is a group 13 
or 14 element of the periodic table, X is carbon and/or nitrogen, and n = 1, 2, or 3. Single-layer 
MXene flakes are generally produced by first etching the A element from the MAX phase using 
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acid and salt mixtures, such as pure hydrofluoric acid (HF), HCl + LiF (forming HF in situ), or 
HF + HCl, and subsequently delaminating the sheets from each other through intercalation 
with organic molecules, such as dimethyl sulfoxide (DMSO), or with solvated Li+ ions [230] 
(Figure 4.1). This top-down selective etching procedure is far more scalable than bottom-up 
approaches, such as chemical vapor deposition (CVD) or physical vapor deposition (PVD), 
which are required for producing many other 2D materials [231].  
Methods for synthesizing single-layer MXene flakes are still evolving and undergoing 
optimization, and the synthesis conditions have a large effect on the properties of the 
resulting MXene material [231]–[233]. For example, early methods of producing single-layer 
Ti3C2 required sonication to complete the delamination, however more recently a method 
called the minimally intensive layer delamination (MILD) method was developed which made 
it possible to isolate single flakes of MXene using manual shaking rather than sonication. This 
resulted in larger single flakes, which could produce films with higher conductivity [233]. 
Another very recent advance has been the development of methods for synthesizing fluorine-
Figure 4.1 Schematic for the exfoliation process of MAX phases and formation of MXenes. Note 
that there are now many variations on this method, not all using HF and not all requiring sonication to 
separate the 2D MXene sheets. From [373]. 
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free MXenes without using HF-containing or HF-forming chemicals, offering improved safety 
[234].   
MXenes have a number of interesting physical, chemical, and electrical properties 
which make them attractive for a wide range of applications. The presence of surface 
terminating functional groups, such as hydroxyl (–OH), oxygen (–O) or fluorine (–F) (the 
composition of the surface terminations can be tuned by varying the processing conditions 
[235]), renders MXenes hydrophilic, which is unusual among 2D materials. This means that 
MXenes are stable in surfactant-free water-based colloidal solutions and can be processed 
using highly scalable solution processing methods. The surface terminations, along with the 
high specific surface area of the 2D sheets, also provide opportunity for flexible 
functionalization of the surfaces of MXene flakes, such as with antibodies or drugs [236]–
[238]. Furthermore, the ultrathin layered structure gives MXenes interesting physiochemical 
properties (e.g. photothermal conversion [239], [240], X-ray attenuation [241], [242], and 
localized surface plasmon resonance [243], [244]) and biological behaviors (e.g. 
biodegradation [239], [245] and cellular endocytosis [241]). Regarding their electrical 
properties, MXenes show metallic electronic conductivity of up to 15,000 – 20,000 S/cm, 
which is higher than all other solution-processed 2D materials [226], [246]. In fact, the unique 
combination of hydrophilicity and metallic conductivity is a key advantage for MXenes over 
graphene and its derivatives. MXenes also have extremely high volumetric capacitance 
(~1,500 F/cm3) [22], which led early research efforts to predominantly focus on energy 
storage [18].  
Since their initial discovery, more than 30 MXene compositions have been 
synthesized and dozens more have been theoretically predicted. Each composition offers a 
unique combination of properties, and potentially even a way to tune the properties by 
varying ratios of M or X elements. To date, the first MXene, Ti3C2, has been the most 
extensively studied and optimized, with more than 70% of all MXene research focusing on 
this single composition [247]. In this thesis, Ti3C2 is the MXene composition of choice because 
at the time of these studies it was the most well-optimized, well-studied, and considered to 
be the most electrically conductive. It is quite possible that other compositions of MXene may 
in time prove even more optimal for biomedical applications such as the ones presented in 
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this thesis work, and even open the doors to new areas of research which have not yet been 
explored. 
4.2.2 Biomedical applications  
As noted above, much of the early research on MXenes focused on energy storage, and 
it is still the dominant area of MXene research. In just the past few years, however, the number 
of applications which have been explored using MXenes has rapidly expanded (Figure 4.2). 
The use of MXenes in the biomedical field first gained traction in 2017, and since then there 
Figure 4.2 Explored applications of MXenes to date. The center pie chart shows the ratio of 
publications in each explored application/property of MXenes with respect to the total number of 
publications on MXenes. The middle pie chart ring, with the same colors, shows the starting year for 
exploration of each application/property of MXenes. NB: although there may be one or two papers 
published prior to the mentioned year, we considered a year with several significant publications as 
the starting (breakthrough) year for each slice. The outer ring shows the ratio of publications on 
Ti3C2Tx MXene versus all other MXene compositions (M2XTx, M3X2Tx, and M4X3Tx). From [374]. 
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has been an explosion of interest. The earliest biomedical-related research using MXenes 
focused on biosensors for small molecule detection, using the nanolayered structure and 
surface functional groups of Ti3C2 to immobilize enzymes for electrochemical detection of 
small molecules such as H2O2 [248] and glucose [249]. Next, MXene was demonstrated for 
cancer theranostics, both as a photothermal conversion agent for in photothermal therapy 
[240], and as a contrast agent for diagnostic imaging techniques such as computed 
tomography (CT), photoacoustic (PA), and magnetic resonance imaging (MRI) (when Ti3C2 is 
decorated with magnetic nanoparticles) [250]. In photothermal therapy, the characteristic 
800 nm absorption peak of Ti3C2 enables efficient conversion of near infrared (NIR) radiation 
to heat in order to ablate tumor cells [240]. The nanosheets preferentially accumulate in 
tumor tissue due to the characteristic high permeability of tumor blood vessels, which allows 
targeted ablation, diagnostic imaging, and also chemotherapeutic drug delivery [251]. Of the 
biomedical applications of MXenes shown to date, cancer theranostics has emerged as one of 
the most promising and well-studied [242], [252]–[254].  
Another interesting application of MXenes in biomedicine has been in dialysis. It has 
been shown that Ti3C2 can selectively adsorb urea from dialysate through binding at the 
surface terminations on the MXene flakes, offering great potential for the realization of a 
wearable artificial kidney [255]. Yet another promising area of research has been in wearable 
mechanical sensors based on MXene. These have predominantly been strain gauge or 
pressure sensors which can be used for tracking limb movement [256] or even decoding 
facial expressions [257] or speech [258]. Beyond these applications, MXenes have been 
explored for pH sensing [259], detection of metabolites in sweat [260], and as antimicrobial 
agents [261], [262].  
Given the high electrical conductivity of MXenes, it seemed natural that they might 
perform well as electrodes for electrophysiological recording from excitable tissues such as 
the brain, muscles, and heart. When I began working on developing MXene electrodes for 
electrophysiology in 2017, however, no other group had yet reported this. The closest 
predicate was a single report from 2016 describing a Ti3C2-based field-effect transistor (FET) 
that could detect the spiking activity of neurons in culture, though it did so by electrochemical 
detection of dopamine rather than by directly recording the extracellular voltage fluctuations 
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[263]. In this chapter and the next, I detail how our group pioneered the use of MXenes for 
recording and stimulating electrodes that directly interface with excitable tissues, thus 
opening a new field of MXene bioelectronics.  
As interest in using MXenes for biomedical applications has grown, so too has 
evidence showing their excellent biocompatibility, which is always an important concern 
whenever nanomaterials are used to interface with biology. One study showed that 
intravenous injection of Ti3C2 into healthy mice at doses up to 20 mg kg-1 did not produce any 
measurable behavioral change, weight loss, change in blood indexes, change in liver or kidney 
function, or toxicology in any major organ [250]. A similar study evaluating the 
biocompatibility of intravenously administered Nb2C MXene also found no measurable 
toxicity in mice [239]. One factor contributing to the lack of toxicity when MXenes are 
administered intravenously is the fact that MXenes have been shown to be biodegradable 
[239], [245], [264]. Thus, they do not accumulate in tissues as micron-sized particles, but 
rather break down into small molecules such as TiO2 (from Ti3C2 MXene) which can be 
cleared from the body. In addition to the intravenous studies, a series of acute toxicity, 
locomotion, and neurotoxicity assays performed in a zebrafish embryo model indicated that 
Ti3C2 could be classified within the “practically nontoxic” group according to the Acute 
Toxicity Rating Scale by the Fish and Wildlife Service [265]. Several studies have also found 
little evidence of cytotoxicity for cells cultured with MXenes [251], [263], [266]. While more 
systematic evaluations are needed, these and other studies indicate that MXenes are safe and 
biocompatible.   
Finally, it is important to note here that MXenes suffer from limited stability in 
physiologic conditions, where oxidation causes degradation of the MXene flakes [267], [268]. 
This is advantageous in applications where biodegradation is desired, but it becomes a 
challenge when the MXene is instead part of a system or device where long-term function 
inside the body is preferable, such as for chronically implanted neural electrodes. In just the 
past few years, however, significant progress has been made toward improving the oxidation 
stability of MXenes [226], [269]–[271]. Thus, it is possible that MXenes may be viable for use 
in long-term implantable devices in the near future.   
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4.2.3 Patterning methods  
 Interest in using MXenes in electronic devices has exploded in the past few years. One 
of the primary challenges of incorporating MXene into devices has been achieving reliable 
patterning of the material with high resolution. This challenge is mainly relevant when 
devices require sub-millimeter spatial resolution. For example, in this thesis chapter I sought 
to develop microscale neural electrodes using MXene, which required patterning the material 
with spatial precision of ~5 µm.  At the time, no method had yet been developed to allow 
precise patterning of MXene at these resolutions. Thus, in this chapter I describe a method I 
developed, which uses a selective lift-off process combining photolithography and reactive 
ion etching (RIE) to form a polymeric shadow mask. In the years since, many advances have 
been made and new methods for patterning MXene have been described, however the 
method described in this thesis chapter still appears to offer the highest spatial resolution to 
date.  
 One of the most common methods of patterning MXene is ink-jet printing. Several 
studies have focused on tuning the rheological properties of MXene-based ink to push the 
limits of ink-jet printing resolution [272]–[274]. Of these, the highest resolution reported is 
~40 µm [272]. Another interesting patterning method demonstrated by B. Lyu et al. is the use 
of UV/ozone treatment of a substrate with an overlaid shadow mask to render the substrate 
selectively hydrophilic [275]. Subsequent dip-coating in MXene ink resulted in selective 
wetting in the patterns exposed through the shadow mask in order to form organic field-
effect transistors (OFETs) with MXene source and drain electrodes sized 1000 x 200 µm. 
Another high-resolution patterning method which has been described is micro-contact 
printing using PDMS stamps with 20 µm-wide alternating grooves and ridges [263].   
 A few other interesting approaches which have been demonstrated for patterning 
MXene include automated scalpel patterning, which can engrave thin MXene films with an 
interspace resolution of 0.1-0.2 mm [276], laser cutting [277], and direct writing [278]. These 
approaches give somewhat lower spatial resolution than those listed above, however they 
represent highly scalable methods suitable for producing devices where micron-scale 
resolution is not needed.  
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4.3 Preparation and characterization of Ti3C2 MXene for neural 
electrodes 
We synthesized Ti3C2 MXene by selectively etching the aluminum atomic layers from 
its ternary carbide MAX phase precursor (Ti3AlC2) in aqueous hydrofluoric (−HF)/ 
hydrochloric (HCl) solution for 24 hours. After washing, intercalation and delamination was 
performed using LiCl and several steps of centrifugation and re-suspension. After collecting 
the supernatant containing well-dispersed single-layer Ti3C2 flakes, the solution was Argon 
bubbled, and packaged in an Argon-sealed headspace vial to ensure longevity. This process 
is outlined in Figure 4.3. This Ti3C2 solution could be used to spin-coat Si wafers on which 
devices are fabricated. An overview of the process flow from Ti3C2 synthesis, through device 
fabrication, to final application in neural signal recording is shown in Figure 4.4a, along with 
the atomic structure of Ti3C2. The atomic model shows the –OH termination for simplicity, 
however the MXenes produced for this study have a distribution of –F, –OH, and –O 
terminations. We characterized the Ti3C2 MXene by scanning electron microscopy (SEM), 
dynamic light scattering, and UV-vis spectroscopy. SEM of Ti3C2 flakes deposited on a porous 
Figure 4.3 Schematic depicting MXene synthesis procedure. (a) Ti3AlC2 MAX is added to a 
selective etchant solution (HF, HCl, and DI H2O), resulting in the removal of aluminum (Al). (b) After 
washing the etching solution to neutral pH using DI H2O, multilayered Ti3C2 is obtained. Multilayered 
Ti3C2 is intercalated with Li+ from an aqueous solution of lithium chloride (LiCl). (c) After washing 
the intercalation reaction, sediment swelling is observed representing the exchange of Li+ with H2O. 
Agitation of the swollen sediment results in exfoliated (or delaminated) single- to few-layer flakes of 
Ti3C2 MXene in H2O. Size selection and separation of delaminated Ti3C2 MXene from multilayered 
Ti3C2 and Ti3AlC2 MAX phase occurs at this stage. (d) Ti3C2 MXene ink is transferred via syringe to 
an Argon sealed headspace vial for long-term storage.  
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alumina membrane from the MXene colloidal solution reveals flake-like morphology and µm-
scale lateral size (Figure 4.4b). Single-layer MXene flakes have a thickness of ~ 1 nm and 
lateral sizes in the range of a few hundred nm to few microns, depending on the synthesis 
Figure 4.4 Synthesis, characterization, and application of Ti3C2 for neural recording. (a) 
Schematics illustrating synthesis and atomic structure of Ti3C2, fabrication of Ti3C2 neural 
microelectrode arrays, and application of Ti3C2 arrays for recording brain activity at different 
locations in the rat brain. (b) SEM image of Ti3C2 flakes deposited onto an alumina membrane. The 
arrows point to Ti3C2 flakes on the membrane. (c) Dynamic light scattering particle size intensity 
distribution (percent) of the Ti3C2 solution in terms of hydrodynamic size (d, nanometer) (d) UV−vis 
absorption spectra of the Ti3C2 aqueous solution diluted 1000×. (e, f) Schematics and bright-field 
microscopy image of (e) Ti3C2 micro-ECoG array and (f) Ti3C2/Au intracortical electrode array. 
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process [224]. For application to neural electrodes, flakes with large lateral size are 
preferable because they produce films with higher conductivity [224]. Thus, we disperse the 
Ti3C2 flakes in solution by manual agitation rather than sonication, as it is gentler and 
produces samples with larger flakes. To determine the distribution of flake sizes in our 
sample, we performed dynamic light scattering on a dilute Ti3C2 solution. The intensity 
distribution reveals a Z-average of 1406 ± 77 nm, a polydispersity index of 0.390, with three 
noticeable peaks located at 1.6 μm (81.1%), 6.8 μm (16.8%) and 164 nm (2.1%), indicating 
the percent intensity of different sized flakes (Figure 4.4c). Finally, to confirm the 
composition of the Ti3C2 aqueous dispersion, we performed UV-vis spectroscopy from 200-
1000 nm. The material in solution absorbed light at the characteristic UV-vis-NIR 
wavelengths for Ti3C2, showing high UV absorption and a broad peak from 760-800 nm 
(Figure 4.4d).  
4.4 Development of Ti3C2 MXene neural electrode arrays 
4.4.1 Fabrication optimization  
To evaluate the performance of Ti3C2 as a bioelectronic material for recording neural 
activity at different spatiotemporal scales, we designed two different electrode array 
geometries. The first electrode array is a 3x3 micro-electrocorticography (micro-ECoG) array 
consisting of 50 µm x 50 µm square electrode contacts with 300 µm pitch, covering a total 
recording area of 750 µm x 750 µm, for recording field potentials from the cortical surface 
(Figure 4.4e). We fabricated micro-ECoG arrays of both gold and Ti3C2 contacts for 
comparison. The second electrode array is a 10-channel laminar array with pairs of 25 µm-
diameter Ti3C2 and Au contacts arranged in a side-by-side “stereotrode” configuration (i.e. 
close enough that each electrode in a pair could plausibly record from the same neurons) 
(Figure 4.4f) [279]. This configuration enables recording the spiking activity of individual 
neurons within deeper brain structures and allows direct comparison of the signals recorded 
by the two types of electrode materials.  
Unlike most carbon-based nanomaterials, the surface of Ti3C2 is inherently 
hydrophilic due to the surface terminations present, thus enabling dispersion in aqueous 
solution without the need for surfactants or strong acids. This property is particularly 
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favorable for developing high-throughput microfabrication processes and patterning high-
quality Ti3C2 films onto flexible, biocompatible polymeric substrates. To precisely and 
reliably micropattern Ti3C2 recording contacts and interconnects on flexible parylene-C 
substrates, we developed and optimized an ad-hoc spin-coat and dry lift-off technique, similar 
to previously-reported techniques for micropatterning thin films of organic polymers such as 
PEDOT:PSS [280]. Briefly, we applied an antiadhesive layer to the wafer, followed by a 
sacrificial parylene-C layer. Patterns in this sacrificial layer were defined by photolithography 
and etched by oxygen plasma reactive ion etching (RIE). Then, we spin-coated the Ti3C2 
colloidal solution onto the wafer, thoroughly dried it, and peeled up the sacrificial parylene 
layer to leave Ti3C2 films behind only in the patterns that had been etched through the 
sacrificial layer. Using this technique, we were able to pattern Ti3C2 features with high fidelity 
and reproducibility. A detailed description of the fabrication procedure outlined in the 
Methods section of this chapter (Section 4.8), and a schematic of the procedure is shown in 
Figure 4.5. 
It is worth noting that we designed the devices such that Ti3C2 contacts and traces 
overlapped with gold traces outside of the electrode array, so that Ti3C2 was the sole material 
comprising the electrode contact and exclusively responsible for the device’s impedance and 
Figure 4.5 Fabrication of multi-channel Ti3C2 neural electrodes. Fabrication process: pattern 
metal traces and connection pads on bottom parylene-C layer; deposit an anti-adhesive layer (1% 
Micro 90) and a sacrificial parylene-C layer; use photolithography and oxygen plasma RIE to pattern 
the sacrificial parylene-C layer; spin coat Ti3C2 and thoroughly dry the film; peel up the sacrificial layer, 
leaving Ti3C2 patterns behind; deposit top parylene-C layer; use photolithography and oxygen plasma 
RIE to pattern and etch open electrode and Au bonding pad contacts; release completed device from 
wafer. 
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recording performance. To provide adequate mechanical strength for precise insertion of the 
intracortical arrays into the brain along a straight trajectory, we manually aligned and affixed 
micromachined steel backings to the parylene substrate with a thin layer of 
polydimethylsiloxane (PDMS). Finally, for interfacing the devices with the data acquisition 
systems, we connected the assembled devices to custom printed circuit boards (PCBs) via 
zero insertion force (ZIF) connectors.  
4.4.2 Characterization of Ti3C2 neural electrodes   
We used electrochemical impedance spectroscopy (EIS) in a three-electrode 
configuration to characterize the electrochemical behavior of the electrode-electrolyte 
interface (Figure 4.6a). At the 1 kHz reference frequency, the 50 µm x 50 µm Ti3C2 and Au 
micro-ECoG electrodes show impedance values of 52 ± 25 kΩ and 206 ± 31 kΩ, respectively, 
while the impedance of 25 µm diameter Ti3C2 and Au intracortical electrodes is 219 ± 60 kΩ 
and 865 ± 125 kΩ, respectively (Figure 4.6b) (Student’s t-test, p < .001). In both cases, Ti3C2 
electrodes exhibit roughly 4-fold lower impedance than comparable Au contacts, showing an 
advantage in utilizing Ti3C2 as the active material. The Ti3C2 electrodes exhibit a more 
complex phase behavior than the Au electrodes, which display predominantly capacitive 
behavior (Figure 4.6a). It has been well established that Ti3C2 exhibits mainly capacitive 
charge transfer mechanisms [281], [282], and the roughness and porosity of the film 
contributes to its behavior as a non-ideal capacitor, as shown by the higher values of the 
impedance phase. Furthermore, the functional groups on the surface of the Ti3C2 flakes can 
interact with the ionic species in the electrolyte, possibly leading to mixed charge-transfer 
mechanisms.  
One attribute that can reduce electrode impedance is the overall surface roughness 
or porosity, which produces an increase in the effective surface area without impacting the 
device footprint. We evaluated the surface morphology of the Ti3C2 electrodes with SEM and 
atomic force microscopy (AFM) and found that the electrode surface is comprised of a dense 
network of overlapping Ti3C2 flakes (Figure 4.6c) of nanoscale thickness and several µm in 
lateral size. AFM mapping of the surface further elucidates the rough and wrinkled 
morphology and reveals an average surface roughness of 32 nm (Figure 4.6d). The thickness 
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of the Ti3C2 films forming the electrodes, as measured by a profilometer following lift-off 
patterning, is 200 ± 30 nm. The rough surface morphology we observe suggests that ions can 
interact with the Ti3C2 electrodes over a large effective surface area, likely contributing to 
their remarkably low impedance compared to metal electrodes.  
4.5 In vivo neural recording with Ti3C2 MXene neural electrode 
arrays 
4.5.1 Cortical surface recording   
To assess the functionality of Ti3C2 neural electrodes in vivo, we performed acute 
recording experiments in rats under ketamine-dexmedetomidine anesthesia. Schematic of 
the recording setup for both the brain surface (micro-ECoG) and the brain-penetrating 
(intracortical) arrays are shown in Figure 4.7a. First, we tested Ti3C2 and Au micro-ECoG 
devices placed over sensorimotor cortex (Figure 4.7a, left). On both electrodes, we detected  
Figure 4.6 Characterization of Ti3C2 neural electrodes. (a) Bode plots of impedance magnitude and 
phase for comparable Ti3C2 and Au micro-ECoG electrodes. Points represent means, and bars show 
standard deviations; Ti3C2 n = 10 and Au n = 10. (b) Scatter plots of 1 kHz impedance values for Ti3C2
and Au electrodes in micro-ECoG and intracortical electrode arrays. Micro-ECoG electrodes are 50 μm 
× 50 μm, and intracortical electrodes are 25 μm in diameter. For both types of electrode arrays, Ti3C2
shows a ∼4× reduction in impedance compared to Au. Black bars indicate means. Micro-ECoG: Ti3C2 n 
= 18 and Au n = 18. Intracortical: Ti3C2 n = 19 and Au n = 19. Single asterisks indicate p < 0.001 (c) SEM 
images of Ti3C2 electrodes. Individual Ti3C2 flakes are visible on the electrode surface. (d) AFM surface 
mapping showing the rough surface morphology of a Ti3C2 electrode. 
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Figure 4.7 In vivo neural recordings with Ti3C2 MXene electrodes. (a) Schematic of in vivo neural 
recording with Ti3C2 electrode arrays. (b) Raw signals obtained from a Ti3C2 micro-ECoG device. (c) 
Power spectral density of micro-ECoG signals showing physiologic peaks for 1−2Hz slow oscillations 
and 40−70 Hz γ oscillations. (d) γ-triggered average showing γ oscillations coupled to the up phase of 
the slow oscillation. (e) Action potentials (spikes) recorded extracellularly in rat hippocampus. Noise 
in the spike frequency band (500−5000 Hz) was 4.67 μVrms. (f) Overlaid spike waveforms (N = 580) 
from a 200 s recording. (g) Interspike intervals had a bimodal distribution. The neuron tended to fire 
rhythmically at 1 to 2 Hz with bursts of 2 spikes separated by about 10 ms. (h) The full bandwidth 
(0.5−5000 Hz) recording revealed that the rhythmic spiking was related to a slow oscillation in the 
field potential. Red lines indicate spike times corresponding to E. (i) Spike-triggered average showing 
that the spikes were locked to the rising phase of the slow oscillation. (j) Power spectrum of the full 
bandwidth recording with a physiological peak at 1.5 Hz. 
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clear physiological signals (Figure 4.7b). However, the background noise level in the spike 
band (500 – 5000 Hz) was lower in the Ti3C2 recordings than in the Au recordings: 3.7 ± 0.3 
µVrms vs. 6.6 ± 2.0 µVrms, respectively. The power spectral density (PSD) of the recorded 
signals confirmed the presence of two brain rhythms commonly observed in rats under this 
type of anesthesia: slow oscillations at 1-2 Hz and gamma oscillations at 40-70 Hz (Figure 
4.7c). These two rhythms were, in fact, coupled, as revealed by computing the signal average 
in a window centered on gamma oscillation events (Figure 4.7d). Gamma bursts occurred on 
average at a specific phase, namely the peak, of the slow oscillation as reported previously 
with traditional metal electrode recordings [283], [284]. Thus, the Ti3C2 electrode surface 
recordings reproduced known physiology in this brain state and with lower noise than Au 
electrodes.  
4.5.1 Intracortical recording   
Next, we inserted electrode arrays intracortically to record neuronal action potentials 
(spikes). The 10-channel intracortical arrays were composed of both Ti3C2 and Au electrodes 
(Figure 4.7a, right). Examples of the neural activity recorded from a Ti3C2 contact are shown 
in Figure 4.7e,f. The neuron recorded on this Ti3C2 electrode tended to fire rhythmically at a 
low frequency (<5 Hz), but with bursts of spikes in each cycle (Figure 4.7e,g). The full 
bandwidth recording revealed that the rhythmic spiking of this cell was related to the slow 
oscillation in the field potential (Figure 4.7h). As with gamma oscillations recorded at the 
brain surface, spikes from this neuron were biased to occur at a particular phase of the 
rhythm (Figure 4.7i), which again had a frequency of 1-2 Hz (Figure 4.7j). Although these 
results demonstrate the functionality of intracortical Ti3C2 electrodes, we next pursued the 
more critical question of how they perform relative to the Au electrodes.  
The intracortical array was designed such that each pair of Ti3C2 and Au electrodes 
was arranged as a stereotrode, with contacts separated by 35 µm. This configuration allows 
the direct comparison of the signal recorded with the two types of electrodes at different 
depths in the sensorimotor cortex (Figure 4.8a). Spiking activity was observed 
predominantly on the distal three pairs of electrodes (Figure 4.8b). Spikes that occurred 
simultaneously on adjacent Ti3C2 and Au electrodes in a pair were considered to be generated 
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by the same neuron. For each of these “common spikes,” we computed the SNR from each 
electrode. The mean of the distribution of SNRMXene – SNRAu was, at all three depths, greater 
than zero (permutation test, p < .001), indicating that spikes recorded on the Ti3C2 electrodes 
had higher SNR than those on the Au electrodes (Figure 4.8c). Additionally, Ti3C2 electrodes 
recorded more “unique spikes”, or spikes that occurred only on one electrode in the pair 
(Figure 4.8d). These unique spikes had lower amplitudes than the common spikes and 
therefore may have arisen from neurons located further from the electrode sites. This result 
suggests that, due to their lower impedance, the Ti3C2 electrodes have a larger “seeing 
distance”, allowing them to resolve spiking activity from a larger volume of tissue.  
Figure 4.8 Comparison of in vivo signal recorded on Ti3C2 and Au electrodes intracortically. (a) 
Schematics of an intracortical electrode array with five Ti3C2/Au stereotrode pairs. The array was 
inserted into the cortex and advanced in approximately 500 µm steps to a depth of 2 mm while 
recording. (b) Multiunit spiking activity observed on the distal three pairs of electrodes in the array at 
three different recording depths. Spikes that were observed simultaneously on adjacent Ti3C2 and Au 
contacts are indicated by blue dots. Spikes unique to a given electrode are indicated by orange dots. 
(c) Histogram of SNRMXene – SNRAu  for the common spikes on the adjacent electrodes outlined in blue 
boxes in (b). In all cases the distribution mean was significantly greater than zero (permutation tests, 
p < 0.001), indicating higher SNR on Ti3C2 contacts compared to Au. (d) Number of unique spikes seen 
on adjacent Ti3C2 and Au electrodes. In all cases, more unique spikes were observed on Ti3C2 contacts, 
indicating these electrodes were more sensitive for recording unit activity than Au electrodes. 
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Finally, we quantified the power spectrum of the wideband neural signal recorded on 
representative Ti3C2 and Au electrodes in the array (Figure 4.9). The Ti3C2 electrode 
recorded higher overall power across a wide range of frequencies. Additionally, a significant 
peak at 60 Hz was observed on the Au electrode, while this peak is completely absent on the 
adjacent Ti3C2 contact, which indicates that the higher impedance Au electrodes are more 
susceptible to mains interference.  
 
Figure 4.9 In vivo noise characteristics. (a) Wide band power spectral density from representative 
Ti3C2 and Au electrodes from the intracortical array. (b) A significant peak in power at 60 Hz, 
attributed to mains noise, was seen on Au electrodes but was not observed on Ti3C2 electrodes. (c,d) 
Ti3C2 electrodes recorded higher power across a broadf range of frequencies, including 1-10 Hz delta 
and theta rhythms (c) and 35-45 Hz gamma rhythms (d). 
 
Chapter 4: High-resolution neural interfaces using Ti3C2 MXene 
 
 96   
 
4.6 Neuronal biocompatibility of Ti3C2 MXene 
MXenes have shown great promise in a number of biomedical applications including 
cancer theranostics [242], diagnostic imaging [285], and biosensing [249]. Recent studies 
report that MXenes are biocompatible to immortalized tumor cell lines in vitro and at the 
systemic level when injected intravenously in vivo [236], [250]. However, very little is known 
about the safety and compatibility of MXenes to neuronal cells. Thus, we performed 
Figure 4.10 Biocompatibility of Ti3C2 MXene films. Representative phase images of primary cortical 
neurons cultured on (a) polystyrene and (b) 200 nm-thick Ti3C2 films at 7 DIV. (c) Quantitative 
comparison shows no significant difference in neuronal survival on Ti3C2 or polystyrene (p>0.6). (d-i) 
Representative multiphoton images of neurons cultured on Ti3C2 at 7 DIV stained for nuclei (blue), 
axons (red), and synapses (green). Outlined region in (d) is shown in (e-g); outlined region in (g) is 
shown in (h-i), highlighting network formation as confirmed by the presence of synapsin-positive 
puncta along axons and cell bodies (arrows). Scale bars: 100 µm (a, b, d), 50 µm (g), 25 µm (i). 
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cytotoxicity studies in vitro on primary cortical neurons grown on Ti3C2 films. At 7 days in 
vitro (DIV), quantification of the percent viable neurons showed no significant difference in 
cell survival between Ti3C2 and control polystyrene cultures (Ti3C2: 84.4 ± 4.40%, 
polystyrene: 87.3 ± 2.05%; p > 0.64) (Figure 4.10a-c). Cell densities on Ti3C2 at 7 DIV were 
significantly sparser than those on polystyrene (Ti3C2: 650 ± 155 neurons/mm2, polystyrene: 
1132 ± 132 neurons/mm2; p < 0.05), suggesting additional surface treatments may be 
required to promote neuronal adhesion. Although there was also a reduction in overall 
neurite density on the Ti3C2 cultures, there were no significant differences in neurite 
outgrowth per neuron (Ti3C2: 5.73 ± 1.05 neurites per neuron, polystyrene: 6.00 ± 0.737 
neurites per neuron; p > 0.8). Immunocytochemistry revealed widespread network 
formation on both substrates (Figure 4.10d-i), with neurons extending branching neurites 
(Figure 4.10e,h) and synapsin-positive puncta present surrounding cell bodies and at axon-
soma junctions (Figure 4.10f,i).  
Overall, neurons reproducibly adhered, grew, and formed neuronal networks on both 
Ti3C2 and polystyrene, with both substrates yielding equivalent neuronal viability and neurite 
outgrowth per neuron out to at least 7 DIV. These results indicate that Ti3C2 is capable of 
supporting neuronal growth and network formation with negligible cytotoxicity relative to 
established cell culture substrates. While both cultures exhibited similar neurite counts per 
neuron and axonal/synaptic presence at 7 DIV, Ti3C2 cultures had a reduction in both neuron 
density and a commensurate reduction in neurite outgrowth compared to polystyrene. These 
results suggest decreased neuronal adhesion on Ti3C2 compared to polystyrene, which 
indicates further optimization of the pre-treatment protocol used to culture neurons and 
promote neuronal adhesion and neurite growth on Ti3C2 films is necessary. 
4.7 Discussion  
In this study, we developed a protocol for fabricating high-resolution Ti3C2 MXene 
neural electrode arrays using simple, scalable solution processing methods. The methodology 
described here can easily be extended to create other types of MXene sensors, and the 
extraordinary processability of MXenes highlights the potential for cost-effective production 
of MXene biosensors at industrial scales, which is not currently possible for devices based on 
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other carbon nanomaterials. The high conductivity of Ti3C2, coupled with the high effective 
surface area of MXene films, endows Ti3C2 neural electrodes with remarkably low impedance, 
which improves their sensitivity for recording neural activity at fine spatial scales. 
Recordings from Ti3C2 micro-ECoG devices showed known physiologic signatures with lower 
baseline noise than control Au electrodes. Using high-resolution intracortical arrays, we 
demonstrated that Ti3C2 electrodes record multiunit neuronal spiking activity with improved 
SNR compared to gold electrodes. Additionally, our observation that Ti3C2 electrodes 
recorded overall a larger number of spikes, many of which were low-amplitude, suggests that 
these electrodes are capable of recording from a larger volume of brain tissue. Thus, Ti3C2 
micro-electrodes may represent a significant advance for the sensitive detection of neuronal 
spiking activity compared to conventional silicon or metal-based micro-electrodes. 
Furthermore, our observations suggest that Ti3C2 could be useful for a range of implantable 
sensors beyond neural recording applications, such as cardiac monitoring, and it may be a 
candidate to replace expensive electrode materials, such as platinum, currently used in many 
implantable devices. Finally, though the biocompatibility of Ti3C2 has been demonstrated 
following systemic injection for cancer theranostic applications, the compatibility of this 
material to neurons and brain cells has so far remained largely untested. Our work shows 
that not only do neurons remain viable in contact with Ti3C2, but that they also extend 
neurites and form functional networks when cultured on Ti3C2 films. While more work needs 
to be done, our experiments indicate that Ti3C2, and possibly other MXenes, have significant 
potential to transform the field of implantable sensors in both research and clinical 
applications. The promising bioelectronic properties and versatility in fabrication of Ti3C2 
MXene may both reduce cost and improve performance in current and future medical 
devices. 
4.8 Materials and methods  
Preparation of Ti3C2 colloidal solution 
Ti3AlC2 MAX phase carbide powder synthesis has been explained elsewhere [232]. 5 g of 
Ti3AlC2 was added slowly to a chemical etchant (50 mL, 12 M HCl (Alfa Aesar), deionized (DI) 
water, 49 % HF (Sigma-Aldrich), 6:3:1 ratio) while it was in an ice bath and was agitated on 
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a stir plate (24 h, 500 rpm, 25 °C, Teflon stir bar) in an unsealed container to make multi-
layer Ti3C2 MXene (ML-MXene). The solution was then centrifuged (2 minutes, 3500 rpm, ~6 
cycles) in 2 large tubes (175 mL) to reach ~6 pH. An intercalant was used to delaminate Ti3C2 
into single flakes by mixing 10 grams lithium chloride (LiCl, Alfa Aesar) and 100 mL DI water 
in an ice bath 30 minutes prior to adding the ML-MXene. After adding Ti3C2, the solution was 
manually shaken until small bubbles appeared on the side of the container (~15 min) and the 
solution was stirred on a stir plate (at least 4 h at 300 rpm). The solution was then centrifuged 
(3500 rpm, 2 cycles, 2 min) in 2 large tubes to cause the sediment to swell. Next, the sediment 
was evenly dispersed and centrifuged (3500 rpm, 1 hr, 2 cycles) in 4 150-mL tubes, Finally, 
to remove insoluble contaminates from the single flake and ML-MXene, the sediment was 
dispersed (10 minutes manual hand shaking) in 300 mL DI water in 2 150-mL tubes and 
centrifuged (500 rpm, 2 minutes). The resulting supernatant was centrifuged at 10000 rpm 
for 15 minutes in 6 small tubes (50 mL) and the sediment (with concentration of 10 mg/mL) 
was collected. Prior to spin coating, the Ti3C2 solution was dispersed for centrifugation (3500 
rpm, 2 minutes) in 2 small tubes and the supernatant was collected to be used for spin 
coating. The concentration of Ti3C2 in the supernatant was measured (~10 mg/mL) by 
vacuum filtration of the solution (1 mL) on a hydrophobic Celgard membrane. 
Characterization of Ti3C2 flakes  
As-prepared Ti3C2 was characterized by SEM, dynamic light scattering, and UV-vis 
spectroscopy. Scanning electron microscopy was performed using a Zeiss Supra 50 VP (Zeiss, 
Germany) at an accelerating voltage of 5 kV by vacuum filtering a dilute (~0.01 mg/mL) 
solution over a porous alumina membrane (Anodisc, 0.1 μm pore size, Whatman). Dynamic 
light scattering was performed using a dilute Ti3C2 solution (<0.1 mg/mL) in a polystyrene 
disposable cuvette (Malvern Instruments, Zetasizer, NanoZS). The measurement was 
repeated 5 times and an average was reported (Figure 1C). UV-vis spectroscopy was 
conducted from 200-1000 nm on a Ti3C2 solution diluted 1000x (ThermoScientific Evolution 
201).  
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Device Fabrication and Assembly 
A silicon wafer was coated with a 4 µm-thick layer of parylene-C. Metal traces and pads 
(Ti/Au = 10/100 nm) were patterned using standard photolithography and lift-off processes. 
The wafer was coated with an anti-adhesive layer (1% Micro-90), then a second, 3 µm thick 
sacrificial layer of parylene-C was deposited. Patterns for MXene traces and electrode 
contacts were defined by photolithography with the negative resist NR71-3000p and 
subsequent oxygen plasma reactive-ion etching (RIE) to etch through the sacrificial parylene-
C layer. A Ti3C2 colloidal solution was spin-coated on the wafer and the wafer was 
subsequently baked at 130 °C for 3 hrs to ensure that the resulting Ti3C2 film was fully dried. 
A 50 nm-thick layer of SiO2 was deposited by e-beam evaporation to serve as a protective 
mask on the Ti3C2 patterns during subsequent fabrication steps. The sacrificial parylene-C 
layer was then manually peeled up with tweezers, leaving behind Ti3C2/SiO2 only on the Ti3C2 
contacts and traces previously defined. After deposition of a top 4 µm-thick parylene-C 
encapsulation layer, an etch mask was defined through photolithography, e-beam deposition 
of aluminum (100 nm), and lift-off to define the outline of the devices, and openings over Au 
bonding pads and electrode contacts. The exposed parylene-C was etched with oxygen RIE, 
and the Al etch mask was subsequently removed via wet etching. The SiO2 protective layer 
covering the Ti3C2 contacts was etched with 1:6 buffered oxide etchant (BOE: 6 parts 40% 
NH4F, 1 part 49% HF, Sigma-Aldrich) to expose the Ti3C2 electrode sites. Finally, the 
completed devices were released from the silicon wafer. Both micro-ECoG and intracortical 
electrode arrays were fabricated using this procedure, with different photomasks to define 
the geometries. Steel backings (2.5 µm thick) were laser-micromachined (IPG IX280-DXF 
Green Laser Micromachining, 532 nm) to provide mechanical support for insertion of the 
intracortical arrays. Devices were carefully aligned and manually fixed to these steel backings 
using polydimethylsiloxane (PDMS) as an adhesive. Both micro-ECoG devices and steel-
backed intracortical array devices were inserted into zero-insertion force (ZIF) connectors 
on custom printed circuit boards for connection to the data acquisition systems for in vitro 
characterization or in vivo neural recording. 
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Electrochemical Impedance Spectroscopy 
EIS of Ti3C2 and Au microelectrodes was performed with a Gamry Reference 600 potentiostat 
(Gamry Instruments) in a phosphate buffered saline (PBS) bath pH 7.4 at room temperature. 
EIS measurements were collected using a three-electrode configuration with Ti3C2 or Au 
microelectrodes as the working electrode, a graphite rod (Bio-Rad Laboratories, Inc.) as the 
counter electrode, and a Ag/AgCl (Sigma Aldrich) electrode as the reference electrode. 
Measurements were acquired by applying a 20 mV rms sinusoidal voltage input in the 1 Hz – 
1 MHz range. 
Electrode Surface Morphology Characterization 
SEM images (Zeiss Supra 50VP) were taken with an accelerating voltage of 5 kV. AFM surface 
mapping (Bruker Dimension Icon AFM) was performed in tapping mode in air and data were 
analyzed in NanoScope Analysis software (Bruker). 
Animal Surgery and In Vivo Recording 
In vivo neural recordings were collected from n = 3 Sprague-Dawley rats during acute, sterile 
procedures. Rats were anesthetized with a solution of ketamine (60 mg/kg) and 
dexmedetomidine (0.25 mg/kg) and placed in a stereotaxic frame. The right somatosensory 
cortex was exposed with a craniectomy and durotomy. Skull screws were placed in the left 
parietal and frontal bones around which Ag wires were wrapped to serve as the reference 
and ground for the recordings. The electrode arrays were mounted on a stereotaxic 
manipulator, positioned over the exposed cortex, and lowered. Ti3C2 and Au micro-ECoG 
arrays were placed over barrel cortex successively and recordings from each were collected 
in 5-minute segments. For intracortical Ti3C2 /Au arrays, recordings were made at a number 
of depths throughout the cortex to sample neural activity. The wideband neural signals (1 Hz 
to 7.5 kHz) were acquired at 30,000 sample/s by an electrophysiology system (Intan 
RHS2000 Stimulation/Recording System, Intan Technologies). All procedures were approved 
by the Institutional Animal Care and Use Committees at the University of Pennsylvania and 
adhered to the guidelines set forth in the NIH Public Health Service Policy on Humane Care 
and Use of Laboratory Animals (2015). 
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In Vivo Data Analysis and Statistical Methods 
For multiunit analysis, signals were band-pass filtered from 300-6000 Hz (2nd order 






and spikes were detected by setting a threshold of 5𝜎  [286]. Spikes observed on both the 
Ti3C2 and Au electrode in a stereotrode pair were assumed to have been generated by the 
same neuron, and classified as “common spikes”, if they occurred within 0.1 ms of each other. 
All remaining spikes were classified as “unique spikes”. To compare signal quality, the SNRs 
for each common spike were computed from the signals observed on the Ti3C2 and Au 
electrodes in the stereotrode pair and subtracted. A permutation test was then performed to 
test if the mean of the resulting distribution was centered around zero. 
Cell Culture Substrate Preparation 
Glass slides coated with Ti3C2 were soaked in 70% ethanol for 20 minutes. Slides were then 
rinsed in sterile cell culture water before exposing each side to UV light for 30 minutes (1 hr 
total exposure). Post-UV, slides were immersed in Poly-L-lysine (PLL) (0.05 mg/mL in sterile 
cell culture water) overnight. Slides were then rinsed in sterile cell culture water before being 
immersed in laminin (20 µg/mL in sterile cell culture water) overnight prior to neuronal 
plating. For control cultures, polystyrene petri dishes were coated in PLL and laminin using 
the same protocol. 
Cortical Neuron Isolation and Culture 
All procedures were approved by the Institutional Animal Care and Use Committees at the 
University of Pennsylvania and the Michael J. Crescenz Veterans Affairs Medical Center and 
adhered to the guidelines set forth in the NIH Public Health Service Policy on Humane Care 
and Use of Laboratory Animals (2015). Neural cell isolation and culture were performed 
following protocols previously published [287]. Briefly, timed-pregnant rats were 
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euthanized, and embryonic day 18 fetuses were removed from the uterus and transferred to 
cold Hank’s balanced salt solution (HBSS). Post-removal, the fetus brains were extracted and 
the cerebral cortical hemispheres isolated under a stereoscope via microdissection. Cortical 
tissue was dissociated in 0.25% trypsin + 1mM Ethylenediaminetetraacetic acid (EDTA) at 
37˚C, after which the trypsin/EDTA was removed and replaced with 0.15 mg/ml DNase in 
HBSS. Dissociated tissue + DNase was centrifuged for 3 min at 3000 RPM before the DNase 
was removed and the cells re-suspended in neuronal culture media, composed of 
Neurobasal® + B27® + Glutamax™ (ThermoFisher) and 1% penicillin-streptomycin. Neurons 
were diluted to ~1.5 x 106 neurons/ml. 200 µL from the primary cortical neuronal 
suspensions were plated on each of the Ti3C2 slides and control dishes within 2 mL of 
neuronal culture media and grown under standard cell culture conditions (37˚C, 5% CO2). 
Half-media changes were performed every 2 days, with phase images taken using a Nikon 
Eclipse Ti-S microscope paired with a QIClick camera and NIS Elements BR 4.13.00.  
Neuronal Viability Assessment 
To assess culture viability, phase images of Ti3C2 slides (n = 6) and control cultures (n = 6) 
were taken at 7 days in vitro (DIV). Neurons within a randomly identified 0.5 mm2 area were 
manually scored as either live or dead, depending on their morphology (i.e. presence and 
integrity of neurites; cell body). Neuronal survival was quantified as the proportion of live 
neurons to total (live + dead) neurons, while cell density was calculated as the total number 
of neurons per mm2. Each metric was averaged across Ti3C2 and polystyrene controls and 
compared via unpaired t-test, with statistical significance identified as a p-value less than 
0.05. All data presented as mean ± s.e.m. 
Immunocytochemistry 
At 7 DIV, Ti3C2 slides (n = 6) and control cultures (n = 6) were fixed in 4% formaldehyde for 
35 min. Fixed cultures were rinsed in 1x PBS and permeabilized with 0.3% Triton X100 + 4% 
horse serum in PBS for 60 min before being incubated with primary antibodies overnight at 
4˚C. Primary antibodies were Tuj-1/beta-III tubulin (T8578, 1:500, Sigma-Aldrich) to label 
axons and synapsin-1 (A6442, 1:500, Invitrogen) to label pre-synaptic specializations. Post-
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incubation, cultures were rinsed in PBS before being incubated with fluorescently-labeled 
secondary antibodies (1:500; sourced from Life Technologies & Invitrogen) for 2h at 18˚-
24˚C. Finally, Hoechst (33342, 1:10,000, ThermoFisher) was added for 10 min at 18˚-24˚C 
before rinsing in PBS. Cultures were imaged on a Nikon A1RMP+ multiphoton confocal 
microscope paired with NIS Elements AR 4.60.00 and a 16x immersion objective. Sequential 
slices of 1-1.2 µm in the z-plane (nslices = 20) were acquired for each fluorescent channel. All 
confocal images presented are maximum intensity projections of the confocal z-slices. 
Neurite Measurement & Data Analysis 
Multiphoton images from the immunocytochemistry performed above were imported into 
ImageJ and processed using the open-source NeuriteQuant plugin. NeuriteQuant provided 
quantitative estimates of neurites per cell from the multiphoton images. Neurites per cell 
were averaged for both polystyrene and Ti3C2 cultures, with unpaired t-tests used to compare 











Chapter 5: Human-scale, translational neurodevices using 
Ti3C2 MXene  
Technologies enabling the seamless integration of electronics with soft biological 
tissues for mapping and modulating excitable networks at high resolution and at large scale 
can enable paradigm-shifting diagnostics, monitoring, and treatment strategies. Realizing 
such technologies has required significant innovation in both materials and fabrication 
strategies to develop bioelectronic interfaces which are soft, biocompatible, and highly 
conformable to the tissue of interest. Many of the most successful advances in this realm so 
far have leveraged traditional metal and silicon materials along with thin-film 
microfabrication strategies to create highly flexible and conformable bioelectronic interfaces. 
While these thin-film technologies can achieve exquisite tissue conformability, they have 
largely failed to translate into clinical and consumer markets because the materials and 
fabrication schemes are expensive, do not scale, and they critically limit the maximum 
attainable resolution and coverage. Solution processing is a cost-effective manufacturing 
alternative, however biocompatible conductive inks matching the performance of 
conventional metals have been lacking. In the previous chapter, I introduced Ti3C2 MXene as 
a solution-processable 2D material that showed excellent performance for neural recording 
when incorporated into microelectrodes. Driven by the success of those MXene 
microelectrodes, I next sought to expand Ti3C2 to human-scale translational neurodevices. In 
this chapter, I introduce MXtrodes, a novel class of soft, high-resolution, large-scale 
bioelectronic interfaces enabled by Ti3C2 MXene and scalable solution processing. I show that 
the electrochemical properties of MXtrodes exceed those of conventional materials in both 
epidermal and implantable use cases. In fact, MXtrodes do not require conductive gels for 
epidermal sensing due to their exceptionally low interface impedance. I then validate 
MXtrodes in a number of applications ranging from mapping large scale neuromuscular 
networks in humans to delivering cortical microstimulation in small animal models. Finally, 
I demonstrate that MXtrodes are compatible with standard clinical neuroimaging modalities. 
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5.1 Introduction  
Recent advances in soft materials and electronics have fueled a new generation of 
bioelectronic technologies for medical diagnostics and therapeutics, healthcare monitoring, 
and wearable devices [29], [112], [288], [289]. Soft and flexible bioelectronic devices 
designed to safely and intimately interface with multiscale networks in the human body offer 
paradigm-shifting opportunities for monitoring brain activity, cardiac health, and muscle 
function, as well as for facilitating human-machine interactions, such as myoelectric control 
of advanced prostheses [290]–[292] or non-invasive brain-computer interfaces [293].  Active 
bioelectronic devices can also implement intelligent control strategies based on electrical 
stimulation of excitable circuits for treating neurological diseases [23], [24], heart 
arrhythmias [25], [26], and inflammatory disorders [27], [28], as well as for rehabilitation 
therapies [294]–[296]. 
Despite significant progress in the field of soft, ultra-thin, and conformable 
bioelectronics [54], [108], [120], [297], [298], conventional materials and fabrication 
processes remain largely inadequate for producing large-scale, high-density multielectrode 
arrays that can map and modulate activity in excitable tissues with high spatiotemporal 
resolution over broad areas. For example, thin-film processing has enabled advances in ultra-
thin and flexible electronics; however, such processes rely on wafer-scale microfabrication 
conducted in a cleanroom facility, which is time consuming, expensive, and typically limits 
the maximum attainable area coverage to a few square centimeters [112]. Recent work has 
demonstrated the possibility to overcome this size limit by implementing the fabrication 
process on large-diameter wafers [120], but microfabrication techniques remain difficult to 
scale and are still not cost-effective. Contributing to the manufacturing challenges is the fact 
that flexible polymeric encapsulation materials require low-temperature processing below 
their glass transition points and can also be incompatible with certain chemicals and solvents 
commonly used in microfabrication. In addition to the processing constraints, conventional 
bioelectronic materials – such as gold (Au), platinum (Pt), iridium (Ir), and silver/silver-
chloride (Ag/AgCl) – are both costly and intrinsically limited in their electronic, mechanical, 
and chemical compatibility with biological tissues. For example, they present challenges in 
achieving low electrode-tissue interface impedance, which is essential for high-fidelity 
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recording and for safe, effective delivery of electrical stimulation. As a result, in applications 
such as epidermal electronics, conventional Ag/AgCl electrodes typically require a 
conductive gel at the skin interface to lower the impedance enough to acquire good quality 
signal. The conductive gels pose a host of issues including skin irritation and impedance 
instability as they dry out [115], [299]. Metal-based devices are also inadequate for coupling 
with clinical imaging modalities such as magnetic resonance imaging (MRI), often causing 
artifacts in the images even if they are considered MR safe. To realize the next generation of 
soft, large-scale, high-density bioelectronic interfaces for human applications, innovation in 
both materials and fabrication is needed.  
Solution processing techniques, such as inkjet or screen printing, offer a scalable and 
low-cost route for fabricating large-area multielectrode arrays unencumbered by the size 
constraints of wafer-level methods. Despite these advantages, widespread adoption of such 
techniques has so far been limited by the lack of conductive inks that can produce electrodes 
with biocompatibility, flexibility, electronic conductivity, and electrochemical properties 
comparable to those made with conventional materials. High conductivity can be achieved by 
printing ink formulations based on metal nanoparticles, however, they typically require high 
annealing temperatures which are not compatible with soft polymeric substrates [300], 
[301]. Furthermore, metal inks raise concerns about potential toxicity [302]. Conducting 
polymer-based inks, notably those using poly(3,4-ethylenedioxythiophene) doped with 
poly(styrene sulfonate) (PEDOT:PSS), can be processed at ambient temperatures to generate 
flexible, biocompatible films, but their conductivity is generally significantly lower than metal 
films [303], [304]. Finally, graphene oxide (GO) inks require an additional reduction step to 
be converted to the conductive reduced graphene oxide (rGO) form, which poses materials 
and safety issues due to the high temperatures and toxic chemicals employed in the reduction 
process [305]. Furthermore, the conductivity of rGO is still far inferior to that of pristine 
graphene [306] and PEDOT:PSS films.  
Transition metal carbides, nitrides, and carbonitrides (MXenes) have emerged as a 
new class of two-dimensional (2D) nanomaterials that enable low-cost, additive-free, 
solution processing and can produce biocompatible films with metallic conductivity. MXenes 
are 2D flakes ~1 nm in thickness and up to 10s of µm in lateral size which contain abundant 
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surface-terminating functional groups, including hydroxyl (-OH), oxygen (-O), or fluorine (-
F), which make them hydrophilic and also allow for versatile surface modification and 
functionalization. The unique hydrophilic nature of MXenes enables a wide range of safe, 
high-throughput, and scalable processing methods using simple water-based inks, including 
spray [307], spin [308], and dip coating [309], direct writing [278], and inkjet printing [274], 
[278]. Of the large variety of MXenes that have been synthesized to date, Ti3C2 (the chemical 
formula is often written as Ti3C2Tx to account for the surface terminations, Tx) has been the 
most widely studied and optimized MXene. It is made of Earth-abundant elements and no 
cytotoxicity has been observed in previous studies [250]. In the past few years, Ti3C2 has 
attracted great attention for a number of biomedical applications [310], including cancer 
theranostics [236], hemodialysis [255], and wearable mechanical sensors [256], [311]. Our 
group has pioneered the use of Ti3C2 for implantable neural microelectrodes [312], [313] and 
skin-conformable, thin-film wearable sensors [314]. Ti3C2 has metallic behavior exhibiting 
electronic conductivity of up to 15,000 – 20,000 S/cm, higher than all other solution-
processed 2D materials [226], [246]. Additionally, MXenes are produced using a top-down 
selective etching procedure which is highly scalable compared to the bottom-up techniques 
such as physical and chemical vapor deposition required to synthesize many other 
nanomaterials [231]. Additional background on MXenes can be found in Section 4.2 of this 
thesis.  
In this work, we demonstrate a new class of flexible, multichannel, high-density 
bioelectronic interfaces – which we have named “MXtrodes” – that are capable of both high-
fidelity recording and effective stimulation of neural and neuromuscular circuits at multiple 
scales. The key value of the work presented here rests on a series of advances: first, we 
leverage the excellent processability of Ti3C2 MXene to develop a rapid, low-cost, and highly 
scalable method for fabricating multichannel electrode arrays of arbitrary size and geometry. 
This process is conducive to industrial manufacturing, and paves the way for translating 
MXene bioelectronics into clinical and consumer markets. Second, we report the first 
comprehensive study of the electrochemical properties of Ti3C2 relevant for recording and 
stimulation of bioelectric circuits. We show that the electrochemical behavior of Ti3C2 is 
comparable, and in many aspects superior to, conventional bioelectronic materials, especially 
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in the context of delivering charge for safe and effective electrical stimulation. Third, we 
demonstrate the utility of MXtrodes for mapping and modulating excitable networks at scales 
ranging from large neural and muscular circuits in humans to small animal models. In 
particular, we show gel-free multichannel arrays for large-scale human epidermal recording 
with electrode-skin interface impedance and recording quality comparable to larger, 
commercially available pre-gelled Ag/AgCl single contact electrodes. Furthermore, we 
demonstrate the ability of MXtrodes to finely map clinically relevant neural and 
neuromuscular activation patterns at high spatial and temporal resolution – which is elusive 
for conventional epidermal sensors – and to deliver effective electrical stimulation. Fourth, 
we experimentally characterize the compatibility of Ti3C2 with clinical imaging modalities 
and we demonstrate that MXtrodes minimally interact with magnetic fields and X-rays, 
resulting in artifact-free high-field MRI and computed tomography (CT) imaging. This finding 
opens up new and exciting opportunities for future research and clinical paradigms 
combining high temporal resolution electrophysiology with advanced functional imaging. 
Propelled by the unique properties of Ti3C2 and the high-throughput, scalable, and cost-
effective fabrication process developed here, MXtrodes show great promise for numerous 
applications in healthcare, research, and wearable electronics.   
5.2 Rapid, low-cost manufacturing of MXtrodes   
We developed a simple method for producing the MXtrode arrays involving 1) laser-
patterning a porous absorbent substrate, 2) infusing it with a water-based Ti3C2 MXene ink, 
and 3) encapsulating the resulting conductive composite in flexible elastomeric films. For the 
various applications demonstrated in this work, we fabricated two types of electrodes by 
slightly varying the same basic process: 1) flat or planar electrodes for gel-free epidermal 
sensing and for epicortical brain recording and stimulation, and 2) 3D “mini-pillar” electrodes 
for gel-free electroencephalography (EEG). The versatility of our fabrication process allows 
addressing application-specific requirements and customizing the electrodes to the 
structures of interest: while for epidermal and cortical recording flat planar electrodes 
achieve adequate tissue coupling, gel-free EEG requires 3D components to overcome the hair 
barrier and make contact with the scalp. The fabrication process, with both variations, is 
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depicted in Figure 5.1a. Briefly, we used a CO2 laser to pattern a nonwoven, hydroentangled 
cellulose-polyester blend substrate into the desired electrode array geometry. This served as 
a scaffold for the MXene flakes, with the laser patterning process allowing for rapid 
prototyping and customization of the array geometry. Next, we infused the cellulose-
Figure 5.1 Rapid, high-throughput manufacturing of MXene ink-infused bioelectronics: 
MXtrodes. (a) Schematic of the fabrication method for laser-patterned planar and 3D mini-pillar 
MXene electrode arrays. (b)-(e) Photographs of different electrode array geometries (top) with their 
intended bioelectronic applications (bottom): (b) EMG, (c) ECG, (d) EEG, and (e) ECoG monitoring. 
Scale bars: (b)-(d) 5 mm; inset in (d) and (e) 2 mm. 
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polyester substrate with MXene ink, which was prepared by a minimally intensive layer 
delamination (MILD) method[232] to produce a water-based MXene ink with a concentration 
of 30 mg/mL. The ink quickly wicked into the absorbent substrate, coating all the fibers. The 
ink-infused substrates were then thoroughly dried in a vacuum oven for 1 h at 70°C and 60 
mmHg. The resulting structure was a rough, macro-porous conductive composite, with 
MXene flakes coating the individual fibers in the textile matrix (Figure 5.2a,b). For the planar 
Figure 5.2 Optical and SEM images of MXtrode composites. Optical microscopy images (top panel) 
and corresponding SEM images (bottom panel) for: (a) pristine cellulose/polyester blend substrate, 
(b) the same substrate after infusing with MXene ink, (c) cross-section of MXene composite trace 
embedded in PDMS, (d) edge of planar electrode contact, (e) side of MXene-infused cellulose foam in 
3D mini-pillar MXtrode.  
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MXtrode arrays, the MXene conductive composite was then encapsulated in ~1 mm-thick 
layers of polydimethylsiloxane (PDMS), with a thorough degassing step prior to curing that 
allows the PDMS to infiltrate into the conductive matrix (Figure 5.2c). Electrode contacts 
were defined by cutting through the top encapsulation layer with a biopsy punch of the 
desired electrode diameter and peeling up the resulting PDMS disk to expose the conductive 
MXene composite beneath (Figure 5.2d). In the planar MXtrode arrays for cortical recording 
and stimulation, an additional 1 µm-thick layer of parylene-C was deposited prior to opening 
Figure 5.3 Scalable fabrication of MXtrode arrays. (a) Photo of laser-patterned array substrates 
for various device and array geometries. (b) The same batch of devices shown in a after infiltrating 
with MXene ink. In the top left are shown the EEG ring MXtrode arrays after addition of the 3D mini-
pillars. (c) Photographs of completed devices (from left to right) designed for ECG, ECoG, EMG, and 
EEG sensing. 
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the electrode contacts to serve as an additional barrier to moisture. To fabricate 3D MXtrode 
arrays for gel-free EEG recording, “mini-pillars” of MXene-infused cellulose foam were 
deposited onto the electrode locations prior to PDMS encapsulation. Similar to the absorbent 
cellulose-polyester substrate, the cellulose foam readily absorbed the MXene ink, which 
thoroughly coated all surfaces to form a porous conductive composite after vacuum drying 
(Figure 5.2e). It is worth noting that no adhesive was required to affix the 3D mini-pillars to 
the underlying laser-patterned substrate: inking the two structures simultaneously with 
MXene and vacuum drying them while in contact resulted in the formation of a continuous 
conductive network fusing the laser-patterned substrate and the cellulose foam together. The 
final steps of the 3D MXtrode array fabrication involved PDMS encapsulation and manual 
trimming of the mini-pillars to expose the conductive MXene-cellulose foam composite. The 
versatility, simplicity, scalability, and low cost of this process enabled parallel fabrication of 
MXtrodes in a variety of geometries for diverse bioelectronic applications, even within the 
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5.2 Electrical and electrochemical properties of MXtrodes   
5.2.1 DC conductivity   
In the MXtrode arrays, the MXene-cellulose-polyester conductive composite forms 
the wires which carry the signal out to the recording amplifier. Thus, it is important that this 
composite is highly conductive in order to reduce Ohmic losses, minimize noise, and acquire 
high-quality signals. We measured the bulk conductivity of the MXene composites and 
determined it to be 3015 ± 333 S/m (Figure 5.4) which is in agreement with previously 
reported values for MXene-coated cellulose fibers [315]. To highlight the conductivity 
advantage of Ti3C2 MXene compared to other conductive inks – which could in principle be 
used in our fabrication process – we also fabricated conductive composites using PEDOT:PSS 
and rGO inks with the same cellulose-polyester absorbent substrate. The bulk conductivity of 
Figure 5.4 DC conductivity of ink-infused composites. (a) Plot of length vs. DC resistance for 
composites made using MXene, PEDOT:PSS, and rGO as the conductive ink. Test structures were 20 cm 
x 3 mm x 285 µm (L x W x H) strips. (b)-(d) Individual plots of DC resistance vs. length for (b) MXene, 
(c) PEDOT:PSS, and (d) rGO, with linear fitting curves shown as dashed lines. The linear relation of 
resistance vs. length, along with the cross-sectional area of the test structure, is used to compute the 
bulk conductivity, σ, of the composites. DC resistance of the rGO composite could only be measured 
out to 8 cm due to high resistance. (e) Demonstration of exceptional conductivity of the MXene 
composite here used as conductive trace to power an LED. 
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PEDOT:PSS and rGO composites was 7.6 ± 0.4 S/m and 0.005 ± 0.002 S/m, respectively, both 
significantly lower than MXene.  
5.2.2 Electrochemical properties in saline and their scaling relations   
To evaluate the impedance and charge transfer properties of MXene electrodes and 
compare them with other common bioelectronic materials, we conducted electrochemical 
measurements on MXtrodes with diameters ranging from 500 µm to 3 mm and compared 
them to 2.3 mm-diameter clinical Pt electrodes. Specifically, we performed electrochemical 
impedance spectroscopy (EIS), cyclic voltammetry (CV) and voltage transient 
(chronopotentiometry) experiments to measure the impedance magnitude, charge storage 
capacity (CSC), safe voltage window, and charge injection capacity (CIC) of each electrode, 
and to determine how these properties scale with electrode diameter.  
Data are shown in Table 5.1, along with additional comparisons to other common 
electrode materials from literature. EIS revealed that the MXtrodes of all diameters tested 
showed significantly reduced impedance compared to the Pt electrodes at frequencies below 
500 Hz – where impedance is dominated by the electrochemical properties of the electrode 
interface [321] and where most physiologic signals of interest lie (Figure 5.5a). At 10 Hz, the 
impedance of the MXtrodes ranging from 500 µm to 3 mm was 1343.3 ± 81.6 Ω (500 µm), 
644.2 ± 97.3 Ω (1 mm), 451.2 ± 35.4 Ω (2 mm), and 241.4 ± 14.7 Ω (3 mm), while the 
impedance of the Pt electrodes was 8838.3 ± 1154.2 Ω (2.3 mm). At the reference frequency 
of 1 kHz – where the interface impedance is controlled by the solution resistance and 
electrode size [321] – the impedance of similar-sized MXtrodes is comparable to, and in some 
cases lower than, Pt and other bioelectronic materials like PEDOT:PSS (Figure 5.5a and 
Table 5.1). The 1 kHz impedance values can be found in Table 5.1. We attribute the 
exceptionally low impedance of the MXtrodes to the highly porous and rough morphology of 
the electrodes, which endows the interface with a high effective surface area. 
The safe voltage window for MXtrodes determined from wide-scan CVs is −1.8 – +0.6 
V (Figure 5.6a,b), showing that MXene is exceptionally stable in the cathodic region, with 
hydrolysis beginning at −1.9 V. This wide safe potential range is advantageous for therapeutic 
electrical stimulation applications, and while the safe anodic potential limit (+0.6 V) is slightly  
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lower than that of Pt, PtIr, or IrOx (+0.8 V), stimulation waveforms can be engineered to 
minimize voltage excursions in the anodic range while taking advantage of the large cathodic 
limit [60], [322], [323]. While previous studies have reported anodic oxidation of Ti3C2 films 
at +430 mV [324], we observed no oxidation peak and negligible current loss when MXtrodes 
were cycled within the range of −1.8 – +0.6 V. We attribute the improved anodic stability to 


















7.069 205.6 ± 11.1 -1.8 – 0.6 233.1 ± 19.6 0.55 ± 0.10 This work 
3.142 369.2 ± 40.2 -1.8 – 0.6 392.3 ± 9.8 0.69 ± 0.03 This work 
0.7854 430.2 ± 86.1 -1.8 – 0.6 604.8 ± 61.4 1.07 ± 0.07 This work 
0.1963 729.2 ± 71.2 -1.8 – 0.6 1024.1 ± 3.0 2.12 ± 0.48 This work 
Pt 4.155 287.3 ± 7.8 -0.6 – 0.8 4.3 ± 0.2 0.07 ± 0.003 This work 
Pt 3.142 1910 a -0.6 – 0.8 3.6 a 0.17 a [316], [317] 
Au 3.142 470 a -0.9 – 0.6 0.3 a 0.21 a [316], [317] 
PEDOT:PSS 
on Pt 3.142 1690 
a -0.9 – 0.6 2.3 a 0.18 a [316], [317] 
PEDOT: PSS 
on Au 3.142 430 
a -0.9 – 0.6 1.0 a 0.86 a [316], [317] 
Pt 0.1963 7790 a -0.6 – 0.8 5.1 a 0.50 a [316], [317] 
Au 0.1963 4430 a -0.9 – 0.6 0.3 a 0.21 a [316], [317] 
PEDOT:PSS 
on Pt 0.1963 2110 
a -0.9 – 0.6 3.7 a 0.66 a [316], [317] 
PEDOT:PSS 
on Au 0.1963 990 
a -0.9 – 0.6 1.5 a 1.35 a [316], [317] 
laser-
roughened Pt 0.7854 760 
a -0.6 – 0.8 2.1 ± 0.1 0.026 a [123] 
PEDOT/CNT 
coating on Pt 0.0314 2100 




0.09 519 -1.3 – 0.8 50 3.1 [16] 
CNT fiber 0.00145 
11.2 ± 7.6 
x103 -1.5 – 1.5 372 ± 56 
b 6.52 [133] 
TiN 0.004 11.5 x103  a -0.9 – 0.9 2.47 0.55 [319] 
IrOx 0.004 7.1 x103  a -0.6 – 0.8 11 4 [319] 
PtIr 5.985 125 -0.7 – 0.7 5.0 – [320] 
Table 5.1 Electrochemical properties in saline. Summary of electrochemical properties of 
MXtrode planar electrodes of varying diameters, compared to a 2.3 mm-diameter Pt electrode and 
to literature values for other electrode materials.  
a Represents values extracted from plots from the respective references.  
b CSC calculated from CV in Pt window, -0.6 – 0.8 V at 100 mV/s.    
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cathodic region, the 1 mm, 2 mm, and 3 mm MXtrodes showed stable capacitive behavior 
down to −1.8 V, however the 500 µm-diameter MXtrode showed initial evidence of faradaic 
current near this negative limit (Figure 5.6c) likely due to size effects. Still, the 500 µm-
diameter MXtrode showed stable behavior through repeated CV cycles and no evidence of 
hydrolysis, confirming −1.8 V as a reasonable cathodic limit.  
Analysis of cathodal CSC (CSCC) for MXtrodes and Pt electrodes from CVs at 50 mV/s 
within their respective water windows reveals enhanced capacitive charging and charge 
delivery properties for MXtrodes with ~100 times larger CSCC than Pt electrodes and other 
common materials such as PtIr and PEDOT:PSS (Figure 5.6c,d, Table 5.1). To enable a more 
direct comparison of CSCC values between MXtrodes and Pt electrodes, we also ran CV scans 
in the intersection of the MXene and Pt voltage windows, –0.6 – +0.6 V (Figure 5.5b, Figure 
5.6d, and Table 5.2). Even in this more constrained voltage range, the MXtrodes showed 
more than 20 times enhanced CSCC compared to Pt, which we attribute both to the 
exceptionally high intrinsic capacitance of Ti3C2 MXene [18], [21], [325] and to the high 
effective surface area of the MXtrode surface. The scaling dependency of CSCC on the electrode 
diameter for the MXtrodes is shown in Figure 5.6e. The non-linear relationship between CSCC  
Figure 5.5 Electrochemical properties of MXtrodes. (a) EIS spectra measured in 1X PBS for 3 mm, 
2 mm, 1 mm, and 500 µm planar MXene electrodes compared to 2.3 mm Pt electrodes. (b) CVs for 3 
mm planar MXtrode and 2.3 mm Pt electrodes scanned from −0.6 – +0.6 V at 50 mV/s. (c) Voltage 
transients in response to biphasic current pulses, with tc = ta = 500 µs and tip = 250 µs, current 
amplitudes ranging from 1 to 5 mA for 3 mm planar MXtrode and 2.3 mm Pt electrodes. Anodic and 
cathodic voltage limits for MXene and Pt are displayed on their respective plots as dashed red lines. 
(d) EIS spectra measured on skin for 3 mm MXtrode 3D pillar and planar electrodes. 
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Figure 5.6 Scaling of electrochemical properties in saline. (a) CVs probing the negative voltage 
limit for MXene at 50 mV/s. Hydrolysis of water begins at −1.9 V. (b) CVs probing the positive voltage 
limit for MXene. Current loss and evidence of faradaic current begins at +0.7 V. Test electrode for (a)
and (b) was 3 mm-diameter planar MXene. (c) CVs in MXene safe voltage window, −1.8– +0.6 V, for 3 
mm, 2 mm, 1 mm, and 500 µm-diameter MXtrodes. (d) CVs in MXene-Pt intersection window, −0.6 to 
+0.6 V, for 3 mm, 2 mm, 1 mm, and 500 µm-diameter planar MXtrodes and 2.3 mm-diameter Pt 
electrode. (e) Charge storage capacity of scaled planar MXtrodes as a function of diameter, highlighting 
the CSC scaling dependence on the electrode diameter, due to edge effects. CSC values were calculated 
for CVs in MXene water window. (f)-(i) Voltage transients for biphasic current pulses, with tc = ta = 500 
µs and tip = 250 µs, for currents ranging from 1 to 5 mA for (f) 3 mm, (g) 2 mm, (h) 1 mm, and (i) 500 
µm-diameter planar MXene electrodes. (j) Charge injection capacity of scaled planar MXtrodes as a 
function of diameter, highlighting the CIC scaling dependence on the electrode diameter, due to edge 
effects. (k) Schematic demonstrating the relative electrode sizes used in the study.   
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and electrode diameter is expected, and reflects the known phenomenon of electrochemical 
charge exchange happening predominantly at the edge of the electrode [60], [317]. 
Finally, we measured the voltage transients evolved on each electrode when used to 
deliver charge-balanced, cathodal-first biphasic current pulses ranging from 1 to 5 mA with 
a duration of 500 µs in both phases (tc, ta) and an interpulse interval (tip) of 250 µs (Figure 
5.5c and Figure 5.6f-i). For the 500 µm-diameter MXtrode, the current amplitude range was 
restricted to 600 µA – 2 mA. The maximum cathodal excursion potential, Emc, was taken 10 µs 
after the cathodal pulse end and CICC was defined as the injected charge at which Emc would 
reach the water reduction potential. The resulting CICC values, shown in Table 5.1, reveal 
that the MXtrodes significantly outperform Pt electrodes, with MXtrodes showing ~10 times 
larger CICC than the Pt electrodes. Furthermore, we found a similar ~10 times improvement 
in CICC when we compared MXtrodes to other common electrode materials (Table 5.1). This 
result has significant implications for stimulation applications, and suggests that MXtrodes 
may offer more efficient charge transfer than current state-of-the-art Pt electrodes. This 
could potentially prolong battery life for implantable simulation systems such as deep brain 
stimulation (DBS), vagal nerve stimulation (VNS), and cardiac pacemakers. The scaling 
dependency of CICC on electrode diameter for the MXtrodes is shown in Figure 5.6j, again 
revealing the expected non-linear scaling dependency resulting from edge effects. A 
schematic depicting the relative sizes of the MXtrodes included in the analysis is shown in 




CSCC  (mC cm-2) 
MXene window: -1.8 – 0.6 V 
CSCC  (mC cm-2) 
Intersection: -0.6 – 0.6 V 
CSCC  (mC cm-2) 




3 mm 233.1 ± 19.6 80.9 ± 8.9 N/A 
2 mm 392.3 ± 9.8 118.6 ± 10.1 N/A 
1 mm 604.8 ± 61.4 188.5 ± 28.4 N/A 
500 μm 1024.1 ± 3.0 288.7 ± 1.7 N/A 
Pt 2.3 mm N/A 4.0 ± 0.2 4.3 ± 0.2 
Table 5.2 CSCc values in different voltage windows. CSCC values for planar MXtrodes of varying 
diameters and the comparison clinical Pt ECoG electrode. CV scans were performed at 50 mV/s for 
each electrode in both its safe voltage window and the intersection of the MXene and Pt voltage 
windows.   
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5.2.3 Electrode-skin interface impedance     
While measurements in saline allow comparing the properties of MXtrodes to current 
standard electrode materials such as Pt, for epidermal sensing applications it is also essential 
to evaluate the impedance at the interface with human skin. Specifically, achieving low 
electrode-skin impedance is key for recording high-fidelity signals [326], [327] and becomes 
particularly challenging in gel-free structures like MXtrodes. Thus, we measured EIS for 3 
mm-diameter MXtrodes, both in planar and 3D configurations, on clean human skin following 
standard preparation with an alcohol swab and light abrasion with 3M Trace Prep tape. At 1 
kHz, the planar and 3D MXtrodes showed impedances of 6.6 ± 2.9 kΩ and 4.9 ± 2.6 kΩ, 
respectively, with the lower impedance of the 3D electrodes attributable to the improved 
contact from the protruding mini-pillars pressing into the skin (Figure 5.5d). When 
normalized by their geometric surface area (GSA) of 0.071 cm2, the impedance is 0.47 ± 0.20 
kΩ·cm2 for planar and 0.35 ± 0.12 kΩ·cm2 for 3D MXtrodes, which are among the best values 
reported so far for dry, gel-free epidermal electrodes [111], [112], [328] and ~100 times 
lower than those of commercially available gelled Ag/AgCl electrodes commonly used for 
electrodiagnostics and monitoring [314].  
5.3 Gel-free epidermal sensing in humans   
5.3.1 Scalp electroencephalography (EEG) 
Motivated by the exceptionally low electrode-skin interface impedance of the dry 
MXtrodes, we investigated their use in a variety of human epidermal sensing applications, 
with custom geometries specifically designed for each application. First, we acquired scalp 
EEG on a healthy human subject using high resolution gel-free MXtrodes and standard gelled 
Ag/AgCl EEG electrodes for comparison. We designed an 8-channel MXtrode, with 3 mm-
diameter 3D mini-pillar electrodes arranged in a ring around a central opening, where we 
placed a standard 1 cm-diameter gelled Ag/AgCl EEG electrode for side-by-side comparison 
of simultaneously acquired EEG (Figure 5.7a). In the first EEG task, we placed the MXtrode 
array over the parietal region near EEG site P1 (as defined in the EEG 10-20 system, located 
over inferior parietal cortex to the immediate left of the midline). The gelled Ag/AgCl EEG  
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Figure 5.7 Dry EEG recording enabled by 3D pillar MXtrodes. (a) Images of a MXtrode 3D EEG 
array with eight 3 mm-diameter MXene electrodes in a circular arrangement around a central opening. 
(b) Image of MXtrode electrode array and standard gelled Ag/AgCl cup electrode placed on head of 
human subject. (c) Map of 1 kHz impedance values for all electrodes on the subject’s head. (d)
Segments of recorded EEG signal from all electrodes during the eyes open (left) and eyes closed (right) 
tasks at resting state. (e) Spectrograms of the EEG signal recorded on MXene electrode b in the eyes 
open (top) and eyes closed (bottom) conditions. Alpha frequency band is enclosed in dashed box to 
highlight differences between eyes open and eyes closed states. (f) Power spectral density during eyes 
open and eyes closed EEG recordings. The 8-12 Hz alpha band is highlighted. 
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electrode was placed in the center of the MXtrode ring (Figure 5.7b). Ground and reference 
for all EEG recordings were gelled Ag/AgCl electrodes placed at the center forehead and left 
mastoid, respectively. The slightly lateralized recording position was chosen because the 
subject had the shortest hair at that location (~5 mm). Before placing the electrodes on the 
skin, the entire recording area was cleaned with an alcohol swab and lightly abraded with 3M 
Trace Prep tape. Notably, we found that the electrode-skin interface impedance at 1 kHz for 
the dry MXtrodes was 2.8 ± 0.9 kΩ, while the impedance of the larger gelled Ag/AgCl electrode 
during the same experiment was 1.2 kΩ at 1 kHz (Figure 5.7c). Given the critical role of the 
electrode-skin interface impedance in determining the quality of scalp EEG signals [329], 
most standard EEG electrodes require conductive gels at this interface, as well as a large 
contact area of at least ~1 cm2 to achieve suitably low impedance (e.g., less than 5 kΩ) [330]. 
Due to their enhanced material and surface area properties, our mm-scale, gel-free MXtrodes 
can achieve strikingly low impedance, which enables high-resolution EEG recording. We 
recorded EEG in 2 min sessions, with the subject alternating between a resting state with the 
eyes closed and a resting state with the eyes open and fixating on a target. In both tasks, the 
EEG signal recorded on the dry MXtrodes was indistinguishable from the signal recorded on 
the gelled Ag/AgCl electrode (Figure 5.7d). Additionally, a clear 10 Hz alpha rhythm emerged 
in the eyes closed state with a significantly higher amplitude than in the eyes open condition 
(Figure 5.7e-f). This alpha signature is one of the most reliable and widely studied 
behaviorally-linked EEG signatures in human subjects research [331], and arises from 
endogenous thalamic input to the visual cortex in the absence of visual input (i.e. when the 
eyes are closed) [332]. During the recording session, there was no significant difference 
between the alpha bandpower on the gelled Ag/AgCl electrode and any individual dry 
MXtrode, confirming that the signals were comparable between the electrode types (Figure 
5.8). Interestingly, when alpha bandpower values were calculated in 1 s windows with 0.5 s 
of overlap and observed sequentially, distinct spatiotemporal patterns of alpha activation 
emerged even across the small sampled scalp area. MXtrodes could be spaced much closer 
than they were in the ring configuration we used in this experiment, however the density we 
tested already approximates or exceeds the densest configurations of traditional Ag/AgCl 
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electrodes in common use today (the 10-5 system). This highlights the potential of mm-scale, 
gel-free MXtrodes to enable ultra high-density EEG mapping.  
For the second EEG task, the electrodes were removed and replaced at site C3 near 
the hand motor area. The precise location of the hand motor area was determined using 
single pulses of transcranial magnetic stimulation (TMS) to evoke lateral finger movements, 
and the electrodes were centered over this location (Figure 5.9a). The subject performed 2 
min periods of imagined and actual hand flexion while the EEG was recorded simultaneously 
with the co-located MXtrodes and gelled Ag/AgCl electrode. During this motor task, we also 
found that the EEG signal was indistinguishable between the two electrode types. 
Furthermore, we observed a suppression of the 8–12 Hz motor mu rhythm during the actual 
hand flexion relative to the imagined hand flexion (Figure 5.9b). The mu suppression 
signature during imagined hand movement is an important EEG feature which has been 
successfully used as a control signal for EEG-based brain-computer interfaces (BCIs) [333], 
Figure 5.8 EEG alpha bandpower mapping. (a) 8-12 Hz alpha bandpower across the 2 min recording 
in the eyes open state. Color plot (top) shows average alpha power for each electrode, mapped to its 
corresponding location on the scalp. Bar plot (bottom) shows average alpha power, with error bars 
corresponding to standard error of the mean across all time windows. No significant difference was 
detected between the gelled Ag/AgCl electrode (labelled i) and the dry MXtrode electrodes (labelled 
a-h). (b) The same alpha bandpower analysis shown in (a), for the eyes closed task. 
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[334]. Together, the results of these EEG experiments confirm that mm-scale, gel-free 
MXtrodes can record EEG signal at least as well as standard gelled Ag/AgCl EEG electrodes, 
while also improving spatiotemporal resolution for high-density EEG applications. 
Furthermore, the application of MXtrodes to the scalp is faster and easier than standard 
Ag/AgCl electrodes and leaves no residue on the head. This positions MXtrodes to 
dramatically lower the effort of conducting EEG experiments, and to expand the use of high-
fidelity EEG to environments outside the laboratory.  
5.3.2 High-density surface electromyography (HDsEMG) 
Next, we evaluated MXtrodes for high-density surface electromyography (HDsEMG) 
recording, muscle activation mapping and localization of the of innervation zones (IZs). 
HDsEMG is attracting growing interest for a number of applications in neuromuscular 
diagnostics and rehabilitation, including control of multifunctional prostheses [120], studies 
of muscle activation and coordination [335], peripheral nerve/muscle fiber conduction 
velocity measurements [336], and for accurate localization of neuromuscular junctions 
(NMJs) to target chemodenervation therapies for muscle spasticity [337], [338]. HDsEMG 
recordings require flexible, large-area, and high-density electrode arrays capable of covering 
the wide range of muscle sizes. To demonstrate the versatility of the MXtrode fabrication 
process, we created custom HDsEMG arrays to map muscle activation and localize IZs in two  
Figure 5.9 Motor EEG recording. (a) Photograph of the EEG recording setup with electrodes centered 
over the hand motor region, as localized with single TMS pulses. (b) PSDs of the recorded EEG signal 
reveal a suppression of the 8-12 Hz motor mu rhythm during actual hand flexion as compared to 
imagined hand flexion. 
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Figure 5.10 High density surface EMG mapping with MXtrode arrays. (a)-(b) EMG recordings from 
the APB muscle. (a) Average evoked response following N=10 median nerve stimulation epochs 
recorded on 20-ch MXtrode array placed over APB. Blue ticks indicate time of nerve stimulation, and 
purple dots indicate time of peak evoked response. (b) Latency map of peak response overlaid on 
photo of the MXtrode array on the APB. White “x” indicates the channel with shortest latency, 
corresponding to the IZ. c-d EMG recordings from the biceps muscle. (c) Average evoked response 
following N=10 supraclavicular nerve stimulation epochs recorded on 40-ch MXtrode array placed 
over the biceps. Blue ticks indicate time of nerve stimulation, and purple dots indicate time of peak 
evoked response. (d) Latency map of peak response overlaid on photo of the MXtrode array on the 
subject’s biceps. Distributed IZ running perpendicular to the muscle is apparent as the band with the 
shortest latency. 
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muscle groups of different sizes (Figure 5.10). First, we used a 20-ch planar MXtrode array 
placed over the abductor pollicis brevis (APB) at the base of the thumb. In this experiment, the 
3 mm-diameter dry MXtrodes had an average electrode-skin interface impedance of 54.6 ± 
28.4 kΩ at 1 kHz (Figure 5.11a). We then stimulated the median nerve with a handheld 
bipolar stimulator to evoke APB contractions and recorded the EMG on the MXtrode array. 
We calculated the mean evoked muscle response across stimulation trials (Figure 5.10a) and 
constructed a latency map of the peak of the evoked response. The location with the shortest 
latency indicates the location of the IZ, which can be seen overlaid on the subject’s hand in 
Figure 5.11 Impedance and bipolar subtraction EMG experiment. (a), (b) 1 kHz impedance 
magnitude maps for the (a) 20-ch planar MXtrode array used to map the APB muscle and the (b) 40-
ch planar MXtrode array used to map the biceps, overlaid on images of the arrays on the subject during 
the experiment. (c) Schematic showing the arrangement for bipolar signal subtraction shown in (d) 
for resisted flexion EMG recordings on the biceps. The latency map obtained from the supraclavicular 
stimulation experiment is shown overlaid on the bottom image. (d) Bipolar EMG signals recorded 
during resisted flexion on the biceps. The location of the innervation zone is indicated by the arrows, 
and is clear from the propagation of the EMG signal outward from this region with some delay, as well 
as the inversion of the spikes on either side. The innervation zone determined from this analysis is in 
agreement with the region identified by the electrical stimulation-derived latency map shown in (c).   
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Figure 5.10b, and it is in good agreement with expectations based on anatomical landmarks 
[339].  
Following the APB mapping experiment, we mapped the activation of the larger 
biceps brachii with a 40-ch planar MXtrode array. Here, the 3 mm-diameter dry MXtrodes had 
an average electrode-skin interface impedance of 22.0 ± 14.3 kΩ at 1 kHz (Figure 5.11b). 
Unlike the smaller APB muscle, which has a small and spatially confined IZ corresponding to 
a single NMJ, the larger biceps brachii has distributed NMJs in IZ regions that run 
perpendicular to the muscle and are typically located near the center [340]. To further 
confirm the validity of our approach, we used two different methods to localize these IZs in 
the biceps: first we stimulated the supraclavicular nerve and constructed a latency map of the 
peak evoked response, similar to the methods described for the APB (Figure 5.10c,d). This 
produced a clear mapping of the IZ location as the region with the shortest latency, running 
across the short head of the biceps brachii. Second, we recorded motor unit action potentials 
(MUAPs) as the subject performed isometric contractions of the biceps (Figure 5.11c,d). In 
these recordings, bipolar subtraction of the raw EMG signal along the length of the biceps 
muscle revealed MUAPs that propagated outward in both directions from the IZ, with signal 
inversion and a clear latency as the MUAP traveled away from the IZ (Figure 5.11d). 
Localization of the biceps IZ obtained from both methods were in excellent agreement with 
each other, and with previous reports [340]. These results demonstrate that dry, high-
resolution MXtrode arrays are capable of mapping muscle activation with high accuracy in 
order to precisely localize IZs in both small and large muscle groups. 
5.3.3 Electrocardiography (ECG) 
To demonstrate the applicability of MXtrodes to electrocardiogram (ECG), we 
acquired ECG recordings on a healthy human subject with 1.3 cm-diameter MXtrodes in a 
simplified 3-electrode montage as shown in Figure 5.12a. For validation and signal 
comparison, we recorded sequentially from the MXtrodes and from 1 cm-diameter pre-gelled 
Ag/AgCl electrodes, placed in the same locations. The dry MXtrodes and pre-gelled electrodes 
had average 1 kHz skin-electrode impedances of 1.29 kΩ and 1.38 kΩ, respectively. On both 
types of electrodes, characteristic ECG features were clearly visible, with the P wave followed 
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by the QRS complex and the T wave (Figure 5.12b,c). Mean R peak amplitude, however, was 
slightly higher on the MXtrodes compared to the commercial electrodes: 2.55 ± 0.06 mV vs. 
2.47 ± 0.30 mV. Thus, we confirmed that dry MXtrodes can record the ECG with comparable 
signal quality compared to standard clinical gelled electrodes. 
 
5.3.4 Electrooculography (EOG) 
As a final demonstration of MXtrodes for human epidermal sensing, we acquired 
electrooculography (EOG), which has applications in ophthalmological diagnosis, BCIs, and 
for monitoring attention and fatigue [341], [342]. The EOG signal arises from the standing 
dipole potential between the positively charged cornea and the negatively charged retina, 
which enables tracking eye movements as this dipole is rotated. With the same 1.3 cm-
diameter dry MXtrode geometry used in ECGs, we recorded the EOG in two configurations to 
track up-down and left-right eye movements (Figure 5.13). By placing MXtrodes above and 
below the eye, recorded voltage fluctuations could be decoded to track the up and down 
movements of the eye (Figure 5.13a,b). Similarly, placing MXtrodes on both sides of the eyes 
enabled decoding the left-right movements (Figure 5.13c,d).  
  
Figure 5.12 Electrocardiography with MXtrodes. (a) Photo of ECG recording setup on human 
subject. Electrodes were interchanged in the same locations to obtain sequential recordings from 
either dry MXene or pre-gelled commercial electrodes. (b) Ten seconds of ECG recordings on the dry 
MXtrodes (top) and the pre-gelled commercial electrodes (bottom). (c) Average ECG waveforms 
recorded on the two electrode types, marked with salient ECG features. 
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5.4 Cortical neural recording and microstimulation in animal 
models   
5.4.1 Intraoperative electrocorticography (ECoG)  
Beyond epidermal sensing modalities, the favorable electrochemical interface of the 
MXtrodes also supports their use for implantable sensing and stimulation applications. One 
such application is intraoperative electrocorticography (ECoG), a common mapping 
technique used in resective brain surgery for epilepsy or tumors. We acquired ECoG 
recordings in an anesthetized swine, a relevant animal model in neuroscience given the 
gyrencephalic structure and neuro-anatomical similarity of the swine brain to the human 
brain. In this experiment we inserted a 6-ch array of 500 µm-diameter planar MXtrodes 
through an 8 mm craniotomy/durotomy and placed MXtrodes in direct contact with the 
Figure 5.13 Electrooculography with MXtrodes. (a) Schematic of EOG recording for monitoring up-
down eye movements. (b) EOG data recorded on MXtrodes, showing distinct up and down eye 
movements. (c) Schematic of EOG recording for monitoring left-right eye movements. (d) EOG data 
recorded on MXtrodes, showing distinct left and right eye movements. 
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cortical surface (Figure 5.14a). The array configuration consisted of 3 rows of electrode pairs 
with 5 mm inter-row spacing and 4.5 mm pitch, so that the rows of electrodes spanned 
several cortical gyri. A few seconds of representative raw ECoG signal are shown in Figure 
5.14b. The signals were large in amplitude with negligible 60 Hz noise interference, as 
evidenced by the power spectra (Figure 5.14c). Furthermore, maps of interpolated voltage 
across the MXtrode array revealed stereotyped spatial patterns emerging during the “up” and 
“down” states in the ECoG signal (Figure 5.14d,e), highlighting the advantages and 
opportunities offered by high-density cortical brain mapping with MXtrodes. 
Figure 5.14 ECoG recording with MXtrode arrays in swine brain. (a) Schematic depicting ECoG 
recording setup with the 6-ch array of 500 µm-diameter MXtrodes placed subdurally on 
somatosensory cortex. (b) A few seconds of representative ECoG data recorded on the MXtrode array. 
(c) Power spectral density of the ECoG recording, illustrating the low-noise quality of the ECoG signals 
obtained, evidenced by the lack of a 60 Hz noise peak. (d) Segment of ECoG data, displayed according 
to the spatial arrangement of the 6 MXtrodes. (e) Instantaneous snapshots of the voltage mapping 
recorded across the 6 MXtrodes reveals stereotyped patterns during down states (panels 1 and 4) and 
up states (panels 2 and 3). The timing of these voltage snapshots is indicated in (e) by the vertical lines. 
Voltage was interpolated across the array and normalized, with black dots indicating location of the 6 
MXtrode contacts. 
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5.4.2 Cortical microstimulation 
In addition to ECoG recording, direct stimulation of the cortical surface is used 
clinically for intraoperative cortical mapping [343] and neuromodulation therapies [344], as 
well as for closed-loop BCIs [345]. Given that the MXtrodes showed superior CSC and CIC 
compared to Pt, a material commonly used in stimulating electrodes, we sought to 
demonstrate the effectiveness of MXtrodes for electrical stimulation by evoking motor 
responses via intraoperative stimulation in rat brain. Specifically, we placed a 500 µm-
diameter planar MXtrode subdurally onto the whisker motor cortex of an anesthetized rat. 
Contralateral to the MXtrode, an optical micrometer was positioned to track whisker 
displacement, with one whisker placed into a plastic tube to maximize detection sensitivity 
Figure 5.15 Cortical stimulation with MXtrode arrays in rat brain. (a) Schematic of the cortical 
stimulation setup, with the 4-ch array of 500 µm-diameter MXtrodes placed over barrel cortex, and the 
optical micrometer used to detect and amplify the whisker deflection signal. (b) Whisker deflection 
data recorded by the optical micrometer during a series of stimulation pulse trains delivered at 1.4 
mA. (c) Average first whisker deflection for each stimulation pulse amplitude, time-aligned by the 
stimulation onset. (d) Whisker deflection amplitude scales with stimulation amplitude, with 
stimulation at 1.0 mA falling below the threshold required to evoke whisker movement.   
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(Figure 5.15a). Trains of charge-balanced, cathodal-first stimulation pulses with amplitudes 
ranging from 1.0 to 1.4 mA were delivered through the MXtrode. We observed stimulation-
evoked whisker movements for amplitudes greater than 1.0 mA, with the whisker deflection 
amplitude scaling with the stimulation intensity (Figure 5.15b-d). Whisker movements 
registered as oscillatory deflections on the micrometer, with the first deflection peak always 
being the largest in amplitude. To compare whisker deflection across stimulation current 
amplitudes, we computed the mean amplitude of the first whisker deflection peak for each 
stimulation trial at each current level. These results confirm that MXtrodes are capable of 
delivering electrical stimulation to effectively modulate neural activity.  
5.5 Compatibility of MXtrodes with clinical imaging    
With the widespread adoption of bioelectronic technologies, compatibility with 
clinical imaging has become increasingly important. MRI and CT are the two most common 
imaging techniques used in the diagnosis of injury and disease, as well as in image-guided 
interventions. However, many of the conductive materials traditionally used in bioelectronic 
devices are incompatible with the challenging MRI environment and can produce heating or 
exert forces on the tissues. Even devices considered MR-safe often produce imaging artifacts 
that shadow the surrounding anatomical structures because of the mismatch in magnetic 
susceptibility between the device materials and the tissue [346]. These challenges are 
compounded at high field strengths, which are increasingly being used for high resolution 
imaging, as well as for novel functional and metabolic imaging techniques [347], [348]. While 
the magnetic susceptibility of Ti3C2 MXene had not been previously characterized, we 
hypothesized from the weak dia- and paramagnetic properties of C and Ti, respectively, that 
Ti3C2 may have a low magnetic susceptibility and thus prove compatible with the MR 
environment. To verify our hypotheses, we performed MRI scans of MXtrodes and measured 
the magnetic properties of Ti3C2 at body temperature. First, we imaged cross-sections of 3 
mm-diameter planar MXtrodes and 2.3 mm-diameter commercial Pt electrodes embedded in 
conductive agarose phantoms in a 9.4T high-field research MRI system (Figure 5.16a,b). In 
the MR images, we found significant shadowing around the Pt electrodes, while no artifact 
was visible around the MXtrode (Figure 5.16b). In fact, the MXene composite forming the 
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conductive electrode was almost completely indistinguishable from the surrounding PDMS 
encapsulation. To further explore the MRI compatibility of the MXtrodes, we next imaged an 
array of 3 mm-diameter 3D mini-pillar MXtrodes – the same array used for EEG recording in 
this work – in a 3T clinical MRI scanner. The MXtrodes were placed atop a tissue phantom 
and imaged using a battery of scan sequences typical of structural and functional MRI. 
Regardless of the scan sequence, the MXtrodes showed no artifact and were nearly invisible 
in the images (Figure 5.17a). Thermal IR images of the MXtrode array immediately following 
a 10 min scan sequence also showed no evidence of RF heating (Figure 5.17b). Finally, we 
measured the magnetic susceptibility of a Ti3C2 free-standing film at 310 K, and found it to be 
2.08 x 10−7 (Figure 5.17c), indicating that Ti3C2 is weakly paramagnetic with magnetic 
susceptibility very close to that of human tissues (−11.0 to −7.0 x 10−6). This innate property 
Figure 5.16 MRI and CT compatibility of MXtrodes. (a) Schematic of the phantom imaging setup for 
MRI and CT imaging. Strips of disk electrodes (3 mm-diameter MXtrodes or 2.3 mm-diameter clinical 
Pt ECoG strip electrodes) were embedded in a conductive agarose phantom and imaged in the 
transverse plane. (b) A high-field 9.4T MRI scan showing significant shadow artifact and image 
distortion around the Pt electrode (top), but no visible artifact from MXtrodes (bottom). The MXene 
contact is indistinguishable from the PDMS encapsulation in the device. (c) High-resolution CT scans 
with Pt electrodes (top) showing significant x-ray scattering artifacts, while no artifact is visible from 
the MXtrodes (bottom). 
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of Ti3C2, which has not been reported previously, leads directly to the excellent compatibility 
of the MXtrodes with MRI imaging. For comparison, the magnetic susceptibility of Pt is 2.79 
x 10−4, several orders of magnitude larger than the susceptibility of human tissues [346]. In 
situations where it might be important for implanted electrodes to be visible in MRI images, 
such as in epilepsy seizure foci localization relative to electrode locations, a marker such as 
iron oxide nanoparticles could in principle be incorporated into the electrode contacts to aid 
in their visualization [349].  
Figure 5.17 3T MRI compatibility and magnetic susceptibility of MXene. (a) MXtrode EEG array, 
imaged in a 3T clinical MRI with a T2 weighted sequence. The array was placed atop an MRI phantom 
and a Vitamin E marker was placed on top of the MXtrode array. The Vitamin E marker is visible, while 
the MXtrode array is not. (b) Thermal IR image of MXtrode EEG array captured immediately after a 10 
min MRI sequence, showing no sign of heating. Left image shows MXtrode array atop the MRI phantom, 
and right image shows the thermal image overlay. (c) Magnetic susceptibility of Ti3C2 MXene 
measured at body temperature (i.e., 310 K) for applied magnetic field up to 9T. For calculation of the 
magnetic susceptibility value, Χ, magnetization and field strength were both converted to units of A/m 
such that Χ is unitless. 
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As for CT compatibility, the X-ray attenuation characteristics resulting from the high 
density and large atomic mass of metals in conventional electrodes poses challenges for CT 
imaging with bioelectronic devices [350]. Multilayer Ti3C2 MXene has a density of about 4 
g/cm3, which is ~5 times lower than Pt. Thus, we hypothesized that Ti3C2 could minimize 
attenuation and scattering artifacts in CT [351]. To test our hypothesis, we imaged 3 mm-
diameter planar MXtrodes and 2.3 mm-diameter commercial Pt electrodes embedded in 
conductive agarose phantoms in a microCT scanner. As expected from the density matching 
considerations, we observed significant X-ray scattering artifacts around the Pt electrodes, 
but not around the MXtrodes (Figure 5.16c). 
5.6 Discussion    
In this work we developed a new class of MXene-based bioelectronic interfaces and 
demonstrated their use for high-fidelity recording and effective stimulation of neural and 
neuromuscular circuits across multiple scales. The simple fabrication method reported here 
offers a scalable and low-cost means of producing large-area, multichannel electrode arrays 
from high performance, solution processable 2D materials. The method is conducive to large-
scale manufacturing, a key aspect for translation beyond the lab and into clinical and 
consumer markets. It also enables rapid customization of array geometries for various 
applications as well as for patient- or subject-specific fit where desired. The exceptional 
properties of Ti3C2 endow MXtrodes with impedance and charge delivery properties that 
meet and even exceed current state-of-the-art noble metal electrode materials in both 
epidermal and implantable use cases. In epidermal sensing applications, the remarkably low 
electrode-skin interface impedance of gel-free MXtrodes opens exciting new possibilities for 
high-resolution EMG and EEG, while eliminating the challenges associated with wet 
conductive gels. In HDsEMG mapping, MXtrode arrays hold promise for accurately localizing 
NMJs for use with neurolytic procedures for the treatment of spasticity and excessive muscle 
tone. In the future, this may eliminate the need for intramuscular needle EMG stimulation in 
search of the NMJ – the optimal place for injecting medications (e.g. botulinum toxin and 
phenol) for denervation. Furthermore, such HDsEMG arrays can also be integrated within an 
active prosthesis system where EMG from the residual limb serves as input signal for the 
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prosthesis control [352], [353]. In EEG applications, a dry electrode system enabled by 
MXtrodes may offer a route toward minimizing skin breakdown and alleviating many of the 
key logistical challenges associated with current gelled EEG systems, such as the time 
required to apply each electrode and impedance fluctuations over time as the gels dry out. 
These advantages, coupled with the possibility for obtaining high density EEG recording with 
mm-scaled MXtrodes, also make this technology attractive for neuroscience research [354], 
[355], non-invasive BCI systems [356], [357], neuro-rehabilitation [358], and brain-
controlled videogaming [41]. The compatibility of MXtrodes with both CT and MRI imaging 
enables accurate, artifact-free imaging without the need for removing electrodes from the 
subject before the scan, thus opening exciting possibilities for multimodal studies in both 
clinical diagnostics and neuroscience research, such as those combining simultaneous EEG 
with functional MRI or GluCEST imaging [348], [359]. In addition to the low interface 
impedance, the extensive characterization of the electrochemical behavior of MXtrodes 
presented in this work demonstrates for the first time the advantages of Ti3C2 for electrical 
stimulation, as highlighted by remarkably high CSC and CIC compared to many commonly 
adopted bioelectronic materials. This finding suggests that MXtrodes may represent a 
suitable alternative for stimulation electrodes with enhanced safety, charge transfer 
efficiency, and reduced power consumption. While the technology presented here already 
shows great potential for translation, ongoing efforts include evaluating and improving the 
stability of Ti3C2 for long-term use [226], [269], [360], optimizing the MXene infusion process 
to maximize the MXene loading and conductivity of the resulting composite [315], and 
exploring alternative encapsulation materials to further improve the flexibility and 
breathability of the electrode arrays [120]. Overall, our results indicate that MXene-based 
bioelectronics have tremendous potential for enabling the next generation of soft interfaces 





Chapter 5: Human-scale, translational neurodevices using Ti3C2 MXene 
 
 137   
 
5.7 Materials and methods     
Synthesis of Ti3C2 MXene 
Ti3C2 MXene was provided by Murata Manufacturing Co., Ltd. It was produced using the MILD 
synthesis method [232] to create an ink of 30 mg/mL Ti3C2 in deionized water, which was 
placed in a vial and sealed under Argon atmosphere for long term storage.  
Fabrication of MXtrode devices  
Devices were fabricated by first laser-patterning absorbent nonwoven textile substrates 
comprised of hydroentangled 55% cellulose / 45% polyester blend (Texwipe TechniCloth) 
using a CO2 laser (Universal Laser Systems PLS 4.75) such that electrode array patterns were 
easily separable from the surrounding textile, but could still be lifted and handled as one 
sheet. These were transferred to a thin and slightly tacky bottom layer of 1:10 PDMS (Sylgard 
184) on a flat acrylic sheet, and the excess textile surrounding the array patterns was then 
peeled up. The textile patterns were then inked with 30 mg/mL Ti3C2 MXene, allowed to air 
dry for 15 min, then placed in a vacuum oven (Across International) at 70 °C and 60 mmHg 
for 1 h to remove all remaining water. For devices incorporating 3D mini-pillar electrodes, 3 
mm circles were cut from absorbent cellulose sponges (EyeTec Cellulose Eye Spears) using a 
3 mm biopsy punch and these circular sponges were inked with MXene and placed onto the 
electrode locations of the MXene-textile constructs at the same time that the laser-patterned 
textile was inked. The subsequent drying steps were identical. No adhesive was necessary at 
this interface, as the dried MXene and the subsequent PDMS encapsulation was sufficient to 
hold the 3D mini-pillars firmly in place. For multichannel arrays, connectors (FCI/Amphenol 
FFC&FPC clincher connectors) were then attached by screen printing silver conductive epoxy 
(CircuitWorks CW2400) onto the ends of the dried MXene constructs, inserting these into the 
connectors, and clinching shut. The devices were baked at 70 °C for 30 min to cure the silver 
epoxy. Next, 1:10 PDMS was layered over the devices to form the top insulation layer, 
thoroughly degassed at 60 mmHg for 15 min – which forced PDMS to infiltrate into the MXene 
composite matrix – and subsequently cured at 70 °C for 1 h. Finally, devices were cut out with 
a razor blade, and peeled up from the acrylic substrate. For planar electrodes, electrode 
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contacts were exposed by cutting circular holes though the top PDMS layer using a biopsy 
punch (diameters ranging from 500 µm – 3 mm) and carefully peeling up the disk of PDMS to 
expose the MXene composite electrode below. For 3D mini-pillar electrodes, contacts were 
exposed by trimming the tops of the mini-pillars with a flat razor blade, exposing the MXene-
sponge composite electrode. Slight variations on this method were utilized for MXtrode 
arrays designed for different applications: for EMG arrays, a thin layer of silicone medical 
adhesive spray (Hollister Adapt 7730) was applied to the skin-facing side of the array prior 
to opening the electrode contacts to enhance skin adhesion; for single-channel ECG and EOG 
MXtrodes, EcoFlex (Smooth-on Ecoflex 00-30) in a 1:2 ratio (part A:part B) was used as the 
encapsulation rather than PDMS to offer enhanced skin adhesion and comfort; for the ECoG 
electrodes, arrays were fabricated in PDMS as described above, but were additionally coated 
in a 1 µm-thick layer of Parylene-C prior to opening electrode contacts to enhance the 
moisture barrier properties of the encapsulation.  
Imaging of MXtrode devices 
Optical images of MXtrodes and their constituent parts were taken with a Keyence VHX6000 
digital microscope. Scanning electron microscopy (SEM) images were captured using a Zeiss 
Supra 50VP scanning electron microscope with an accelerating voltage of 5 kV. 
DC conductivity of ink-infused composites 
DC conductivity measurements were made on laser-cut test structures 20 cm long x 3 mm 
wide x 285 µm thick comprising 55% cellulose / 45% polyester blend (Texwipe TechniCloth) 
infused with either: (1) 30 mg/mL Ti3C2 MXene in DI, (2) 1.1% high conductivity grade 
PEDOT:PSS in H2O (Sigma Aldrich), or (3) 18 mg/mL highly concentrated single-layer 
graphene oxide (Graphene Supermarket) which was subsequently reduced using a vitamin-
C reduction method[361]. Measurements were taken with a handheld multimeter with flat 
alligator clip terminations, where the negative lead was fixed at the end of the construct and 
the positive lead was moved in 2 cm increments for each measurement.  
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Electrochemical characterization  
For cutaneous EIS measurements, the skin of the inner forearm was prepared with an alcohol 
swab followed by light abrasion (3M TracePrep abrasive tape) before placing 3 mm planar 
and 3D mini-pillar MXtrodes and measuring EIS from 1 – 105 Hz with a 10 mVpp driving 
voltage using a Gamry Reference 600 potentiostat. Reference was placed on the inner wrist 
and ground was placed on the elbow (Natus disposable disk electrodes). Electrochemical 
measurements in saline, including EIS, CV, and current pulsing, were performed for planar 
MXtrodes with diameters of 3 mm, 2 mm, 1 mm, and 500 µm, and Pt electrodes with a 
diameter of 2.3 mm (Adtec epilepsy subdural grid TG48G-SP10X-000) in 10 mM phosphate 
buffered saline (Quality Biological, pH 7.4) using a Gamry Reference 600 potentiostat. All 
electrochemical measurements were done in a 3 electrode configuration with a graphite rod 
counter electrode (Bio-Rad Laboratories, Inc.) and a Ag/AgCl reference electrode (Sigma-
Aldrich). EIS was measured from 1 – 105 Hz with 10 mVpp driving voltage. Cyclic voltammetry 
was performed at a sweep rate of 50 mV/s. Safe voltage limits for MXtrodes were determined 
by incrementally increasing the negative limit of the CV scan until water reduction was 
observed (beginning at −1.9 V), then the positive limit of the CV scan until a linear, resistive 
behavior was observed (beginning at +0.7 V) beyond which the MXtrode showed current loss 
with subsequent scans. CSCc was determined from the CV scans by taking the time integral of 
the cathodal current. Current pulsing was performed using chronopotentiometry with 
biphasic, charge-balanced current pulses with tc = ta = 500 µs and tip = 250 µs for currents 
ranging from 600 µA to 5 mA for N=3 electrodes of each size. For CICc calculations, Emc was 
determined as the instantaneous voltage 10 µs after the end of the cathodal current pulse. Emc 
values were plotted as a function of injected current amplitude, and the linear relation was 
determined to estimate the current limit at which the electrode would reach its cathodal limit 
(−1.8 V for MXtrodes, −0.6 V for Pt). Any series of measurements in which current amplitude 
vs. Emc was not linear with R2 < 0.95 were excluded. CICc was defined as: 𝐶𝐼𝐶 =
 ×  
 , where 
Ilim is the cathodal current limit, tc is the cathodal pulse width, and GSA is the electrode 
geometric surface area. CSC and CIC scaling relations were determined by fitting power 
functions to the data, similar to work by M. Ganji et al [317]. 
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EEG experiments 
EEG experiments were conducted under a protocol approved by the Institutional Review 
Board of Drexel University (Protocol # 1904007140). One healthy human subject was seated 
in a comfortable chair with a head rest. Prior to placing electrodes, the subject’s scalp was 
prepared with an alcohol swab and light abrasion (3M TracePrep abrasive tape), though the 
presence of hair may have limited the efficacy of the skin abrasion. Recordings were made 
using an 8-electrode MXtrode device with dry 3 mm-diameter 3D mini-pillar electrodes and 
1 standard gelled Ag/AgCl EEG cup electrode (Technomed Disposable EEG cup) placed in the 
center of the MXtrode array. Recordings were obtained using a NeuroNexus SmartBox 
amplifier system with a sampling rate of 20 kHz. Standard gelled Ag/AgCl EEG cup electrodes 
were used for reference (placed on left mastoid) and ground (placed on forehead center). In 
the first set of recordings, electrodes were positioned on the parietal region, centered over 
10-20 site P1. Pre-wrap (Mueller) was used to hold the electrodes in place, and a small hole 
was made in this wrapping to allow application of conductive gel (SuperVisc, EASYCAP 
GmbH) beneath the standard EEG cup electrode. To evoke identifiable changes in the alpha 
band[362], six 2-minute-long recordings were obtained, alternating between eyes open and 
eyes closed states. During resting state, the subject was instructed to remain relaxed but alert. 
For the eyes open state, the subject was asked to fixate on a cross on a computer monitor to 
reduce oculomotor saccades and maintain a consistent level of external vigilance. In the 
second set of recordings, the hand motor region was localized using single TMS pulses to 
isolate a location that evoked lateral finger movements [363] via induced contractions of the 
first dorsal interosseus, and the electrodes were positioned centered over this location, 
approximately at site C3. Six 2-minute-long recordings were obtained, cycling through a 
resting state, imagined hand flexion, and actual hand flexion. Signals were notch filtered at 60 
Hz and bandpass filtered from 0.1 – 100 Hz. Bridging analysis was performed to ensure that 
gel did not leak from the cup electrode to contact any recording surface on the MXtrode array. 
EMG experiments  
EMG, ECG, and EOG human epidermal recordings were conducted under an experimental 
protocol approved by the Institutional Review Board of the University of Pennsylvania 
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(Protocol # 831802). For all EMG experiments, skin preparation prior to placing MXtrode 
arrays included an alcohol swab followed by light abrasion (3M TracePrep abrasive tape), 
and signals were recorded at a sampling rate of 20 kHz on an Intan RHS2000 
Stimulation/Recording Controller (Intan Technologies). For recordings from abductor 
pollicis brevis (APB), a 5x4 grid of 3 mm planar MXtrodes with center-to-center spacing of 
7.5 mm horizontal, 6.5 mm vertical, was placed over the APB at the base of the thumb. 
Reference was placed over the bony interphalangeal thumb joint and ground was placed on 
the back of the hand (Natus disposable adhesive electrodes). The median nerve was 
stimulated at the wrist using a VikingQuest handheld bipolar stimulator (Nicolet), starting at 
10 mA and gradually increasing until supramaximal activation of the APB was achieved in the 
form of a thumb twitch (amplitude 38.8 mA for the subject shown). For localization of the 
NMJ of the APB, evoked responses recorded on each electrode in the array (no signal filtering 
was used) were averaged across all stim trials (N=10), the peak of the average evoked 
response was determined, and a map of the latency of this peak from the onset of the 
stimulation was created. The location of the NMJ was approximated as the location with the 
shortest latency in the peak evoked response. For recordings of the biceps, a 10x4 grid of 3 
mm planar MXtrodes with center-to-center spacing of 8.5 mm horizontal, 8.5 mm vertical, 
was placed over the center of the biceps muscle. Reference was placed distal to the array just 
above the inner elbow and ground was placed proximal to the array on the deltoid (Natus 
disposable adhesive electrodes). The supraclavicular nerve was stimulated using the same 
VikingQuest handheld bipolar stimulator (Nicolet), starting at 30 mA and gradually 
increasing until clear submaximal activation of biceps was observed (amplitude 49.0 mA for 
the subject shown). As for the APB recordings, evoked responses recorded on each electrode 
were averaged across all stim trials (N=11), the peak of the average evoked response was 
determined, and a map of the latency of this peak from the onset of the stimulation was 
created. The IZ was determined as the area with the shortest latency in the peak evoked 
response. To further validate the IZ localization in the biceps, additional EMG recordings 
were made with the subject performing periods of isometric voluntary contractions. Signals 
were subtracted in bipolar configuration down the length of the MXtrode array, and MUAPs 
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were identified in the raw EMG signal. The IZ was determined as the region where the MUAP 
appears earliest and where the signal polarity inverts.  
ECG recording 
For ECG recording experiments, skin preparation prior to placing electrodes included an 
alcohol swab followed by light abrasion (3M TracePrep abrasive tape), and signals were 
recorded at a 20 kHz sampling rate on an Intan RHS2000 Stimulation/Recording Controller 
(Intan Technologies). Recordings were made in a 3-electrode configuration with reference 
placed just below the subject’s right clavicle, ground placed just below the subject’s left 
clavicle, and the working electrode placed on the lower left ribs. For comparison, recordings 
were made sequentially using either all 2 cm gelled Natus electrodes (Natus disposable 
adhesive electrodes) or all 1.3 cm dry MXtrodes, with electrodes placed in the same locations. 
EOG recording 
EOG recording experiments followed a similar protocol to ECG recording. Skin preparation 
prior to placing the electrodes included an alcohol swab followed by light abrasion (3M 
TracePrep abrasive tape), and signals were recorded at a 20 kHz sampling rate on an Intan 
RHS2000 Stimulation/Recording Controller (Intan Technologies). 1.3 cm-diameter dry 
MXtrodes were used for ground, (+) and (-) contacts. For tracking up-down eye movements, 
the (+) and (-) electrodes were placed below and above the right eye, respectively. The 
subject moved their eyes in a center-down-center-up-center pattern for 2 minutes. For 
tracking left-right eye movements, the (+) and (-) electrodes were placed just lateral to the 
left and right eyes, respectively. The subject moved their eyes in a center-left-center-right-
center pattern for 2 minutes. The ground electrode was centered on the forehead for both 
EOG recording paradigms.  
ECoG recording  
Pigs were pair housed when possible and were always in a shared room with other pigs in a 
research facility certified by the Association for Assessment and Accreditation of Laboratory 
Animal Care International (AAALAC facility). All experiments were conducted according to 
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the ethical guidelines set by the Institutional Animal Care and Use Committee of the 
University of Pennsylvania and adhered to the guidelines set forth in the NIH Public Health 
Service Policy on Humane Care and Use of Laboratory Animals (2015).  Prior to the 
procedures, animals were fasted for 16 hours with water remaining ad libitum. After 
induction with 20 mg/kg of ketamine (Hospira, 0409-2051-05) and 0.5 mg/kg of midazolam 
(Hospira, 0409–2596-05), anesthesia was provided with using 2−2.5% isoflurane (Piramal, 
66794-013-25) via a snout mask and glycopyrrolate was given subcutaneously to curb 
secretions (0.01 mg/kg; West-Ward Pharmaceutical Corp., 0143-9682-25). The animals were 
intubated with a size 6.0 mm endotracheal tube and anesthesia was maintained with 2−2.5% 
isoflurane per 2 liters O2. Animals were then moved to an operating room, where they were 
transferred onto a ventilator. The ventilator provided the same rate of isoflurane and O2 for 
anesthesia maintenance at a rate of 20-25 breaths per minute. Heart rate, respiratory rate, 
arterial oxygen saturation, end tidal CO2, blood pressure and rectal temperature were 
continuously monitored, while pain response to pinch was periodically assessed. All of these 
measures were used to maintain an adequate level of anesthesia. A forced air warming 
system was used to maintain normothermia.  Prior to electrode insertion, the pig was placed 
in a stereotaxic frame described previously [364], and the surgical site was prepared and 
draped in the standard sterile fashion. After the skull was exposed, an 11 mm craniectomy 
was performed at the recording site, 7 mm lateral to midline and 4.5 mm posterior to bregma 
in order to expose the frontoparietal cortex. The dura was opened to expose the cortical 
surface and the MXtrode array was then placed in the subdural space for recording. 
Recordings were obtained using an HS-36 amplifier and collected continuously at 32 kHz 
using a Neuralynx Digital Lynx SX recording system. Raw data was collected and stored using 
Neuralynx’s Cheetah recording software. 
Cortical stimulation 
An adult male Sprague Dawley rat (Crl:SD, 300 g) was used for the stimulation experiment. 
Anesthesia was induced with 5% isoflurane and the rat was placed in a stereotaxic frame. 
Depth of anesthesia was monitored by respiratory rate and pedal reflex and maintained at a 
surgical plane with 1.5−2.5% isoflurane. Whisker motor cortex (wM1) was exposed 
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bilaterally with a craniotomy centered on the midline. A durotomy was performed over right 
wM1. A stimulation return skull screw was placed in the left frontal bone. Trains of biphasic 
current pulses (300 µs/phase, 3 µs interpulse interval, 100 pulses, variable pulse amplitude 
from 1.0 to 1.4 mA) were delivered through a single electrode in the MXtrode array using the 
Intan RHS System (Intan Technologies). Stimulus-evoked contralateral whisker movement 
was quantified with a laser micrometer (IG-028, Keyence Corp.), which had a measurement 
range of 28 mm, a spatial resolution of 5 µm, and a temporal resolution of 490 µs. A 360 µm 
diameter polyimide tube was placed over a whisker with visually apparent stimulus evoked 
movement. Spatial sensitivity of the micrometer was adjusted to detect only the motion of 
the whisker in the tube [365]. At the conclusion of the experiment, the rat was killed with an 
intraperitoneal injection of sodium pentobarbital. These procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Pennsylvania. 
Evaluation of MRI and CT compatibility 
A strip of six 3 mm-diameter MXtrodes were prepared with PDMS encapsulation to match the 
geometry of the comparison Pt clinical ECoG electrode strips (Adtec epilepsy subdural grid 
TG48G-SP10X-000). Both types of electrode arrays were placed in 0.6% agarose (IBI 
Scientific) prepared with 10 mM PBS (Quality Biological, pH 7.4) in a 15 mm inner-diameter 
glass test tube, with degassing to remove air bubbles. A 9.4 T Horizontal bore MRI scanner 
(Bruker, Erlangen) and 35 mm diameter volume coil (m2m Imaging, USA) were used to 
acquire T1-weighted gradient echo MR images of cross-sections of both electrode types. The 
acquisition parameters for T1-W MRI were: TE/TR = 7/150 ms, FOV = 30x30 mm2, Matrix 
size = 256x256, Averages = 4, Flip angle = 30°, slice thickness = 0.7 mm. For CT imaging, a 
µCT50 specimen scanner (Scanco Medical, Bruttisellen, Switzerland) was used to scan the 
electrodes at 70 kV, 115 µA, and 10 µm isotropic resolution. 2D images in the axial plane of 
each electrode type were acquired for comparison.  
Magnetic susceptibility measurements 
Magnetic properties of Ti3C2 were measured with Quantum Design EverCool II physical 
property measurement system. A free-standing film of Ti3C2 with a mass of 4.820 mg was 
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packed in a plastic sample container. The sample was heated to 310 K and was allowed to 
reach thermal equilibrium for about 10 min. Magnetization was recorded with respect to the 
applied magnetic field up to 9 T. The measured data was subtracted from that of the plastic 
sample holder and normalized by sample mass.  
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5.8 Supplementary material: MXtrode stability     
Given the promise of MXtrodes for numerous applications, there has already been 
considerable interest in commercializing the technology. One important factor to consider is 
the usable “shelf life” of MXtrodes stored in ambient conditions, given prior knowledge that 
Ti3C2 MXene is prone to oxidation. To assess the stability of MXtrodes in ambient conditions, 
I performed periodic EIS testing of two 10 channel MXtrode arrays stored in air over a period 
of 6 months.  
Methods  
Two, 10 channel planar MXtrode arrays with 3 mm-diameter contacts were 
fabricated for the evaluation. For device 1, EIS was performed in PBS for all 10 channels every 
two weeks. Following EIS, the device was rinsed with DI water, gently dried with a Kim Wipe, 
then baked at 70°C for 1 h. For device 2, EIS was performed in PBS for channels 1-6 every two 
weeks and for channels 7 and 8 at fewer selected time points. Channels 9 and 10 were not 
tested until the final time point. Care was taken not to expose the un-tested channels to PBS 
or to DI water. Following EIS, the channels which were tested were rinsed with DI water and 
gently dried with a Kim Wipe. Device 2 was not baked. Between tests, both devices were 
stored in a foil pouch in ambient conditions.  
Results 
 Bode plots of the impedance magnitude and phase at a few selected time points are 
shown in Figure 5.18 for Device 1 (all channels) and Device 2 (channels 1-6) and plots 
showing the progression of impedance values at 1 kHz and at 10 Hz are shown in Figure 5.19. 
Throughout the course of the study the impedance gradually increased, however the changes 
were most pronounced in the first 6 weeks. The changes were also more pronounced at low 
frequencies. By week 16, the MXtrodes stabilized, and they showed little change in the last 10 
weeks of the study. Accompanying the rise in impedance magnitude, the phase behavior 
dramatically shifted, consistent with the formation of a porous oxide layer on the surface of 
the electrodes. Comparing between the two devices, Device 1 showed faster oxidation and 
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stabilized to a higher overall impedance value compared to Device 2, indicating that the 
baking step following the EIS testing likely contributed to oxidation, as expected.  
 An important concern in the test design is how much the periodic EIS testing 
contributed to accelerating the oxidation and degradation of the devices. Because the 
electrodes are exposed to PBS and DI water during each test, and because moisture is known 
to accelerate Ti3C2 oxidation, the results may not accurately represent the aging conditions of 
a device left in ambient air for a prolonged period, and thus may not give an accurate measure 
of the stable “shelf life” of the devices. To assess the contribution of the periodic EIS testing 
Figure 5.18 EIS spectra for two MXtrode devices over 26 weeks. (a-b) Impedance modulus (a) and 
phase (b) shown at selected time points for Device 1. All 10 channels were tested every 2 weeks and 
Device 1 was baked following each test. (c-d) Impedance modulus (c) and phase (d) shown at selected 
time points for Device 2. Only channels 1-6 were tested every 2 weeks, and no baking was performed 
following EIS testing.  
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to the rate of oxidation, 4 channels on Device 2 were held aside and tested at fewer time 
points: channels 7 and 8 were tested at four time points throughout the study, and channels 
9 and 10 were only tested at the final time point. The results, shown in Figure 5.20, indicate 
that channels 7 and 8 had undergone significantly less oxidation by the final time point than 
the channels which were tested more frequently, suggesting that the EIS testing does 
accelerate the degradation. The behavior of channels 9 and 10, however, do not match 
expectations. These two channels were never exposed to PBS prior to testing at the final time 
point, thus we expected to see significantly less oxidation than any of the other channels, and 
phase behavior similar to that of un-aged MXtrodes at the initial time point. While the 
impedance at 1 kHz was lower than the other channels, the impedance in the low frequency 
regime was higher than expected. Furthermore, the phase behavior of these channels was 
unlike that of the other MXtrodes channels at any time point in the study.  
Figure 5.19 1 kHz and 10 Hz impedance values monitored over 26 weeks. (a) 1 kHz impedance 
values over time for Devices 1 and 2. Device 1 was baked following each test, while Device 2 was not. 
(b) 10 Hz impedance over time for Devices 1 and 2. (c-d) Normalized impedance change from initial 
value at (c) 1 kHz and (d) 10 Hz for each device.  
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 Despite the formation of the oxide layer over the course of the study, even the aged 
MXtrodes that appear to have reached a stable state of oxidation still have low enough 
impedance that they may be able to record biosignals, though likely with reduced signal 
fidelity. Further evaluation will be needed to fully assess the useable shelf life of MXtrodes, 
and to determine an acceptable level of oxidation for functional devices.  
Figure 5.20 Effect of repeated impedance testing on device aging. (a-b) Impedance modulus (a) 
and phase (b) at the final 26 week time point for subsets of channels on Device 2, which were tested 
with varying frequencies. Channels 1-6 were tested every 2 weeks for a total of 13 tests by the final 
time point. Channels 7 and 8 were tested 4 times throughout the study. Channels 9 and 10 were tested 
only at the final time point. (c-d) 1 kHz (c) and 10 Hz (d) impedance values over time for each subset 




Chapter 6: Conclusions and Future Directions 
In this thesis, I have developed neurotechnologies that leverage unique properties of 
carbon nanomaterials to enable recording and modulating neural and neuromuscular activity 
across spatial scales. Starting at the microscale, I showed how transparent graphene 
microelectrodes could be used with simultaneous optical imaging to enable new insights into 
microscale brain dynamics. By optimizing the fabrication and processing of transparent 
graphene electronics, I improved the impedance and optical transparency properties of the 
electrodes beyond what had previously been reported. Still, such graphene-based 
transparent electrodes reach a fundamental limit in how far impedance can be reduced due 
to the quantum capacitance of graphene [144]. Thus, it remains challenging to scale 
transparent graphene electrodes down to the dimensions required for resolving neuronal 
spiking activity (~10s of µm) because their high impedance at these scales significantly 
degrades the recorded signal quality. New materials may soon enable transparent electrodes 
at these scales, however, and Ti3C2 MXene is a very promising candidate. A number of recent 
studies have shown that thin films of Ti3C2 MXene can achieve an optoelectronic figure of 
merit that meets or even exceeds that of CVD-grown graphene [21], [366], [367]. In Chapter 
4 of this thesis, I showed that non-transparent Ti3C2 microelectrodes are highly sensitive for 
recording neural spiking activity. It would be a fairly simple matter to tune the processing 
conditions to fabricate similar Ti3C2 microelectrodes where the MXene films are optically 
transparent, and it seems plausible that such electrodes could achieve lower impedance than 
their graphene counterparts. In the future, Ti3C2 could push the bounds of transparent 
microelectrode density and spatial resolution beyond what is possible with graphene.  
In Chapter 3, I also presented a new approach for combining multimodal data to 
harness the key advantages of electrophysiology and optical imaging, while accounting for 
their differences in temporal and spatial sampling. Such an approach can help elucidate the 
relation between individual cellular activity and network oscillations observed in neurologic 
phenomenon such as epileptogenesis. For example, high frequency oscillations (HFOs) have 
been proposed as a biomarker for identifying the seizure onset zone in epilepsy and for 
predicting epileptogenesis following cerebral insult or prolonged febrile seizures [183]–
[185]. HFOs can also occur in the healthy brain, however, and distinguishing between normal 
and pathologic HFOs has been the subject of some debate [368]. It is now believed that 
 
Chapter 6: Conclusions and Future Directions 
 
 151   
 
different cellular mechanisms give rise to normal and pathologic HFOs, however it has been 
challenging to study this phenomenon because the oscillations are too fast to be detected 
using optical imaging methods alone. The multimodal approach presented in Chapter 3 offers 
the necessary spatiotemporal resolution to begin to answer these questions. By using 
genetically-targeted optical reporter molecules, it may be possible to discern the individual 
contributions of specific neuronal and even glial sub-types to broader network oscillations 
such as HFOs. 
In Chapter 4, I introduced Ti3C2 MXene as a new material for neural microelectrodes. 
I showed that Ti3C2 electrodes offered lower impedance, lower noise, and improved neural 
recording performance compared to gold electrodes. This was the first demonstration of any 
MXene for in vivo electrophysiology, and it identified the tremendous potential of MXenes for 
bioelectronics. Motivated by this success, I then developed a new class of MXene 
bioelectronics suitable for human-scale electrophysiology, with a focus on clinical 
translation. These MXtrodes, which are fast, simple, and low-cost to produce, have excellent 
electrochemical properties, outperforming current state-of-the-art electrode materials. In 
particular, their low electrode-skin interface impedance enables gel-free epidermal 
recording with high spatial resolution, which has been challenging for epidermal electronics.  
Of the epidermal applications shown in Chapter 4, gel-free, high-density EEG with 
MXtrodes is one that has generated significant interest. In current clinical practice, recording 
an EEG requires a certified EEG technician to measure and individually place each gelled EEG 
electrode on the subject’s scalp. This process is time-consuming, thus limiting the ability to 
rapidly obtain EEG in emergency situations, and it is costly to health systems to staff certified 
EEG technicians around-the-clock. The conductive gels used with current EEG electrodes 
leave unwanted residues in the hair, and in patients who require long-term EEG monitoring 
they can cause skin irritation and breakdown as well as impedance fluctuations over time as 
the gels dry out. This often necessitates periodic replacement of the gels, which is again a 
time-consuming process requiring an EEG technician. Given the success of MXtrodes in 
recording high-quality EEG signals without any conductive gel, it’s possible that MXtrodes 
could be incorporated into an EEG cap or headband system that could be deployed rapidly 
without the need for a certified EEG technician. This could significantly improve access to 
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rapid EEG diagnostics in emergency and trauma situations. It could also enable simpler at-
home monitoring for epilepsy patients, if they could put on the cap or headband system 
themselves at home and stream the data to a secure cloud-based platform where a clinician 
could monitor the EEG. More work is certainly needed to develop such a system, particularly 
in ensuring that the gel-free MXtrodes can achieve good scalp contact in subjects with long or 
thick hair, but initial results are promising.  
In addition to clinical EEG applications, high-density EEG enabled by the mm-scale 
dry MXtrodes has also generated significant interest in the research community. High-density 
EEG can be used to study important phenomena in cognitive neuroscience and in sleep 
research, and can also be used as a non-invasive tool for epilepsy source localization [369]. It 
is also of great interest to the BCI community, where enhanced spatial resolution can improve 
decoding accuracy for non-invasive EEG-based BCIs [370]. So far, the spatial resolution of 
EEG has been limited because gelled electrodes can experience bridging when placed too 
close together, and because dry electrodes have so far required scalp contact areas >1 cm2 in 
order to achieve sufficiently low interface impedance. Thus, it is not yet clear what the limit 
of scalp EEG resolution is, in part because there have not been electrodes capable of pushing 
the spatial sampling down to sub-cm scales. MXtrodes could enable studies to begin to 
answer this question. Spatial smearing from the skull and scalp as well as volume conduction 
surely limit the unique information content that can be obtained from closely adjacent scalp 
electrodes. However, techniques such as independent component analysis can help to detect 
subtle differences to leverage high spatial sampling [371].  
Another key advantage of the MXtrodes is their compatibility with clinical imaging 
techniques. In clinical practice, inpatients requiring long-term EEG monitoring are often set 
up with MRI-compatible EEG leads so that they can be disconnected and taken for diagnostic 
imaging without requiring the EEG electrodes to be removed and replaced. Current MRI-
compatible leads are very expensive, however, and MXtrodes may offer a significantly lower-
cost solution. In research, the compatibility of MXtrodes with clinical imaging techniques 
opens new possibilities for multimodal studies combining EEG with imaging. Concurrent 
collection of EEG with fMRI or metabolic imaging such as GluCEST can yield complementary 
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information to enable new insights into brain activity, similar to the advantages of 
multimodal recording described in Chapter 3, albeit on a different scale.   
Beyond epidermal recording applications, the MXtrodes were also found to possess 
exceptional electrochemical properties in saline, suggesting that they could outperform Pt 
and other noble metals in implantable electrodes. This observation matched the results 
shown for the Ti3C2 microelectrodes, which had ~4x lower impedance compared to size-
matched Au electrodes. The MXtrodes have a slightly different morphology than the 
microelectrodes shown in Chapter 4, because the electrode contact is comprised of a MXene-
coated textile composite rather than a pure thin film of Ti3C2. This is strong evidence that the 
unique properties of Ti3C2 are largely responsible for the exceptional electrochemical 
performance of MXene-based electrodes, though the electrode surface morphology and 
roughness certainly play a role.  
One striking finding is that MXtrodes have significantly enhanced CSCc and CICc 
compared to Pt and other common materials used for stimulation electrodes. The use of 
implantable neuromodulation systems to treat neurological conditions is rapidly expanding, 
with deep brain stimulation used to treat the motor symptoms of Parkinson’s disease, vagus 
nerve stimulation used to treat depression and other conditions, and newer responsive 
neuromodulation systems developed for epilepsy seizure control such as the NeuroPace and 
Medtronic RC+S. These systems rely on safe, efficient charge transfer through their 
stimulation electrodes, and the efficiency of charge delivery has a significant effect on the 
battery life of the implanted system. While more work is needed to fully characterize the 
stimulation efficiency and safety of MXene-based electrodes, the results shown in this thesis 
suggest that they could offer more efficient stimulation performance, potentially prolonging 
the battery life of such implanted systems.  
A notable caveat to any notion of using MXene for implantable electrodes is their poor 
oxidation stability in physiologic environments. Further optimization of the synthesis and 
processing conditions will be needed to realize stable MXene compositions for chronic 
bioelectronic applications. Significant progress toward oxidation-resistant MXene 
compositions has been made just in the past two years, however, so there is hope that this 
challenge can be overcome in the future.  
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The ultimate goal of this thesis was to develop new neurotechnologies that could 
expand our capabilities for recording and modulating neural and neuromuscular activity. 
Interfacing manmade electronics with biological tissues presents numerous challenges, and 
it is clear that new materials and fabrication methods can offer solutions to some of these 
challenges. In this work, I’ve shown that the unique properties of graphene and MXene can 
be harnessed to offer new capabilities for high-resolution neural recording and stimulation 
electrodes. Additionally, the fabrication methods developed here represent a significant step 
toward translating nanomaterial-based technologies beyond academic research by 
improving scalability. It is my hope that these technologies will enable future research studies 
aimed at unraveling complex neural dynamics, as well as advances in clinical monitoring and 
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arrays for in vivo neural recording 
Abstract 
Implantable microelectrode technologies have been widely used to elucidate neural 
dynamics at the microscale to gain a deeper understanding of the neural underpinnings of 
brain disease and injury. As electrodes are miniaturized to the scale of individual cells, a 
corresponding rise in the interface impedance limits the quality of recorded signals. 
Additionally, conventional electrode materials are stiff, resulting in a significant mechanical 
mismatch between the electrode and the surrounding brain tissue, which elicits an 
inflammatory response that eventually leads to a degradation of the device performance. To 
address these challenges, we have developed a process to fabricate flexible microelectrodes 
based on Ti3C2 MXene, a recently discovered nanomaterial that possesses remarkably high 
volumetric capacitance, electrical conductivity, surface functionality, and processability in 
aqueous dispersions. Flexible arrays of Ti3C2 MXene microelectrodes have remarkably low 
impedance due to the high conductivity and high specific surface area of the Ti3C2 MXene 
films, and they have proven to be exquisitely sensitive for recording neuronal activity. In this 
protocol, we describe a novel method for micropatterning Ti3C2 MXene into microelectrode 
arrays on flexible polymeric substrates and outline their use for in vivo micro-
electrocorticography recording. This method can easily be extended to create MXene 
electrode arrays of arbitrary size or geometry for a range of other applications in 
bioelectronics and it can also be adapted for use with other conductive inks besides Ti3C2 
MXene. This protocol enables simple and scalable fabrication of microelectrodes from 
solution-based conductive inks, and specifically allows harnessing the unique properties of 
hydrophilic Ti3C2 MXene to overcome many of the barriers that have long hindered the 
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1. Synthesis of Ti3C2 MXene  
NOTE: The reaction procedures described in this section are intended for use inside a 
chemical fume hood. Washing steps included in this procedure are intended to be used with 
balanced centrifuge tubes. All waste produced is considered hazardous waste and should be 
discarded appropriately following University guidelines. 
CAUTION: Hydrofluoric acid (HF) is an extremely dangerous, highly corrosive acid. Consult 
the materials safety data sheets (MSDS) for the chemicals used to synthesize MXenes before 
use and implement and follow appropriate safety measures. Appropriate personal protective 
equipment (PPE) for handling HF includes a laboratory coat, acid resistant apron, close-toed 
shoes, long pants, goggles, full face shield, nitrile gloves, and HF resistant gloves made of butyl 
rubber or neoprene rubber.  
1.1. MAX phase synthesis: The Ti3AlC2 MAX phase precursor used to synthesize MXenes has 
been shown to have direct implications on the resulting Ti3C2 MXene properties[372]. 
The Ti3C2 used to fabricate neural electrodes was selectively etched from MAX prepared 
following a previous procedure.[224] Ti3AlC2 was synthesized by ball milling TiC (2 µm), 
Ti (44 µm), and Al (44 µm) powders at a molar ratio (TiC:Ti:Al) of 2:1:1 for 18 h using 
zirconia balls. Then, the powders were placed in an alumina crucible and heated to 1380 
°C (5 °C heating rate) and held for 2 h under argon. After the powders have been cooled, 
the MAX block was milled and sieved through a 200 mesh sieve (< 74 µm particle size). 
1.2. Etching: Removal of the Al layer in Ti3AlC2 in an acidic etchant solution. Prepare the 
selective etching solution in a 125 mL plastic container by first adding 12 mL deionized 
water (DI H2O) followed by the addition of 24 mL hydrochloric acid (HCl). Wearing all 
appropriate HF etching PPE, add 4 mL of hydrofluoric acid (HF) to the etchant container. 
Perform selective etching by slowly adding 2 g Ti3AlC2 MAX phase to the reaction 
container and stirring with a Teflon magnetic bar for 24 h at 35 °C at 400 rpm.  
1.3. Washing: Bringing the material to neutral pH. Fill (2) 175 mL centrifuge tubes with 
100 mL of deionized water. Split the etching reaction mixture into 175 mL centrifuge 
tubes and wash the material by repeated centrifugation at 3500 rpm (2550 rcf) for 5 
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min. Decant the acidic supernatant into a plastic hazardous waste container. Repeat until 
the pH reaches 6.  
1.4. Intercalation: Insertion of molecules between multilayer MXene particle to waken 
out-of-plane interactions. Add 2 g lithium chloride (LiCl) to 100 mL of DI H2O and stir 
at 200 rpm until dissolved. Mix 100 mL of LiCl/H2O with the Ti3C2/Ti3AlC2 sediment and 
stir the reaction for 12 h at 25 °C. 
1.5. Delamination: Exfoliation from bulk multilayer particle into single- to few- layer 
Ti3C2 MXene. Wash the intercalation reaction in 175 mL centrifuge tubes by 
centrifugation at 3500 rpm for 5 min. Decant the clear supernatant. Repeat until a dark 
supernatant is found. Continue to centrifuge for 1 h at 3500 rpm (2550 rcf). Decant the 
dilute-green supernatant. Re-disperse the swollen sediment with 150 mL of DI H2O (re-
dispersion will become difficult and will require agitation or manual shaking). Transfer 
supernatant to 50 mL centrifuge tubes and centrifuge at 3500 rpm for 10 min to separate 
remaining MAX (sediment) from MXene (supernatant). Collect supernatant as Ti3C2 
MXene. Further size selection and optimization of the solution should be performed to 
isolate single- to few-layer flakes by collecting the supernatant following a 
centrifugation step at 3500 rpm for 1 h.  
1.6. Solution Storage: Packaging the MXene ink for long-term storage. Solutions are 
Argon bubbled for 30 min prior to packaging in an Argon sealed headspace vial (transfer 
via a syringe). Solutions are stored at high concentrations (> 5 mg/mL), away from 
sunlight, and at low temperatures (≤ 5 °C) to ensure longevity.  
 
2. Fabrication of Ti3C2 MXene Microelectrode Arrays 
NOTE: The procedure described in this section is intended for use inside a standard 
university clean room facility, such as the Singh Center for Nanotechnology at the University 
of Pennsylvania. This facility, as well as similar facilities, are accessible to outside users as 
part of the National Nanotechnology Infrastructure Network (NNIN) supported by the 
National Science Foundation (NSF). In these facilities, many of the tools, equipment, and 
materials described in this section are provided along with access to the clean room facility 
and would not require separate purchase.  
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CAUTION: Many of the chemicals used in the fabrication of MXene electrodes are hazardous, 
including photoresists, RD6 developer, remover PG, aluminum etching solution, and buffered 
oxide etchant. Consult the materials safety data sheets (MSDS) for these chemicals before use 
and implement and follow appropriate safety measures at all times.  
2.1. Deposit a 4 μm-thick bottom layer of parylene-C onto a clean Si wafer. (Figure A1a) 
2.2. Use the first photomask (mask-1) to define the metal interconnects of the devices, 
as well as a metal ring around the edge of the wafer to aid in later lift-off steps. 
(Figure A1b) 
2.2.1. Spin coat NR71-3000p onto the wafer at 3000 rpm for 40 s.  
2.2.2.  Soft bake the wafer on a hot plate for 14.5 min at 95 °C. 
2.2.3.  Load the wafer and mask-1 into a mask aligner. Position the wafer so that the ring 
on the photomask overlaps with all edges of the wafer.   
2.2.4.  Expose with i-line (365 nm wavelength) at a dose of 90 mJ/cm2.   
2.2.5.  Hard bake the wafer on a hot plate for 1 min at 115 °C.  
2.2.6.  Immerse the wafer in RD6 developer for 2 min, continuously agitating the 
solution. Rinse thoroughly with DI and blow dry with an N2 gun.  
2.2.7.  Use an electron beam evaporator to deposit 10 nm Ti, followed by 100 nm Au 
onto the wafer. NOTE: Typical deposition parameters are a base pressure of 5 x 10-
7 Torr and a rate of 2 Å/s.  
2.2.8.  Immerse the wafer in remover PG for approximately 10 min until the photoresist 
has dissolved and the excess metal has fully lifted off, leaving Ti/Au only in the 
desired interconnect traces and the ring around the edge of the wafer. Once lift-off 
appears complete, sonicate for 30s to remove any remaining traces of unwanted 
metal. Rinse wafer first in clean remover PG solution, then thoroughly rinse in DI 
H2O and dry the wafer with an N2 gun.  
2.3.   Deposit the sacrificial parylene-C layer. (Figure A1c) 
2.3.1. Expose the wafer to O2 plasma for 30 s to render the underlying parylene-C layer 
hydrophilic. 
2.3.2.  Spin coat 2% Micro-90 in DI H2O solution onto the wafer at 1000 rpm for 30 s. 
This dilute soap solution acts as an anti-adhesive, allowing the sacrificial parylene-
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C layer to be peeled up later in the process. Allow wafer to air dry for at least 5 
mins.  
2.3.3. Deposit 3 μm of parylene-C onto the wafer 
2.4.  Use the second photomask (mask-2) to define the MXene patterns and a ring 
around the edge of the wafer. (Figure A1d) 
2.4.1.  Repeat steps 2.2.1 through 2.2.6, this time using mask-2 and carefully aligning the 
alignment marks between the wafer and photomask before exposure.  
2.4.2.  Use O2 plasma reactive ion etching (RIE) to etch through the sacrificial parylene-
C layer in the areas not covered by the photoresist to define the MXene electrodes 
and traces, which should partially overlap with the Ti/Au interconnects, as well as 
the ring around the edges of the wafer. Confirm complete etching of the sacrificial 
parylene-C layer by using a profilometer to measure the profile between the 
exposed Ti/Au interconnects and the bottom parylene-C layer. When etching is 
complete, the profile across the exposed metal surface will be smooth, while the 
bottom parylene-C layer will be rough and partially etched. NOTE: This etch step 
should be completed in a planar etch RIE system, not a barrel asher, and etch times 
and parameters will be highly dependent on the RIE system.  
2.5. Spin-coat the MXene solution onto the wafer. (Figure A1e) 
2.5.1.  Pipette MXene solution onto each of the desired MXene patterns, then spin the 
wafer at 1000 rpm for 40 s.   
2.5.2.  Dry the wafer on a 120 °C hot plate for 10 mins to remove any residual water from 
the MXene film.  
2.6.  Use an electron beam evaporator to deposit 50 nm SiO2 onto the wafer, to act as a 
protective layer over the MXene patterns for subsequent processing steps. NOTE: 
Typical deposition parameters are a base pressure of 5 x 10-7 Torr and a rate of 2 Å/s.  
2.7. Remove the sacrificial parylene-C layer to pattern the MXene and SiO2 layers. 
(Figure A1f). 
2.7.1. Apply a small drop of DI H2O to the edge of the wafer and use tweezers to peel up 
the sacrificial parylene-C layer, beginning where its edges are defined in the ring 
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around the outside of the wafer. The water will combine with the soap residue 
beneath the sacrificial parylene-C layer to enable this lift-off. 
2.7.2.  Rinse the wafer thoroughly in DI H2O to remove any remaining Micro-90 residue. 
Dry the wafer with an N2 gun, then place on a 120 °C hot plate for 1 h to remove 
any residual water from the patterned MXene films.  
2.8.  Deposit the 4 μm-thick top layer of parylene-C. (Figure A1g) 
2.9. Use the third photomask (mask-3) to define device outline and openings over 
electrodes and Au bonding pads (VIAs) (Figure A1h) 
2.9.1. Repeat steps 2.2.1 through 2.2.6, this time using mask-3 and carefully aligning the 
alignment marks between the wafer and photomask before exposure. 
Figure A1. Schematics of the fabrication procedure for MXene microelectrode arrays. (a) Bottom 
parylene-C layer is deposited on a clean Si wafer. (b) Ti/Au (10 nm/100 nm) conductive traces are 
patterned through photolithography, e-beam deposition, and lift-off. (c) An anti-adhesive layer of 1% 
Micro-90 in DI H2O is applied, followed by deposition of a sacrificial parylene-C layer. (d) The 
sacrificial parylene-C layer is patterned through photolithography and O2 RIE etching. (e) Ti3C2 
MXene is spin-coated onto the wafer, followed by e-beam deposition of 50 nm of SiO2. (f) The sacrificial 
parylene-C layer is lifted off, residues of Micro-90 are rinsed off, and the wafer is baked dry. (g) Top 
parylene-C layer is deposited. (h) An Al etch mask layer is patterned through photolithography, e-beam 
deposition, and lift-off to define VIAs and device outline. (i) Parylene-C over electrode contacts and 
surrounding devices is etched away through O2 RIE. (j) Al etch mask and SiO2 protective layer over 
MXene are etched away through wet etch processes. (k) Finished device is lifted off wafer. 
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2.9.2. Use an electron beam evaporator to deposit 100 nm Al onto the wafer. NOTE: 
Typical deposition parameters are a base pressure of 5 x 10-7 Torr and a rate of 2 
Å/s.  
2.9.3. Immerse the wafer in remover PG for approximately 10 min until the metal has 
fully lifted off, leaving Al covering the devices with openings for the electrodes and 
bonding pads. When lift-off is complete, sonicate for 30s to remove any remaining 
traces of unwanted metal. Rinse wafer first in clean remover PG solution, then 
thoroughly rinse in DI H2O and dry the wafer with an N2 gun.  
2.10. Etch the parylene-C to pattern the device outline and openings over electrodes 
and Au bonding pads (VIAs) (Figure A1i) 
2.10.1. Use O2 plasma RIE to etch through the parylene-C layers surrounding the 
devices, and through the top parylene-C layer covering both the MXene electrode 
contacts and the Au bonding pads. Etching is complete when no parylene-C residue 
remains on the wafer between devices. The SiO2 layer covering the MXene will act 
as an etch-stop layer, preventing the O2 plasma from etching into or damaging the 
MXene electrode contacts.  
2.11. Etch the Al layer covering the devices using a wet chemical etch in Al etchant Type 
A at 50 °C for 10 min, or for 1 min past when all visual traces of Al have been removed.  
2.12. Etch the SiO2 covering the MXene electrodes using a wet chemical etch in 6:1 
buffered oxide etchant (BOE) for 30 s. (Figure A1j) 
2.13. The MXene microelectrode arrays are now complete. They can be released from 
the Si substrate wafer by placing a small drop of DI H2O water at the edge of a device, 
and gently peeling up the device as water is wicked underneath it by capillary action. 
(Figure A1k and Figure A2) 
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3. Adapter Construction and Interfacing  
NOTE: At this point, the thin film microelectrode arrays must be interfaced with an adapter 
to connect to the electrophysiology recording system. In this protocol, we use the Intan 128ch 
Stimulation/Recording Controller with the RHS2000 16-ch stim/record headstage, which 
requires input via a connector compatible with the Omnetics 18-pin connector A79039-001. 
This section uses a printed circuit board (PCB, Figure A3a) with a zero-insertion force (ZIF) 
connector for interfacing with the Au bonding pads on the microelectrode array and 
Omnetics connector A79040-001 for interfacing with the head-stage of the recording system. 
Depending on the data acquisition system, different connectors can be used on the PCB to 
enable interfacing with the electrophysiology headstage. 
3.1. Solder the Omnetics and ZIF connectors to the PCB by applying a thin film of solder 
paste to each of the contact pads on the PCB, placing the parts in their appropriate 
locations, and heating on a hot plate until the solder reflows to form connections (Figure 
A3b). NOTE: Reflow soldering can be done very easily on a hot plate or in a toaster oven 
and does not require the use of a costly reflow oven.  
3.2. Apply two layers of Kapton tape to the back side of the Au bonding pad region of the 
MXene microelectrode array to give the device sufficient thickness to be secured in the 
Figure A2. Photographs and optical microscopy images of MXene microelectrode arrays. (a) 
Photograph of a 3 inch Si wafer containing 14 completed MXene microelectrode arrays. Note the gold 
ring around the outer edge of the wafer, which is helpful for performing step 2.7 effectively.  (b) Optical 
microscope image showing the peeling up of a completed device from the wafer using a small amount 
of DI H2O. (c) Optical microscope image showing the array of MXene microelectrodes. (d) Optical 
microscope image of an individual MXene electrode.  Scale bars, left to right: 1 cm, 3 mm, 500 μm, 20 
μm. 
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ZIF connector. After applying the tape, trim any excess beyond the edges of the parylene-
C device using a razor blade or precision scissors (Figure A3c). 
3.3. Either under an inspection scope or using magnifying glasses, align the MXene 
microelectrode array in the ZIF connector so that the Au bonding pads align with the 
pins inside the ZIF connector, then close the ZIF to form a secure connection (Figure 
A3d,e).  NOTE: The ZIF connector used here is an 18-channel connector, while our 
device has 16 channels. The extra uncontacted channels are easily identified as an open 
circuit by means of impedance testing during recording sessions.  
3.4. Test the electrochemical impedance of the MXene electrodes using a potentiostat to 
ensure successful fabrication and connection to the PCB adapter. Reasonable impedance 
values are given in the Discussion section to aid in troubleshooting.   
 
4. Acute Implantation and Neural Recording 
NOTE: All in vivo procedures conformed to the National Institutes of Health (NIH) Guide for 
the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care 
and Use Committee (IACUC) of the University of Pennsylvania. Rat surgeries were performed 
using sterile instruments and with aseptic technique. Respiratory rate, palpebral reflex, and 
Figure A3. Interfacing the MXene microelectrode array with the adapter board. (a) PCB with pads 
for soldering Omnetics and ZIF connectors. (b) PCB after soldering of Omnetics and ZIF connectors. (c) 
Addition of Kapton layers to back side of Au bonding pads of device, to give sufficient thickness for the 
ZIF connector. Two layers of Kapton are added (top) and then trimmed around the edges (bottom). (d) 
MXene microelectrode array inserted into ZIF connector with proper alignment. (e) Top view of MXene 
microelectrode array connected to adapter board and ready for a recording experiment. Scale bars are 
2 mm. 
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pedal pinch reflex were checked every 10 min to monitor depth of anesthesia. Body 
temperature was maintained with a heating pad.  
4.1. Administer preemptive analgesia (subcutaneous injection of buprenorphine SR, 1.2 
mg/kg). 
4.2. Administer anesthesia (intraperitoneal injection of a mixture of 60 mg/kg ketamine and 
0.25 mg/kg dexdomitor) 
4.3. Secure rat in stereotaxic frame, apply ocular lubricant to the eyes, and clean shaved scalp 
with 10% povidone-iodine. 
4.4. Expose the calvaria with single midline scalp incision and blunt dissection of underlying 
tissue. 
4.5. Place a 00-90 screw into the skull to serve as the ground for recordings. 
4.6. Using a dental drill with a small burr, make a craniotomy at the desired cortical 
recording site. 
4.7. Secure the array connector to a stereotaxic manipulator and position the device over the 
craniotomy. Gently lower until the entire array is in contact with the exposed cortex. 
4.8. Wrap the ground wire around the skull screw. 
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Discussion  
The MXene synthesis and delamination procedure described in this protocol 
(HF/HCl/LiCl) was built from the MILD etching approach which employed a LiF/HCl (in situ 
HF) etchant medium [224]. The MILD approach allows for large Ti3C2 flakes (several µm in 
lateral size) to be spontaneously delaminated during washing once pH ~5-6 has been 
attained. Compared to etching with HF alone, this results in material with higher quality and 
improved material properties, such as electronic conductivity and chemical stability. The 
HF/HCl/LiCl method takes advantage of the MILD synthesis improvements, while 
additionally separating each step (etching, intercalation, and delamination) allowing for 
more user control.  
During step 1.1, the ratio of raw materials (TiC, Al, Ti), temperature, temperature 
ramp rate, and time are critical to achieving the correct MAX phase. Sieving of the MAX phase 
prior to etching will ensure more homogenous etching. Adding the MAX phase to the etchant 
media (step 1.2) must be conducted slowly to prevent overheating and a general rule of 5 min 
per 1 g of MAX is suggested. If overheating becomes a challenge, an ice bath should be 
employed during addition of the Ti3AlC2 MAX phase. When washing the etching reaction to 
neutral pH (step 1.3), each acidic supernatant after centrifugation should be transparent. If 
the supernatant after centrifugation is dark or dilute green, increase the centrifuge time 
and/or speed to sediment material. Because the addition of LiCl to H2O is exothermic, some 
heating will occur (step 1.4). In this procedure, the intercalation time (step 1.4) is 12 h, 
although it can be modified or shortened to as little as 15 minutes. The quality of delamination 
(step 1.5) is specific to the quantity of water used during washing and the degree of agitation. 
The supernatants decanted during this step may be dilute instead of transparent. If 
sedimentation of material becomes a challenge, increasing the centrifuge speed/rcf should 
be used. It is critical to perform separation and size selection by centrifugation (step 1.5) to 
avoid polydisperse samples. Failure to perform this step will result in an ink that has both 
Ti3AlC2 MAX phase contamination and large multilayer Ti3C2 particles. During step 1.6, it is 
important that the headspace volume of the vial is minimized. 
During the fabrication of the MXene microelectrode arrays, there are several critical 
steps which are essential for producing functioning, high-quality electrodes. It is important 
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to design the first photomask such that there is a metal ring patterned around the outer edge 
of the wafer (step 2.2) and the second photomask such that there is a corresponding, slightly 
larger diameter ring which will be etched through the sacrificial parylene-C (step 2.4) layer 
to aid in removing the sacrificial layer. Without this ring, it can be difficult to establish an edge 
to begin peeling up the sacrificial parylene-C layer in step 2.7. During step 2.3, it is critical to 
expose the wafer to O2 plasma to allow the dilute Micro-90 solution to properly wet and 
adhere to the wafer. Failure to perform this step will result in areas of the wafer not 
accumulating a Micro-90 anti-adhesive layer, which renders the removal of the sacrificial 
parylene-C layer in step 2.7 impossible. During the removal of the sacrificial parylene-C layer 
in step 2.7, it is important to be careful to avoid scratching or damaging the bottom parylene-
C layer, as this can lead to the formation of bubbles between the bottom parylene-C and the 
Si wafer, and subsequent delamination. If the sacrificial parylene-C layer does not peel up 
easily, a slightly more concentrated Micro-90 solution (4% in DI) can be used in step 2.3.2, or 
the O2 plasma exposure in step 2.3.1 can be prolonged to improve hydrophilicity of the 
underlying parylene-C layer.  
After the fabrication is completed, properly interfacing the MXene device with the 
connector board is essential. The addition of two layers of Kapton tape in step 3.2 is essential 
to ensure proper thickness for insertion into the ZIF connector, however care should be taken 
to avoid accidental folding or crumpling of the thin parylene-C device while the tape is added, 
as it is not possible to remove the tape without damaging the device. Subsequently, proper 
alignment of the Au bonding pads on the MXene device with pins inside the ZIF connector 
(Figure A3d) is essential for forming a robust connection (step 3.3). At this stage, measuring 
the impedance of the MXene electrodes is helpful for troubleshooting. A 50 μm x 50 μm 
square MXene electrode should have an impedance magnitude near 50 kΩ at a frequency of 
1 kHz in 1x PBS, and a 25 μm diameter circular MXene electrode should have an impedance 
magnitude near 200 kΩ under the same parameters [312]. An impedance significantly larger 
than this can indicate that the electrode is not properly connected in the ZIF connector, or 
that the MXene electrode is not exposed, as may happen if either the top parylene-C layer was 
not completely etched in step 2.10.1 or the SiO2 protective layer was not fully etched in step 
2.12.  
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One limitation of this method is variability in MXene film thickness that is sometimes 
observed after spin-casting MXene onto the wafer. This variability can become more 
pronounced if electrodes are scaled up to larger areas. This limitation can be readily 
overcome by utilizing spray-coating instead of spin-coating to apply MXene to the wafer, 
representing another simple, low-cost solution processing method with which MXene, and 
this protocol, are compatible [307].  
The protocol described here presents exciting new opportunities in neuroscience and 
in the larger field of bioelectronics. While there has long been interest in leveraging carbon-
based nanomaterials for neural microelectrodes, the incorporation of Ti3C2 MXene into such 
electrodes has enabled significantly simpler and more high-throughput fabrication than has 
been possible with other carbon-based nanomaterials. Furthermore, the outstanding 
properties of Ti3C2 MXene endow the electrodes with remarkably low impedance for their 
size, thus improving sensitivity and signal quality. A growing body of literature also describes 
a number of methods for micropatterning MXene, which may be adapted for fabricating 
MXene microelectrodes in the future, including micro-contact printing [263], inkjet printing 
[274], [278], and automated scalpel engraving [276]. There exists great potential to extend 
this protocol to fabricate Ti3C2 MXene electrodes of arbitrary size and geometry for a range 
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